var title_f10_21_10576="Apply pin to foreskin2";
var content_f10_21_10576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Apply pin to foreskin 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David G Weismiller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10576=[""].join("\n");
var outline_f10_21_10576=null;
var title_f10_21_10577="CT scan showing ureteral stone";
var content_f10_21_10577=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F69052&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F69052&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan showing ureteral stone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows a calculus in the proximal left ureter causing delayed excretion of contrast material from the left kidney (long arrow). All the contrast has been excreted from the normal functioning right kidney and is in the nondilated right ureter (small arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10577=[""].join("\n");
var outline_f10_21_10577=null;
var title_f10_21_10578="Front view knee PI";
var content_f10_21_10578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F77293&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F77293&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 513px\">",
"   <div class=\"ttl\">",
"    Front view of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 493px; height: 506px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAH6Ae0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKTcKAFopu4UbqV0Ow6imbxRvHrS5kFmPoqPzB60eaPWjnQWZJRUfmj1FKJBQpJhZj6Kb5i0oIPencQtFFFMAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACgnAJoqlrdwbXSLycHBjiZh+VKT5U2NK7sPkuUTlmAqnJqcY+6Qa8+i1ea4JLOT+NXradm6mvErZk9onoQwfc606nk8U1tQY96xoCSKnUVy/XKkupp7CCNJbtm71Ks7GqMQqwtbQqze7M5QiiV7hhVV7tgafKOKozDk1nWqzWzKpwiyV9QZagfWmTqaqXHSsW/YgGsIYuonub+wizoF8TorYYitiw1mG5xhhmvGdTuXRzgmptE1iWOZRvPX1rup46S3MZ4VPY96ikDgYOakrkvDmr+c0SM3UgV1terh66rRujgq03TdmFFFFdBkFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWN4zbZ4W1M/8ATE1s1zvxBlEXhHUM9WCp+bCsq7tTk/Jl0tZr1PMNLORXQWfGK5/Sa6G1HIr5KR7xs2/QVbQVTg4Aq5HV0tTGZPGKnUVHEKsKtd9OJzSZFIOKpTDmtFxxVKYVFeOg6bM6ccVh6ivBrfmHBrG1BflNed1OyJwusr87Vl2LlZh9a29ZT5jXPx/LN+NdEdgPSPDs5URsD90g16yDkAjoea8V8NzZQCvYdLk87Trd/VBn616OVStOcPQ4cdHSLLVFFFe2ecFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXI/FJ9vhNxn700Y/XP8ASuurh/i3Jt0C0j7vdL+itXPinajL0NqCvUicRo6/LmuitB0rE0pf3YrftF4FfKTPbNCLoKuRVUjHSrUVVSMpl6GrSjiq0FWl6V61FaHFPcZJ0qjP3q/J0qlMOTUYhDpMz5RWXerkGteUVn3S5BrypaM7os4vWIuvFcrMu2XpXeanDkGuQvodsh4rWDKZq+HJ9rgE17F4SuBLpmzPzRsR+B5/xrw/Sm8uUV6f4MvhHdIrH5JRsP17V04Sr7Kum9noYYmHPTfkd5RRRX0p4wUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFee/F5sxaRF/eldvyA/xr0KvNfiy+7U9HiHZZG/VR/SuTHO1CX9dTowqvVRlaZHiJa3bdcKKyNNX92K2oRwK+VkeyWI6sxdarxirMQrSkjKbLsFXE6VThq0hr1qLsjhqCyDiqUw5q454qs/JorajhoUZV61RnXIrVkXNU504NeZVhY64SOevosg8Vyup2+CeK7e4j61h6hbAg8VnF2Njko8o4rq9CujhcHBHSueuoSjGrOlTFJBzVyV0B7np1yLuyimHVhz7HvVmuS8G343NbM3Djcn17/p/Kutr6XB1/b0lLr19Txa9P2c2gooorqMQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK5iwmSFbTUmfdLcsRcHd0Vj8px2CnaPoTXT0AFFFFABXl3xIfzvFdrGP+WNsM/Usf8AAV6jXkPiKYXni/UJByEcRD/gIA/nmvOzOXLRt3Z14KN6l+xcsFworViHArPsxgCtJOgr5pnrE0dW4hVSOrsNdFHcwqFqMVMDUSCpegr04aI5HuNc1A5qR2qBjWdSRUUJmoZVyKkzR1rnlqarQy7iPk1lXceQeK6CeMEVmXMfBrknHlZvCVzz3WP7YW4kFvYae8IPyu966sR7qIiB+ZrKS51uN/8AkH6b/wCBz/8Axmu7v4cg1zt3EVY4rWM1a1vz/wAymn3Lui6t4iikjeHTdJLIQRnUpB/7Qr0m01TxbdW6TRaHoBRhnnWps/8ApLXmGlXJSQA16X4O1IBjbSN8snKezen4124DEKlU5GrJ/mcmKo80OZbotfbPGP8A0AvD/wD4Opv/AJEo+2eMf+gF4f8A/B1N/wDIldLRX0B5ZnaNNq8qy/21Y2FowI8sWl49wGHfO6KPHb1/CvIvAl3rrJ4s154bzVl0zU9QWFW1y6DHywSkK2uDEy5IAJORngZAB9uooA8CX4xeIx4S1nVTaaG8trb208SrLGWR3mRHjkhS4eQYD8MdnI5UHitm4+JHiKx1m4trmPSJ4LTxBb6NKY7aSNpI5hneuZSFZcd9wOe3f2SigDw+2+LusS3mlWbQaULua61OC7g2PvhFum6L5d+VLc5z1xxiu9+FOueIPEvheDWPEUWlRJeIktqlj5mQuOd+/ODnoATx3rs6KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm9AjF1oMcDgN5YkhkDdD8xAB/DBrT0ieQIbO7P8ApUAxyeXTs39D71z2iagljqt9BNxbmSTcf7pDkZ+nNbdxa+eiSNKYihJglQfOo/qPagDXorHstWYMsd8gUFtiXCD927eh/un68e9bFAEN5cJaWk1xKcRxIXY+wGa8X0wtPK87j55XLn6k5/rXffE3UPs+hrZRn97ePs/4AOW/oPxrjNMh2RrXhZrVvJQXQ9PAwtFy7mxaDmtFelUbUVfUV4r3O1ksY5q7AKqxirsIxXXQjqc9RlhOBQ7YozgVVmk612znyowjG7CSSoWlqtLPjvVZrgetcM6rZ0xpmh5gpwkrKN0Kel0CetQqjK5DRZs1VnjzSpIGFSdRT5uYVuUxbuDOeK5/ULbk8V2k8OQaxL+368UuVxLjK5xxUxyZFdDo92Rt+Ygis67t8E8VHaP5MmKHqij2TQdRF/agOw89Bhh6+9aleaaLqDQSJLE2HX9fY16JZXUd5brNEeD1HofSvfy/F+2jyT+JfieViqHs3zLZk9FFFeicgUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBwTRD+39TibqxlA/EKwq/wDa7m2ki2ESxi3Eio2eM9cGq2rBoPGDE/dl8tvwKlD/ACqw3CWZPJ8l4/yNAGbeeIkk0+aJbRwWdo23sCu5hj+oNdto9wbrSbK4JyZYUcn3IGa8l1MlDfr2WVXx+AP9K7KLVxpngFJUb9+oa3iH+1uIH5Dn8Kmc1CLk+hUYuTSRzHi6+Gq+KJth3QWo8hPTI+8fz/lT7ZcKKzNLg2Jk8k9zWzbjkV8lWqOpNyfU92EVCKii9bLgCriCoIRxU6GsFuDLMdWkOBVSM1MGwK7KcrGElclkk4qhcy4BqSR6zL2bAPNZ1al9CoQsVrm4561Te4PrUczls4qKMbmFZWNx5uCZSnORUkczA81GkBNyzdutTiLDDNIC9aznvWnE+a5iBnXUCMnBOMVuwvxRexLVy8TkVSuogwNWFalYZFbKSkjO1jlr63xnisK6XY2RXZ30GVPFczqEOCeKWxoncbpl2VIBNdr4f1U2swJOYm4cf1rzkZjfNbem3mCATQpSpyU4boJRU1ys9lRldFdCCrDII70tcp4Y1UIRbzP+7b7hP8J9Poa6uvp8LiI4iHMt+p4tak6UuVhRRRXQZBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAch4xXytXs7j1ib/x1lP9TUl0u23Ru0dyy/g3/wCun+PE/wBDtJMf8tWjJ/3kb+oFRIfP0eU/xGOOb8cYP8qAOS1m3/0+8iI/1kSkfgSKzPtU1xb29k+PKiPnD3ZgAf5H866TxBgXlrIP+WiMv6Aj+tYFvEPtP0LL+AIYf+hGuPHpuhKx0YV2qouQJtUAVdgHNQqvFTx8da+XZ7JoQ9KlBxWc12FIVAWY9hTxHey8hAg/2jipUWJmisg9af5lZrWd1jIkTNML3UH+tiJX1Xmru0TZM0JXwKxb2XJNXBcpMnB5rMuyFPzHBPQVKKSsVJ2JhcD1FLYA8gjpSqu4MPXirFumw5xyaroMtpjPI5p5UU0Lg5qO9leOBfLO1mbBPtUgO8tVk345qzE1U7R2eNt5yQcZNToeaGI0I2qwnNUoWq3GaIuzE0JPHuU1z+o2/J4rpyMrWdfQ5GcV0PVERdmcbc2+CagiLRuK3bqDk8VlTxbSeKhM1NXT7voCa9E8N6mLy3EUjZmjHf8AiHrXkkLlGre0vUHgkR43KupyDW2GrvDVOdbdTGtSVWNj1aiqGkalHqNuGXCyr99PT3HtV+vp6dSNSKlF3TPGlFxdmFFFFWSFFZWv+INP0KOI30pM852wW0SmSadv7qIOWP6Dviue+Kt7q3/CvbuLQtPvJdV1JUs44kjLtB5vDM+3IUKu7LZwDjmgDtqK+e9AtvG/gXQNQ8MadZXqvBqVtNa3VnbtdxG3lP75FdowDtPJ+UEZPbmpfEtt4v1NrJtVbXJYdF8WkRXUGnIZjaBflnCLEQ+3nBVCpycg8YAPf6K8XTXPiIfF9zFL50FhHeSRxRPYSyJNbbfkdWS2IEh6kvKozwUWodJTx1c6X4L1LxC8mpXdzqsLTW02ixo+nxhZAzMdhKZOw78KR260Ae3UV4ZB4g+JJt5GEGqPfHT9QkvYJNMVYrOdFb7MLZ/L/fFiFGN0mc16X8OItfXwtaz+K9Sa+1G6RLgq9mts1sGjXMJUdSG3ZJAOT0GMUAdRRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGN4viEmg3DYyYiso/4CwJ/TNZeiYe3ii/2JID+ByP0rptQg+1WFzAf+WsbJ+YxXIeGpt0Ic/eRo5T+I2t/KgChrSbrO3k7xSDPtg4NYMi+VdK54AcE/jlT/MV1mr2xMeowEchiy/jXL3KfaIU7eahXPoSOP8Ax4CoqQVSDg+pUJcslLsXelRb2eURpyxOBUaz+ZZxzf31Bx71o6Lb/Kbh/vHha+P5bOzPevpdF2ztktE4+aU9WqYknvSqueamWOizkQ3Yr4PrSh2FWfKqN4qHTaBSTKV1aRXA3AbJPUVhahBIjKsowRnB7GukZSDUcsaTIUkGQaSfcpaHPIMVPFw4zjnmkvrSS1O4EvEe/pVUEm5V/YU7FGsaguF8yPb3ByKhupWFo20kHIGR6U+zYtD8xJIJHNTbqBPEoCEAYzzTc4OKd7imSttikcDJC5FADb3c1su3OAwJHtWjpzN9nUOeQSOfSs2zlMsXzgZ6GtCFsAUPsJmpG2RTJ0yppkD1MxBWtovQya1MO7i5NY95GADXRXi9aw74YBqOprHYyduGqzGCMEVAPvVaj+7VMZr6RqEltMjxttda9D0vUItQg3JxIPvp6f8A1q8nV9jU6Pxb/Z9+LbS4pL/VAAfs8JACA95HPCD68nsDXVg8TOhKy1i9/wDM5sRRjUV+p7BcTxW0Ek9zKkMMalnkkYKqgdSSeAK5T+3dT8R5j8JRLBYHrrN3GTGw/wCmEfBk/wB44TuC3SoNH0V/EJS/8WXKX80bBk06MEWduR0Ow8yN/tP+CrXbDjpX0kJxnFSi7pnkSi4uzMXQPDdjo0styhlu9SnAE9/dNvnlx2J6KvoqgKOwqzr+tad4f0yTUNYuktrSMgF2BJJJwFVQCWJ7AAk1o1i+LvDdj4p0g6fqJmRFkSeKWB9skMinKupwRke4I9qoRk6t8SfC2ji0/te/uLBrvd5KXVhcRO+0gH5WjBHJHUc9qsW3j/wzcy2EcOqKWvpZ4LfdDIoZ4BmUElQFCjucA9s0sPg+H/hIdK1u+1XUr/UdOjmiikn8lQyyYyGEcajjHGMe+axLX4TaFBqNpcG71OWC0nup4bSSSPylNwu2VchA5Ujplsj1oAu3nxG0b+y0v9NlM1s9xHAtxc291BBJvfZ+7lELBznpt49SBzV+/wDHGi2OpNp1zJexX5ExiilsLiMXBiUs4iYx7ZDgcbCc5GM5FZQ+GlidAt9El1nWZdJtZopra2doMQeW+9VDCLcR2+Yniq9r8JtCt/FKa99q1GW8W6kuwJWibLOpUqX8vzGXB4Bc4xx3yAO8MfFPRtV8KabrGpR3OnTXpkVLQW807sUyWMe2PMihRksoIHQnir/jXxiunfDO+8VeHJLW9VIFntnkDGNwWA5AIPc8ZHNZB+D2gNpGmadLdX80WlvI1k06W8xgWTlo9rxFXUnn51Yg9CK6K+8F6de+BJfCkssyadJH5TPBHDC4G/dkKiCMc+iD8+aAKafEDSraTUl1e4t7cWU8FriATTSPLKm5U2CIfMewQv7kdKsxePvD82lTalBNfzWcM0kEzxaZdOYXjALh1EeUxnqwA6+hrD8SfDW2uDd32lGeTVZr+21CN5btYBBLAmxWRvJk7dVZWBPpWTo/wciuNEjh8UajNLffb7q/kFsY5IWafAIZZYyrEBchtikEkjHFAHVXPxN8I2yB5NWLR/Zo7wvHazSKsLttV2ZUIUZ45xg9cVYHxB8M/Z7+ZtSKCxmjgnR7eVZA8gzGqoV3PuHK7QcjkZrBj+D2gR6ZdWIvNV8q401NLYmWPcIkk8wEfJ97PfpjtVjVfhR4e1Q6ubx72RtSktZWJZCInt4zGjIChHKk5DBgc9KANA/EnwqFtyNRmd53njSJLKdpQ0ABlVowm5SoIJDAGqdt8S9MvfGOj6Np0E93Z6nZfbIb+KKUr97aF2hOnqxICng4NGn/AAw0ayvNMuY7i58zT2umiEUFtbo3nxLG+5YYUBIVRg4z6kjAEmi/DbS9EudAuNNvtTim0e3a0jYvG3nws+8pICmOueV2n3oA7iiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvPNAuILjVLuKzkElvK88SOvQ4bI/rWz8RtVfT/AA/LDbNturoGJCDyq/xH8uPxrzb4bzmyt2iJ+a1ulf8A4CeD/OsPbr2vsl2NfZP2fOen6gu+a3mPS4h2t/vDn/GuJdDEJo8cxOcfnuFdzOM2PJz9ln5/3Sf8DXK6vD5Orvn7siZ/EH/A1uZGMuFlkt05UPuX/dbkfzNdXCgjhRB0AxXOwQj7bat/tNC34fMv6ZrpR1FfMZhT9nWl56/eexh581NeRNEuatRpxUEIq6lKjBMmoxNgpjxjFT01q6HFGabKM0dVGGDWlKOKoyjmuCtCx0U5XISAylWGQexrJvdOKZkthkd09PpWsaAcVgnY2OZ8wMhRuM8GrETbVGDWne6fFdAlfkl/vD+tYs9vc2n+uQlP7y8ir3HcsT3BjKBQDkEnNTFgeOxrNS4UkZIJHrVqOUNSaAsQRhBhatJwKqxSDPWlE7/bSn/LPH9OtIDRifBq0H4rPRuaso2RQnYlojueaxdQTg1tTGsu+wEYkgAckmmmNGCww1LeX9pptt517MsSE7VHJZz2VVHLH2GTWNNq0+ozNF4eiSdQSrXsmfIT1245kPsvHqwrX0PQYbWYXdy73uokYNzPgsoPUIOiD2H45rdxUdZ/d/Wwua/wmVJHqms8yebpWnn+AEfaZR7npGPplvda19HtrfS4BBZwpDEDnC9yepJ6kn1PNad3Hhc1mFsPUufMrLYFG2p2Oiag8LrJGeR1HqPSu8glWeFJYzlWGRXk+lS4bGeK7zwzdZ327Hr86/1Fd2WYh06nsns/zOTGUuaPOt0dBRRRX0J5YUUVheNfE1n4Q8PT6xqMNzNbxOiFLdVLkuwUYDEDqR3oA3aK5TS/Hmj3T6tHqTPok+lSRx3kepyRR+UZF3J86uyEMOmGrTufFHh+10+2v7rXNKhsbnPkXEl3GscuOu1icN+FAGxRXJ6V8QfDup+I9X0W3v4VuNNjSV5Xmj8qZWTeTGQxLBR944GK0U8XeG3sxeJ4g0hrQyiETC9jKGQgkJu3Y3YBOOvFAG3RWBbeLdHmfUma9tIrOxSGR7x7yAwskq7kYFXJUEYwXC5zlcjmpX8WeHY7OC7k1/SFtZ93lTNeRhJNoy21s4OO+OlAG1RSI6yIrowZGGQwOQR6iloAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKqarM1vpl1Kn31jYr9ccfrSk+VNsaV3Y8z8U3Z1bxDMQcwwfuk/DqfxOa53RomtvFFxanhbqE4+o5FbmmwguS3Unms7xN/xLta0y/TgLIAx9jXzmGrN4hTfVnr1qa9lyLoekaXILuEo3S7thn/AHl4Nc/4hUva29yfvRNh/wD0E1paJP5TEZ/1E/8A44//AOunaxbBjf2rD5W+dfow/wAa+kPHOXDlXlwMsFEy/wC8nX9K6KNg6q6nKsAR9DXMLJs+zzNyUYBvoeDW5pb/ALgxE5MLGP8ADt+hFeNm9O8Y1F00O7BS1cTXgq2pqjA3NW1biuCi9DomtSXNIxpu6ms1bORmkMkNVJamkeq7muSrK5vBWIjSUGiuQ3CnbuMHkU3NJkUXCxWudOtLgktHtY914qqNFVT+7nYD0IrTzSjrVc7CxmDSZh92VT+FOXTblTkFSa146sKBitoK5nKTRheXcRffiJHtUiXK9G+U1palfWml2Ul3qNxFbW0Y+aSVgo9h7n0HU1y9wNU8TH/QoZNG0w/8vU0eLqYf7EZ/1Y/2nGf9kdat0Lq/QSq9B2t6/a2Ey2sayXmoyDMdnbANIR6nsq/7TECsSTR7zWCJPEkqGHOV063Y+SP+ujcGQ+3C+x61t2Oj23h9HhtItokbc8rEs8rersclj9TUkjjOajmUNIff/WxaV9yoLdUVURQqKMAAYAA7CrUC4FRs4oSUDvUFklyMoawrgbZDW47gqeawdXnitkaWeRIox1Z2CgfiacOwMuWMwVxXX6LceVcwSdgwz9DxXlNt4hjnkA0u2udQbs0K7Y/+/jYU/gTXTWUXiDUIf319baVCR920Tzpf+/jjaP8Avg/WtHCUJKT0t/XqRJqStueyXl3b2Vu9xezxW8CDLSSuEVR7k8CubHjW0vW2eHbHUNcJ4EtnFtt/r50hWMj/AHSx9qdpngzRUeC8vbeTVL4AMLnUpWuXUkdVD5VP+AgV1A46V9andXPCehzMcHirUXVrq6sNFt85MVov2qYj/ro4CL7jY319T4jeFf8AhM/ClxopvDZCaSJ/OEe/Gxw2Mbh1xjOeK6auU+JniO98LeFZdS061jnmEscTPKGMVurHBlkC8lV6nBH1FMRm6v8ADTTpBYzaHKbDUbTUU1IXFz5l558qgr+93vvcYPHzgjtisOT4QyJptvFZa4ltqEctxcHUY7eZJ45Jj8/kmOdAi4GNrBx37ml1Dxt4kl8QeH9G8Maj4U1qTUoriR71UkSAeXt4GyWTnBOeTzjpWZpnxa1i51bRbBrPTpby4vdRt7u0hVxMggTdEAC5Ks3PUHPYCgZu6l8K31CXxIs+vSvba9Z2ttd77fM3mW6BUkEgcDkjLKVOckZFUV+DUMq2w1C/s7grqNpfXJNrPJ9rWBXTy5POuJBgq+MjAAGMEYxlXfxD1DUPBdpqc2paLJey3tskmlWjTwXFlum2lZWScMSBxgqoJ6girEvxS1O68dDQNMazmtri5urEO9mYZreREJQ7ftBdxkckxx7sHafQA3dW+FNvd6lq13Z6glkLm50+6tII7QeVbNaIUVWQMA6EH7o24wKgh+EFrLq9jf6tfQahs1K61K7tpbIGC4eZFXaqM7BFXaDzuJriPDPxK8QaR8PfDQN3aaldXUlxFc3l4QzWTISVinaS4Qb2zwWZMLjAY9ex+IerXOu/s8anqV/FbQ3VxZq0qWs6TxBhKAdroWUjjPBPpQB6wiLGioihUUYCgYAHoKWvEr3x7qeh6hrsVrFapHHqun2Bu7yWaSC1jlh3NLIpkwqg9k2Dnnmq7fF/VF0B52m0v+0DqV5ZW7JZE29wkKqVO97lFQnd/eYnIAUnqCPdaK8Fl+MHiKbSrnULS00mJLbRINVeOWGRy7PN5bIGEgwO4ODj3rQ1T4p+IdNg8TI2n2N1PplzYxpPDEyxxRXMZcvIrSc7MBc70BJBO0UAe1UV4nYfE3xPf3WiWUSeH0mvpNRUzxst0hW3hSWNsQ3DBCdxDKXYjg9MZr+G/Get65478Eaje6nbabY6tpTlrRg/kSzCXayKDIAZD/CeSoOMN1oA90ooooAKKKKACiiigAooooAKKKKACiiigAooooAKwvGs3laE6g/NLLHGPf5gT+gNbtch42k8/UtLsAerGVh9fkX/ANCb8qGrgUdRsUgjWdCBhFyoHc1yvi+A3ujSBfvp8y16KiRzpe+cAY2fyFHTOP8A6+Pyrz2e5Zp54JkCkMRgdMV4GYYf2M1Uhsz1MJU9pFxlujU8L3Zu7a2kB5ubbyz/AL611d44ntrG5x/rF8pz6E9P1FeceDbnyTd2p4aynEy/7pPNeiKpmsry3X+EieP6Hn+de5Sn7SCl3PNnHlk4nHXVuEu7q3cYDHcPof8A69T6TP8A6RHk/wCvj2n/AH04/l/Kp9dXL290oxvG1vY//rrLSURl37xMLlfp0cflmssVS9rRlAujPkmpHVI2KsLLx1qirg8g8U7zMV8pGbiew43LplqN5aqNNioHuPeqdRsSgXGk96ieUDqaoSXQHeqFzfcHBqHdlpGpLdoneqMuojPBrJaSSZuM1PDZu/Jo5Uii6t/nvTvtx9aalgQKRrEijQCdL4etXIblXxzWM9s69Kz9R1m30gxpOzvcSf6q3hXfLL/uqO3v0HcihQ5tEJtLc7RHHasS58TPcXMlj4bt11G8Q7ZJixW2tz/tyAHLD+4uT67etYcVrqOvDOuSmz08j/kH20nzP/11kHJ/3VwPUsK6qyEFpbx29pFHDBGNqRxqFVR6ADpWiap76v8AAzcXLyGaX4ejF5HqOtXDapqicpJIu2KA/wDTGPkJ/vcse7V0D4IqlFOPWkvdRtbG2ae+uYbaBeskzhFH1J4rX23PuZ8nKF5EssbIwyDXK3BkgmMUv4H1qxJ4sjveNB06+1XPSWOPyoP+/smAR/u7qo3ul6/q6Zv7200yMciKyTzpB9ZXAH5J+NZuFn72n9feaxlpoRXl3DawtLczRwxL1eRgqj8TWG/iNZv+QTaXWoHs8a7Iv+/j4BH+7mpoPD9lZ3e66gNzdp0nunMzj3Utnb+GK0pVBp+4vMr3n5GOv9u3w/0i9t9NiP8ABar5smP+ujjaPwT8aryaFp8comkje7uR/wAtrtzM4+m7hfwxWwVI6VBLnFVzvpoLlXUhtpdr811GnXQ8vANcdysnvmup0a0aJEnuxthK71H97DAUKlKq+WISmoK7PYYceSmOm0U+qulv5mmWjjo0KH9BVqvq1ojwQooopgFFFFABRRRQAUUUUAU9V06HVLQ21y90kZYNm2upbd+P9uNlbHtmofD+h6d4e05bDR7YW9sHaQruZ2ZmOSzMxLMSe5JNaVFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXBXEwu/G1zKTmO1IQfRF3H/AMeb9K72vNtDP2mXVJ058wyYPr5jn+mKALHivUjo3hRJj/r/ACXuMerucKPzb9K4TSoZEtojMxaUjc7E9Setdr8Q7IaklxAv3bZUb2wuDj82FcbF5y8BeK8XNJtyjA9LAxXK5EdnJ9i8YQZ4hvUMD/U9K9I8O3RKWxm6gtbSf0/lXmWuLttVnB/ewsJAR2wa7vQZlunlCN8l3Es8Z/2h1rpy2pzUuXsYYyHLO/cvataBorq1IwyHcv0PQ1ybYDxyH7ucN9Dwwrv74iWG1vMY3L5Unse361xV9AIry4t3HDZZfoeteichY024YW3lOf3kJMbfh0P5Yq0ZvesOKURtHKx5ceRJ/vL90/iKmkugOhr5XG0PZVmls9T2sPP2lNM0ZJ/eqFxd7c881TluiehqsSXNc6ibk73LM1CI0h9aW3tixHFa9padOKG0gG2FmOCRVy+u7XSrRp7twiDoByzH0A7mmajfwaTbCSY5ZuEjHVj/AJ71laNoF3rt8NR1ZcgnEUZ4UD0Hoa6sJgpYl8z0ic1fEKlotzOg17WNalkOlQx2tsh6uNzn6g9Kmmvdf0yB7nUGgNug3MZFCgAdy3GK3tbvbLzjpmiWj6jrVuOHtiE+xn/pvJgqF/2Tlj2U9aj0vw9NPrED+OZ0vLjdvtgnFmMdPLTu4/vPlh/DiveWCoJcvKjzniKjd7nL2vim78QyR2unRLpcbj5r65QsG9oUIGc/3mwPQNW3Y+HbTShI8CvLdSf625nbfLL/ALzensMAdgK6Xxnpa3GmtJp2ni42kKoWRI/x3Meg74yfQda4Kyg8Qyzrp2saiumRMP3a2kYeRv8AZ8yQdPfYDXnYvAckealouqOqhieZ2nual9eW+mwtPeXEVvCvV5XCqPxNZ0XioXJxo9heah6ShPKh+u98ZH+6Gq6vhTTLWYXH2c3N2P8Al4unM8g+jOSR9BgU6ZWRq8pOHTX+v66nd7z8iKOPXr//AI+9Rg02I/8ALKxTzJP+/sgx+SD61cstB0q3uFuJLb7XdjkXF45nkB9mcnb9BgVDFcEdasLPnvSc5bLQORdTdWcHvTt4I61iCcjvUqXJ9aycShdbsxPCWXiReVNc0kxIKt94V1ok3riuU1mH7PfkgYV+RWkOwArgnBqCU5fGOKj8zDZpXlDD3q7CKcBMniPS7YdJbhSw/wBkcn9BXoPiNFt9LIAwVhRR7Fmyf5VxHhmA3PjWMjlba2dz7FsIP/Qq6DxT4q8Ozal9lGv6QF+1rE+byMbQowSfm45Jr38uppUubqzy8ZJudj1fSojBplnEeqQop/BRVquaHj3wd/0Nfh//AMGMP/xVH/CfeDv+hs8P/wDgyh/+Kr0DjOlormv+E+8Hf9DZ4f8A/BlD/wDFVNZ+NPC17dRW1n4l0S4uZWCRxRX8Tu7HoAA2SfagDforhfjXrmqeHvh5fahoV0LTUElgSOUxq+3dKqnhgR0J7Vwun/ETxba+MoB4os5rDS7bSrmWeyEC+Zcy26ZkmUlc7WbIXBAwM+9AHulFeQxfGO5/saTULjwnfxRyrbmzkJlWCdpWChDLJEgBGQSVDg9ietZPh3xhq9n4jv4tVurotceLBp5hivBJDAhi3FA0kRJjBHRRGfcdKAPdKK8Z1P4rNqtlrmm2tqsJl0a+urLU7G4mZGMSOCVZ4Y+QR95CwBGM5rpP+Ewbw18JfDes3kU2o3dzZ2UQDy7TJNJGvzSSNnAzkljn8aAPQqK8+8Q+O9V0S+t9Mm0Oxk1aSzuL90XUmECwxDJxIYQWc/3dgA7mvL/GHjjUdVsfFmraRqGp2FvJoum3VtEtw6GBnuFDFcHAJGQSOooA+kaK8y1X4pfY/F8OiW2nWt7HNf8A9mi5hupsRTkcJITBsU56hXZgOcVzfhL4r6zb+BPDd1rdiNW1XWLm4ht5ImcbxG7ZLpFAxUjgBUV9wGTjmgD3GivL7b4natd6xoumW/g27S8vrL7bcQ3d0LZ7RFmMblldRkADcOhII471k6n8Vm1Wy1zTbW1WEy6NfXVlqdjcTMjGJHBKs8MfII+8hYAjGc0AezUVg+AJ5rrwJ4buLmWSaeXTbaSSSRizOxiUliTySTzmt6gAooooAKKKKACiiigAooooAKKKKACiiigCprFx9l0m9uB1igdx+Ck1w/gyEpptsp6yTop+i4z/AOg10/jiXyvCmpH+9Hs/76IX+tYPhobF00fwqkk7f5/GgCn4ink/4mssalg7hDjspYD/ANp1y2Lmb5YYXA9cV6H4ZhS5t9Re6+44TJ9OC2f/AB6udg1iyuSQC8Sk/I0q7Qw7HPSvEzOjUc/aRV1b7j0cHVgo8j0ZjSaQPsUv2lgXKnCjsaz/AANqrLZRo5Pm6dcGNv8AcbpXWXNvvGV5Brg4I10jxpNDIMW+oR7D7N2NYZZW5avK+prjIc0L9j2a02XSXVk33ZU8xD9f/r1y3iKBvIiusHfCcOB3HRqveHb1zZ207n95bSGKX/d6f4GtTWLVftUkZH7q4Xcv+93r6I8k89nRS0kRb5ZwArejDlWqgkryJlgQ3Rh6EdRWjd2rRGW3bO6I5Q/7J6fkaijjWW8jcDC3A59pB1H4jn8K87MaPPT51uvyOvB1OWfK9mQRRMxrStbQnGRWhbaeBgkVeKw2qbpWVF9WOK+dcr6I9a9iC2tAo5FJqd+unQ4ij8+6b7kKnBPuT2HvVmCO+1JgmnReVD3uJV/9BU/zNSX2jx6ZLboCZZZpAWkbksc16WEyydR81bRduv8AwDir4tR0hqzD8Maauuyrqepy74pG2bMf6og42kdq9FitYkhfTLhSYJUKq6sVLL6ZHII9RzXCeFnW11mZHGLO/mlQDPBYEkEfhXf2itPbSW8p/fwNhW7+xr34xUVaOx5jbbuytYaPa6RaxWml28NrHFny1jUBW9d3qT3PeorqGCe2mhuIi1sx/ew55iPZ1PateJ/tVrkfLIOD/ssKrkmeL7RGMTx5V19fUGqEcb4g1tPC9m8mt3S/YbePfDcsPldfTA6v0GO/WvF4fFOr/EfXHhs3bSdJjUySSpzO6g8Zbtn0Fe/69omma7pU2k6nCsul364TI5ik9j2OeRXiHw00KfQNT8S6Nfri7s5o4t39+P5irD2IrKopOSS2Nabik29z0LRb4C3htL12LqoVJpD/AK3Hr/tfzq5dWmc1t2enaZc6aEvBH04JOKy7u2l0/mznjvLYf8s2cblHsa8nFZW789D7v8jro4zpU+8wLi3ZCaqmRkNdCk1rdnYG2S/885Plb/69VbrTMk4FeTJOD5ZqzPQjJSV0Y4uTnmpo7nnrSyacwPSkWycGjQZeguRUGsw/a7bcv305FPhtWBq7FCeM1N7O4HEsx6MOaRWAzk8Cul1LRGZjLbDOeSn+FYOqxLZ2E7SRskgU4Dcc1rF82iE9NTY+FluLzUdQvT92S5jgU/7KAu367a6XTQbzxbpWeQPNuT+OSP5Csv4aR/YfB0MoGH+zzXJ93kfav6LXQeCoxN4lvpQPktYFgB9z/wDsmvqMPDkpxieHWlzTbO6ooorYzCiiigDnPiBqmkaR4alu/EVgNQ04TRI0BhSXLNIqqdrkDhiD7YrQgj03UtQkujYBr2zL2onuLNo3AP3gjuoLIfVSVPqax/id4cu/FXhKXS9OkgjuHnglDTsQuElVzyATnCntXm/inwRqGm6rLql6kGqWEuvT6kdKW3ubiO5jeJVUSCOF8MpUkZUrz1oA9Xh8IeGoUukh8PaPGl0uydVsogJhkHD/AC/MMgHnuKltfDOg2ixraaJpcAimFxGI7SNdkoGA4wOGA4z1xXhOm/C3xTrHw40HT5INJtDHZ3IZL2JVuoJXnd0PmGGQquCuVUo2f4u1bes/CHWtSTVZpLjSn1Ce30tLa4kkffFJbqolbdsyu7BwRyc84oGer2/hHw3bSSyW/h/R4nlV0kZLKNS6uMOCQvIYcEd+9aEumWEumf2bLZWz6d5Yh+ytEpi2AYC7MY2gAcYxXj2sfCbWZ31JNPvNPh02TWf7Qh00HbA8ZQAq6tE6KwIyB5brSD4QXsltYW0/2GW1tdIvbFIru6N0UllYmJlbyUG1SQc7QV7ZwDQI7+PTfBN1qMnhddH0eSewQXhsTp6+XEH43jKbMnHbn1raufD2i3QmFzpGnTCeNIZRJbI3mIhyitkcqpAIB4GOK888DfDe/wDDvi/TtYvYtHvWXSoLOecs3nQzxoVMkZMZ37hhSSUOD3xg+r0AZDeGNAbU/wC0m0PS21HzBN9qNpGZd46NvxncPXOaY/hPw49tPbvoGkNbzyedLEbKMrJJ/fYbcFuTyeea2qKAM3T9B0fTZYZNO0nT7SSGIwxNBbJGY4yxYopA4UsSSBxk5qtb+EfDdtJLJb+H9HieVXSRkso1Lq4w4JC8hhwR371t0UAR20ENrbxW9tFHDBEgjjjjUKqKBgKAOAAOMVJRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzHxGcL4ZdCceZNEv/AI8D/Ss/Sh5NtK/TytN/InP+FSfFCTGl2EX/AD0uc/kjf/WpYUxYaofSGOAfl/8AXoAt6RE8vh7VUgXMj+ZGgHciMKP1FUfBy6ff6ctvMiNJGoRkYcgitzwqudILcjzJpT/4+R/SvN7cRrdTZlkt7uKRkZ0bkkHGSO9c2IxUcO1zrRm1Ki6qfL0O5uPB1mWL2kktux/55sQK4jx/4Uuba1jvjcGUwMGyVGcfhXQWeuarbqAk1vdp6PlG/qKm1TXjfadNb32nyqrqQWTDgflWarYWq73V/uZTp1oaWZkeHLpDNHv4hvYsH/fA5rsQGvNJ2jm5tzx9R/jXlnhu7WSwubSJ909jL5ieuK9H0e8/e29xn91cqEf2bHBrsTvqjBqxg+JoMJBfxD930kH+yev5GsAxFvMgVgrMRJE/91xyDXf39oPMuLVx+7kzIn17j+tcO1s0bvASRJCflP8As9v8KbV9GI0dCt73WId81/5ABKukSAFWHUZ611GnaZpWnNvCtNN0MkylzmuM02/m0vURdW8Rkiu/lkQNt2Sjv+PT8q1bjWL2did8cR/32f8AqBXJKeHwujsjdRq1vM6edyTm1vmh/wBgruX8mAP61javp+sahExh1CwMu3ajGNlK+p4J5rEbUNdVz5Etu6dsh1P6GntrfiCFc/Yo5vXbP/ipqVmOHf2inhKq6Dv7J1mE2KLZwtHbyK5dJhkgexArpRqd3FftKNNuGDxhThozyD/velcuvjfVrdds+iXgQf8APJkb/CnL8SY92JrLU4z6Na5/kTWscVRltJGboVF9k6WHV7yK4uGXSrsrJhgPk645/iqJdU1QXUskGkyjzAMh5ogMj/gRrAk+I1qU+SG+LegsyP51PaeJ9W1L/jy0rUEj/vybYx/OtY1YS+F3JcJR3Rpm31+7hlj8i0topG3/ALyVm2n1GFx1561Vm8LwXWpf2hqt/JJemEQSNbfuVdQcgE8k4Oe4pyXGrzk7xCvsZGkI/LA/Wk+y3tySsl0/HaBAD+f/ANerILUWn6PaAKsIfH8Uh3H82LVO2pabEAiGHHoGJ/lgVmDRIiC7qZWHVpZC2PqTxTGt0j4hRWx+AqJ1I01zTdkVGLk7RRsbNO1BdskUTr6bs/zqGXwuhG7Tby4tx/cLb1/I5rNjnu4cEWtu+P7r4P6ir0fiWa3x5mnXGB/dG4fpmsPb4asrOSfr/wAE09nVhrZorTeHtbjz5cttMP8Aajwf0NVhpOvYObK1P/AyK1m8b2qD95bTofeNh/Sov+E+sT2YH6VP1PDS+yh+3qrqZraZry/8w+2/7+E0n9meIm6W1rH+BP8AWtCXxxCw/ch2PoEJqrP4surmF4l0+adHBVlaL5WB6g54xUvCYSGrS+8ft60tmyIaDrMvF3eeUp7RKF/WuT8dafFpmmmKFzLd3LCJSTk5PFTP4a025Py+EfD1sD3ezh/kFrFg8J6HN4ugt5NJ0to7KNrmdIrKNUfA4UjHIJIq6VXDRlyUrX8v+AKcKrXNO9vM9HtraPTdIW2BG1DHF/wGJfm/XNa3w5tymiy3bj57uZpM+oHA/UGuB17wl4cstNZV8PaP54iWPIsogfMc5P8AD2Fdevgrwdp9rZ2jeFNDur1kChTYQlmIHLMSvA68muswO5ork7PwV4OuUcnwhoMboxR0bToMg/gvPUVP/wAID4O/6FPw/wD+C2H/AOJoA6Wiua/4QHwd/wBCn4f/APBbD/8AE1f0fw1oWizvNo2i6Zp8zrsaS1tY4mZc5wSoGRkDigDl9S+K/hzTNc8Q6Vfm7gudFg+0SlkXbOMKdsXzZZvnUYIHX05rY0vxz4fvdA0vV7jULfTLfUk326ahPHC7c4xgtgn6E1h3Pwt0u+8Ra/q+qOl3PqE8VzaBoipspEiMYYEN8/UHBAHA9AawpfgtGbPSol1nzHtNN/sudZ4phDcRby/KRTxsOTyCzKeOM80AekP4m0GPUBYPremLfGQRC3a7jEhcjIXbnOSCOPeq0fi7R1try41C+tNNgtbx7FpLq8gCtImM8rIQDz91sOO6iuKm+EKSQahGurIgur6yvFC2pIi+zpt2DdISc+pOR3z1p+ofCmSeO+Nvq9vFdT6td6rDdNazCa0adVGI2iuI+V2nk5DcfKMcgHdP4o8PpNZwvrmlLLehWtUN3GGnDHClBn5s5GMZzT4fEeiT/ZvI1nTZPtIkMGy6Q+aI/wDWbcH5tuDnHTHNcz4d8D6j4e16bUrHX1unvYraO/OoWhmlm8lQm5JFkXYWHqH555rnNP8Ag5LZy6ar65a3NnpyX8cFvPpzEOl0rArIRMNwG49NuRxx1oA9M0bXtH1vzv7F1Ww1Hyceb9kuEl8vOcbtpOM4PX0NaVcf8PfCF14TjvIp9ZlvraXy1t7QCUQ2iouNsYllkcA9xuxxwBXYUAFFFFABRRRQAUUUUAFFFFABXNeHPFH9s+KfE2jfY/J/sWWCPzvN3ed5ib87cDbjp1Oa6WuAj0XRLfxVq2p2Hi+4s7rVbyO3u7WG5tdsk6JgQjdGXVtueFYNzkY4wATa78TNF03TtWkhW9k1GxsmvhY3FlcWskqA7cjzIwdu7gsAQOSeAafb/Evw8ui6ffalNcWUl1aLeNbtaTu0MfALtiPIjDHAkICnqDWTpfwY8Oae9yy3OozG4s57GQyGEM0cpyxZkjVnYHozEnscjFTXnwj0O8GnPdXd5PdWNqLGO4uILSdmhU/KrLJAyZXoGChsdSaANo/ETwsPEDaGmqGXVgnmC2ht5ZGdfK87K7VIbKcjGc8DqQKxfGHxLtLPw7qVz4ecS6pYT2sc9rf2k0DRrNIqglHCNypJB6dK1rT4f6XajxF5Nzfodct4La4MbpF5axReWpi2KuzjqOnoAOK5l/hL4S0PSL9bzVLq0tLsWscs0slvbqDFIDH92NV3M2ASQS31OaAPVqKbLGksbxyorxuCrKwyGB6gjuK5z/hAfB3/AEKfh/8A8FsP/wATQB0tFc1/wgPg7/oU/D//AILYf/iaP+EB8Hf9Cn4f/wDBbD/8TQBl/Ek777QoP70rsR9No/rUwJGl6kx6Ncoo/DA/pXL+MPCHhiLxTpVrb+HNGijaPc6pYxKGy4HIC89DW9BbW+n+FLaCygit7c3eEihQIqjcTwBwOlAHTeGmEXhy2kkOF2NIx9iSa8ivFlutRubofK00rSEDtk5rs28XaQ/htNNsbvzrswrBhEYqGwNw3YxxzXNQpsOT614eZ1lKShF7Hp4Km4pyZWijuk5R2q3FPdqMOxNaEJUDmrMQRuoFeTe53XOFud+keJoNSRSIJv3VwAOCD3rv/D0oZ59PLdfnhP6j9aq6rp0V9YyxFRllODWH4ev2e2R2OLzTn8qZe5Ud/wAq9zK6/NF030PMxlPXnR6bMzX2mJOoIuYDyvuOo/Gud1u18wR31uPmxyB3HcVv2dyoljuFIMNyAD/vf/XqKaEQXUluw/czZeM+/cf1r1jhOM2oXZHz5E+MkfwnswqeOAwttn/1g6ns3uKt3Nl5U5iwNkhyhPQN6fQ1BetNGiIwyF+U55K+n/6683M6SnS5uqOvBzcZ8vRlqHBHAq2ijFULRtwFaUYyK+c5T1GwCj0p8UUJfMyEr6KOTTlWpFSrhHW5EmSRw6chEpgHm9uN2Pz4q/LNA8Kliu3HCt83/jo4rO2Uba9KGOrQVtDllh4Sdy959r5a72d/9kDH6dKbeXsYXy0IZP7icL+J71RIqNxSnmNezWgRwtO5JeXQlURxJsQDtVLGFwOAKVyKYWrzq1epWd6juddOnGC91DWLDpVeS4dD0qZmphAYc1kaFc6gw7Uw3+eoFSPAtU541ANUkgJxqOP/AK1JJfsR1rMYYNQPMFOM1XKgNN73ajOx4AzVT4dwNeXF9qdwPkup8An/AJ5Rcn82IH4VzXiDUy/labZndeXbCJFHua7dEj02wt7G1faixCBSO4HBb8WLH/gNevldD3nUZwY2pZKCGzXAvdetWmUtBEzXcij+LBwi/U4UD/ert7KzlEouJXQ3CNvnkP8AE2MFB6KoOP8AJrlPB4t7nUrq8uMLaqQsYYdcDCD8sn8q3vFd6mnaNPBCzCS4+baeqKT8xP1/rXuHmmh4XnN5a3V6fu3Fy7J/uDCr+i1s1neHbc2mh2MLDDLECw9CeT+prRoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArifiRf69ZXOgro5voNLmuHXUrvT7QXVxAgX5NkZR8gtkE7Tjiu2qK6kMVtNIuCyIWGfYUAePeJ9c8cQX14uiPrc0UdtatpOdJBF+7N+++1EwjySBnj93xzWOdF1pfEX2l9G1BgPG320iOBiDF5GN4YgDZnjccDPeux8FfE+HUNGsbrxJLptk76QdVuGjaUbFE5i4QoV28D/loWJONuOa6Sw8e6BqC3v2GXUJ5LIRGeFNMujKglBMZ8vy9xBAJyB0we4oGeRXWoePvEljr2lz2evDTbzRrnZHeWaiVJ1b5ULi2iTLrxtG/gnDZ6WpNT8e6fovh2y0NtUgsU0lA1xc6ZIZI7pSAYpI0tHfYoGBhV3DnzD39NHxI8KtbWc8epSSLdyTQwpHZzvIzxDMilAm4EAjggUtl8R/Cd6geHV0WI2jXyyTQyRI0KnDMrOoBweCAcg8EUAchbX/j248QeJLu5ur+PSNOtIJILG10xA17JJakuIJJVBykvzYZWOcKR/CeR1S78ceI/DOv2Oradq9zb+Zp1xZrNZN5qnzlMqZFvDu24yfk4x1I5Pri/EnwqbWe4bUZY0gkhikSSznSRWmGYv3bIGww6HGD61k6v8WNGtbzSItOhu9QS8v5NPuCltOslq6AFgYvLLM3I+TAPUjoaAPRaKBzzRQIKKKKAPP/ABZ83juyJ6JbL/6E5/pTtUlMXhexfpgPN/46xqLxMxbxnMe0Vsp/8dc/1qHxhMIPCoHQxac7fQ7BSbsBwOgxeRFoiKB84Lt7kqT/AFrobh9rhe9ctJcm0t9JmOQsDIT9MYP6V0uo/JdKwPynkGvkZ6u59AtEX1bEf4VYspM8elUo3DKKdbu0cp9KlAzcj5NcRratoHiy3v8AB+w337icdgT0NdjbyhhUPiDTYtW0ma3kUElflPoe1a4eq6NRTRlUhzxcWX/Dz/LNpsp+XG+Fvb/61dFDm9tNjfLcxHg+4rzbwlqE1xYDef8AiYadJ5cg7sB0/MV6AtwAIdQhP7qQASY7e9fVRkpJSR4souLsyJoUldUcERythT3ik/un2PasnxXbNDPbFlwxG0kd66qRI2YzqAYnws6jt6N+H8vpXNeLZZTdQxSDO0Y8wHhx/Q1xZi0qLR0YRfvEUrBeOa14RxWXZdK1oBxXgQVz0pskC81MicUirUykCuiEEYykMZOOlRMMVaJBFQyDiqnDsKMiqzdqikPFPlGDURORzWFjVFeU4qs0mDVi46VnytzXPJam0SXfzTg9VVfmlaTaOtTYond+KzLuYIGLMAPesfXPFEdpIbe2UzXB/hWs6z0bWfEjh7hmjte4B2qPqe9d2EwFXEaxWnfoc9bFU6PxPXsWrzXbSDKh/Mf+6nJrn9Q1+8dW+yWWT23OAa7i20DQNIhH2hRdSD+AHC5/rWdJbw67q1vp+nWkEHmNtBA+6OpJ+gya92jktGKvUk3+CPMqZlVb9xJHMfD3TLufWW1fUI5Xvm3RWlsi7mGeGfHbAyBXqT+GdVu1UTyW9i0oKRI5LsMDABxwOPrya6vQNBs9IigGlxoiBfnmb5mlz6mq2ua7Hai8S1w0kKlpZycqigZ4/wBrjp2renTjSXLHYznOVR80tzC8KtPaWl/BAyhIZo7fay5zIuAzAg+oNO1CBtQ1mO3eVpDcXIRmbrsQZOPQcmofDSm20TT2lBDsHvpsnkntn8SK0/BVu13qUl7IMrbJ5Sn1kb5nP4Zx+NWtCTtqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKZNGJYnjYna6lTj3p9FAHmVz8IdETRJLS3N5dldIOkxxXNysasnn+erF1jJDB8chSMD7prO0v4TXWoHXpfF2qTGXUprR1FnMsjBbdGRRIzQokgIblTFjgZyea9eooA8+0b4UaFpEunSWtzqGbG7ubyJS0SrvnQI4KrGAFAUYAxj6cVFF8IPDa6fYWM0moXFtZ2M2nokkq/NHI5cliqg7gx4IwOOhr0aigDzm2+EWhQaZ9hFzdeV50EwaO2tIHzCSVBaKBSwOed2T6Ec5tT/DDSXupruC/1S2vX1V9YS4ieMtFMy7SFDIVK4HRgT713lFAAPzooooAKKKKAPPNcG/xdq3+zbBf/HP/AK9Z/wATmEPhzUz2S0CD8SBWnqSiTxRrRB5xHH+JVP8AGsP4w7j4T1ll4A8tB/31UVPhY47o5fV7VJdJhZRw0Yz+VXNHmbUNChLHM9v+5f8ADofyxWLY6mtxpcSSAqyoFwaPCl+LfXZ7Rj+6ulyp9HH+NfKuLt6HvrY6a3dlwD2q+g3YIqlNG0chqzaSZHNZPuMv2wIzWhG/HNUIpBirKvUNisc5dhdE8W295921v/3E3oD2Nd7ox+zyyWsgHlSksgPTP8Q/rXL+IdOXVdKlgJxIBuRvRh0q/oFzLf6JbyHi7jGOf+eidvxHH417+VV+eDpvdHmY2naSmup09oZLa5EPU4Ji9JY+6/7w/wA9awPFjQteIYwQ3Yg/Kw9/QjpXQvLHNpYuei4EiN3R/wD69cXeFZ7+WVDkOdx+veqzSqo01DuGCheXMW7PgCti26VjQ/KBWpaycV4tJ6nfURoDpRmo1elLV1HOP3Ux2pM0x2FFwsQTGqrPipbhxWfNLjNYTkbRQlxKKoyPk02eXJIzVdnPasHqbJWJg3zVh+KNTNtCIIGxM/f0FTavrVnpNs011KoIHC55Ncx4fhvPFOoG7eGaK2kkCxsUPzL3KjvXbgMMq9ZKfw9TnxVZ06bcdy34chtILkTXiGVic7DyXPvXaXcuu6pBi1sZobRR95l8pAPxxXZ6Mukaagi0z7HFBGADM7De7d896uy6taTSMsaSXKxjLFR8oPpk4FfWe1SsoKyR4Spt6yerOKsfA0rFG1m+WINz5VuC7n8ccfkadq8Om6HHpg0O3WPUpbhP3zEu6Kck5z3I6itPVPEd0bR2i2WwJIQR8uw6Dnt+Fcrvzq0Z5ZLKPOTzvlb/AD+tQ5ynuylGMdjo2vbm7VoJpmaOSQ4VflH3vb8aytYH2nfZQj5bydYFUf3F5f8ADoPxqzA/lzgDkwp09WPAH5mm6blrma4Ug+Rm2g9GkOS7/h/SoehSJ9amVIGjgGTIywxgd1XgAfU12+h2C6ZpcFsOWUZdv7zHkn865Pwpp/8AaOrfbXy1pZ4SLI++/r+HX8RXd0hhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHmGsX32bW9TCDMzXSt+AA/wAKdcWU2r2s0d988M5BZCOvOR/Ko9StgfF9/uHWbd+YFddbwqIgMdq8GvWqVqjinZI9OnCFKCdrtnInw9ZhNpgQD2Fcvr/huO1BltV2ODuVh1BFel3ShG7VRu4EuIWRgORXnNShLc6ozujl7GZdRsEmH38bXHow60giZOlZ8pbRNTZ3B+yyHEo9PRq3G2soZSCrDII71D0NCn5kinrViC7OQGpsiZFQFcHiluBuQShxxU+kqlpNdlv9UcTKAOjdD/SsS0l2t1rVilyvXrxWtCtLDz54mdWmqkeVk2p3ZEHkWzkQFmyvseQP1NZ8KjPSprgfLmo4uoqataVaXPIdOmqceVFtRxViF8VWz8tCPg1EHZjkjUSSpDJWas4Hela4HrXSpmLiXmlx3qKSfiqLTUx5Tt4qJVGUoD55ck81Qnc4NEkwLEHrVWaTPQ1lds1SsRyQajI3+jadcyg9G27V/M1C+g+Ibz5TLa2Kn/a82T8l/wAa7fRICmnIyqJ3fkNn/wCsTWou+JALm4WBT0jiX5j+JyfyFe9h8vpOCnLU8yri5qTijgtI+Gtk1ws14sl7cqc+deHIU/7MY4/PNdJfWMVoyR2LHevE0x7DsB2H0rfKu0ZVV+y2oGWcn52H9Pqazb2SK4tkghjZbNjhQo+aZvQe3qa9OEYw0irHHOTlq2Y6XCh4xGMxocQx/wB9v7x9vemXV35cbW6vncS0pB656/nUeorJYMchXuHXA2nIUeg9q564nwWj8wAAb5pCelbWuZXsS6hehS0oG8J8saj+J+wH0pLBPs6BpyWkU+ZKf7znoKq2iPLIk/l9ci3jP8I7ua0IokiVJp9zoDiKMdZn9f8A6/aj4UG7LDCSNI4o2xfXTZB/uDux+nb3q3FbvO9vpemDGVKhv7i/xOfr/nrVfT7eaW4aONRPqVx9/HRF9M9gP88mu/0DR4tJt258y5lwZZfU+g9AKyNC5ptlFp1jFa24xHGMZ7k9yas0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcH42hNlrcF8B+6nUIx/2h/wDWx+VWrbUEMQ57V0euabFq2mTWkvG8ZRv7jdjXk0VzNaXMlldZSeJijA98V4GPpSo1OeOzPUw0lVhyvdHU391ubKmo7W6D8GsT7Qecmobe7Mc/XivMd27nYopKxra9Yx3lo+AC2PzrkNGv20+5/s+8b9yxxEzfwn+7XZRXIcAGuZ8W6bHJ+8VevXFOMr+6wSsbLoQMiqsgwazPDGrF/wDiX3z5lX/VSN/GPT61s3C4zSaadmMrA7WBFXoJeKzXbFOik5osBsF9yEU2Kq0UnvU0bYqbAWGPFM3Uxn7Zp8CbzQkDFVWbpU6QMauW9v6irqQjHAraMWzKUrGWtqaVrb5a2BD7VHLGAtN02SqhyOpo0OStZUVz5hwa3tfAEbVw8M5Wc5PGalRNkz1bwcySadKIS0e0/vC8v8gOgrZguY1ZhYwmeQ9ZBwo+rH/69cl4MvobsS20sNugVQ6naTuPuO9dRJJMYgkR8mPp5jj5j/uoP619JgWnRjY8bEpqoxt6V4+3SefI33LaPhSff1/Hiqd1dmBztAlvHGAq/djX09h796huLhVZ47L/AFh4luW5I9h6n9BWTcSrsk8qUQwLzNcMeT7A9zXWYBcO7yPHGweXrLMfur/+r0rEEMd66BI/9CVtyg8NcsO59EFTu7Xy+VGjRaeDxG3DTn1bvj2796e86QEqmJJsYI/hX/ePb6CgB91LHbxbpQWeT5VRBgyf7K+g9TU2j6fe6peFo0QzYCs4/wBVbr/dHqf51e0Hw1c6nN9r1BpIoCMZIw8g9AP4V/z7131nawWVusFrEsUS9FWgCpoukW2kwFIAWkbmSVvvOf8AD2rRoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvPvihoZkiTV7VcSRYWbHcdm/p+Veg1DeW8d1ay28wzHKpRh7EVjiKKrQcWaUqjpzUjw61uvPUevQippPkkBqre2T6Rr81o/wDCxXPr6Gr86Ziz6V8tJcrsz3E7q5bt5Ohp2ruGtwap2rdBU+p8WgNRbUZy5tRNOQuRzkEdQfWu2u7W4tY4Uu8F3jVww/iBHWud0iHzLrivVvE+mi40JHQfvrVAwwOq45H+fSuunQdaMmt46mNSr7OUU+p5vMpBpiHBqy2HXiqzjaa5UbFhZAO9TpKMVlGXB9qngl3d6LAakeXNbVhb4AJ61maagc59K6K2UACnBXZnNk8UVWEjApEIApWkAFd0VGKOVtsVsAVRu5QBRcXIANZN3c8Ek1jVqrZGkKbMjxBMNjfSuBkk2uTXS6/d7yY16nr7CuWuFw/NZQOm1jt/h9fyxXjI8ii2YYdWONx7Ad81219KzF0VhEv3WcDG0f3VHrXlHhkw/wBpRNczeVHGdxI6t7Cu+vXaaTZu2gAnPZR3Ne5l0nyNHmY2Nppla/vYxG+SY7SL5WK9WPZV9Saz5JjNsnv1WKFOILcchP8AFv5VUjuTfXQa3jBihyIt33Ix3dj3Y+lTRECQsGaaY8ec/YeijsK661eFFc02c1OlKo7RRZYTS/eLRIf4FPzsPc/wiux8K+HUt1ju7yJQ45ii7J7n1NUvCGkC5f7TOMwxngH+Nv8AAV3NZYepOv8AvGrR6efmy6sI0vdWr6hRRRXWYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFcnbeNEvPFGp6Hp+i6rdzaZLFFd3EZt1ij8xdwPzyqxGM5wpPB46Zy5PidpsWuaLaXMcFpY6jFcyPe3F/DsgMJ24JRnQ5P+2COhGeKAPQKKypfEWiQrI0usaaixwrcuWukAWJjhZDzwpJGG6GsPT/H2mS6t4it9Sms9NstJmghW9uLtVjn82PeCCcAewyc9aAOxoqtp99aalaR3enXUF3aycpNBIJEb6MODVmgAooooA8z+KenBNQs79BjzBsY+4/8ArfyrFiHmQfhXoHxCtvP8Pl8ZMMiv+HT+tcFZL8gFfN5jDkrPz1PYwkuamvIht4yJKsasMWgqzHDhs4qrrxxbACuFO7Okh8MRb7xR6sB+tezkAqVIBB4xXkfgdPM1G3H/AE0H869dr28qjpN+h5uOesUeSa3af2Zrdza4xHu3R/7p5H+H4VSlXIrrPihaYSxvkHKsYXPseR/I/nXKod8YNebi6XsaritjsoT54JmfMnaokcxuKtXAxVWUZrFGx1GiShk/GugjkwK4LSr37LJtkPyHvXRx6pEVzvFQ7xehLjc3jcYHWq0136GsS41eBRzIKyrrWi2RCpJquaTJUEb13eqgJZgPqa5zUNUaUlbfn37VTKzXRLTOcenarcFqNoCjilZLc0SMzymZWeTknuaxr0jzMCun1ACOLaK5e4wXJrWLuDH2ed6kEgg5BFd3qt1A2jwCOTAufkcjqEXqPxPFcVZpjk1fjBZh6V00MS6DbSvcwrUFVSuacUjSqsaqI4V+7GvA/H1rY0mxe6uY4YxlnOB7e9ZthHnFeieDbDyoXu5By/yp9O5/z6VnTjPF1kpP19AqONCn7qN+yto7O1jghGEQY+vvU9FFfTJKKsjxm23dhRRRTEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBxel/D7TLbxprniO/is9Qur+aCe38+0UvZtGm3KOSTkkA5G3GBXMwfCO8s4tL/s/xFBHPZRX0O+bTjIHW5YknaJRgqGwOSD1x2r1qigDyC9+C4OnyWWm6+YIJtIj0mfz7PzmYJJ5gkUh12nPY54rTf4Z6hCdTfS/FE9jLfXFpM5igZNyQxeWY2KSq+GxnKspHTnrXplFAHH+BPBEfhfwlPoUt/NdRTTyzGWFpLZ1DnO0Mrlxj+9uyat/8IXpf/P14g/8H9//APHq6WigDmv+EL0v/n68Qf8Ag/v/AP49R/whel/8/XiD/wAH9/8A/Hq6WigDi9f8E6YdFvStzrpZYmYB9cvWGQM9DNg9K4PQvD9kjwzpNqRZG3APqVw6591LkEexFe1Xsfm2c8f9+Nl/MV5X4a5jCnsa8XNW4yi09z0cFZxdzTaEA1jeIF/c4rpZo8HpXPeIl/d14qVpHenctfDqPdqcOexJ/Q16lXmfw2H/ABMlz/db+VemV9Fla/dN+f6I8vHP94vQw/G1p9s8M3qgZeNfNX6rz/LNeYae26EV7RNGs0MkT8q6lT9CK8WsVMReNuqMVP4cVzZtC0oy7m2Blo4hcr1qk44rRmGapunNeUjvG28IkGGHFJcWQXkFgPrVy1UAir0sIaPii9mBgx2gPrU62+3gcVqw2uUpqwfvenFHMBFDb4UVdjiCx04JyBVl02QH1xWbYHM6pyzVz0keZK39RyZDWRsy9bx2AfCu1auWy5aoo04FaNlDkjik2BuaDZG6uoYF4LnBPoO5r1OGNYYkjjGEQBQPauX8EWASOS7cc/cT+prq69vLKPJT9o93+R5WMqc0+VdAooor0zjCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiivM7fxN4nXxxrmi3V7optdKskvnlj0yXfIrAnaAbjAIx15z6CgD0yivFLL4p3qeIob65W7vdAPhgarLBa2sUTI/2gq0u15CQAoxtEjewNdXB8RrM3fiCTLXNlp6WUqAJDa4S4i8wEyzTqrcc8hCOmG60AegUVz3gbxdp3jTRW1PSVmWFJnt3WYLuV1xnlWZSORyCRzT77xl4YsLuW1vvEmi211EdskM19EjofQqWyKAN6iua/4T7wd/0Nnh/wD8GUP/AMVR/wAJ94O/6Gzw/wD+DKH/AOKoA6U8ivJdD+W6lT+65H612v8Awn3g7/obPD//AIMof/iq8xsfFXh2LV7snX9JEZmcqxvI8EbjyDmvJzWDkotLud2CklzXPRZ48xBvauT8RcJitN/GnhQ2wH/CTaHnHT7fF/8AFVyWv+K/Dso/da/pL/7t5Gf615VSjJSTSOylUXc6r4cf8hIf7jV6VXjPgHxf4btdQDXXiDR4V2sMyXsSj9Wr0H/hPvB3/Q2eH/8AwZQ//FV7eWpqk0+/+RwYxp1NOx0teOainka7qEfZbh//AEI133/CfeDv+hs8P/8Agyh/+KryzxB4p8PN4lv5Ide0mSJ5Nyul5GVOQOhBqM0g5QjZdSsFJKTua23dUM0fHSs6PxV4exzr2lf+Bkf+Na5aOaFJInV43UMrKchgehB7ivBcZR3R6aknsRW45Fa8aZjrNt1+atmFP3Ypbg2JCmIyMVEkXJq0EwKdEnNDViUyssX7wVJdjEZqcLh6q3x4rPqWcvqI+dqykGXrW1IcmsyEfPXRHYC5AmcVs6fASVCjJPAHvWfaqCwrsfCNmJ9SjLD5Yh5h+vb9aIQdSagupM5KEXJ9Dt7C3FpZQwKPuKAfr3qxRRX1sYqKSXQ8Fu7uwooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACsg+HNKOrahqZtf9Ov7cWtzJ5j/vIxnC4zgdTyADWvRQBxc3ww8IzJAjaZKEgsxYKqXtwga3DFxGwDjeu45w2c8egq1f8Aw+8L38l09xpY33MlvK7RTyRkPApSEptYbCqkgbce+a6qigDK8OeHtM8OWs9to9u0EU873Mu+Z5S8rY3MWck5OB3rVoooAKKKKACvJGPl+LtRT/p4f+det15Dq37rxrf+82fzAry81X7tep3YH4md5F81mfpXE+JPvEV29lhrMe4rivFA2u1eXXXuxZ1UX7zRa+HRxqqf7rfyr0yvL/h5JnWIh6hh+hr1CvWyv+E/X9EceO/iL0CvIvG42eMLweuw/wDjgr12vIviD8vjGf3jjP6U8zX7lev+YYL+I/QigPyipWGRUNscqKs4yK+dZ6otrH8+a2oE+Ws21XLCtq2X5RVR1ZE2RmOnBMVYKe1RsMU6isRFkLAdazb7oa0n6VlXx4NYrc1RzmpHrWbAcvV7UTkmqNuPmFdC2GbNgMuK9L8GWwj0+SYj5pGx+A/+vmvO9Mj5zXrelQfZtOt4u6oM/U8mu7LKfNWcuyOPGytDl7lqiiivoDygooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvIvFX7vxlen/bU/8Ajor12vJfHI2eLbo+uw/+OivNzRful6/5nZgf4j9DtNLfdYr9K5HxcMA10+gvusF+lc14yHyk15FR3pxO2mrTZX+HrY1u39yR+hr1qvIPAZxrVqf+mlev162Vv93Jef6HHjvjXoFeQ/Ejjxe3vDH/AFr16vIPiZ/yN5/64p/WrzL+D8ycF/E+RXsz8gq8vNUbIfIKvrXzjPWLdoORW7ar8orGsxyK3bYYUVpSWplUY5l4qtKOauP0qnLVViIFd+hrI1A8GtaToax9RPBrmjudBzd9yxqG2j+YVNeffNLZjLit+gHR6Db+bdW8f991B/OvVK888KR7tVtRjoSfyBr0OvZymPuSl5nmY5+8kFFFFescIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXlPxAXHiiY+qIf0r1avL/iEuPEpPrCh/nXn5n/B+Z14L+J8jc8MtusV+lYnjJf3ZrX8LN/ouPas/xcuYWrxZfw4nfH+IzC8Evt1i1/66r/OvZa8U8JHZq1v/ANdV/mK9rr1cr+GSOTHfEgryD4mf8jf/ANsE/rXr9eQfEz/kbj/1xT+tbZl/B+Zngv4nyK9kflFaEYyazbI8CtWEcivm2esaNkvIrZh4Wsm0HStaHpWtHcxqDn6VVl61cYcVXlWrqxuRBlGXoaxdQ71uTjg1hahnmuVLU6Ec7efeNP08ZkFMuuWNWNNT5xWz2Gdx4OTOpofRGNdzXH+DU/05z6Rn+YrsK93KlahfzZ5ONf7wKKKK9I5AooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvM/iIv/FRIfWBf5tXplecfERf+J9CfWAf+hNXBmX8H5nXg/4pb8LH9yR7VD4oGYGqTwzxF+FM8SjMDV4Tf7tHoJfvDk9B+TU4T/00X+Yr22vEdL+W9jPo4/nXt1erlX2/l+pyY/eIV5D8TP8AkbD/ANcU/rXr1eSfExc+Kc/9MU/rXRmX8H5mWC/iFCx6CtiAVlWCnArXgHSvm5HrGla9q1IelZdt2rUg6VrS3MahPjioZRxU46VFL0rpmtDCL1M6cdaxNQXINbk3esq9TINcD3OuJzFxGd5qxp4w4p9wmGNLaD5xVt6FHe+DRmeY+iD+ddVXLeDB89x/ur/M11NfRZYv9nXz/M8fF/xWFFFFd5zBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcL4+tml1O2dRx5WP/AB413VZ+qWK3ZRiMlRiubF0nVpOKNqE/ZzUjltDiKIBik16EyQkAV0cFgI+gol04S8MOK8hYKfLynb9YjzXPO9N0yQzqcH7wNet1nWmnQwfdQZ9a0a9PB4b2Cd+pyYit7VryCuE8caHJfaotzGMjy1X8s13dRyxCTr1revRVaHKzOlUdOXMjy+30+WEYZTVlY2B5Fd7JYxt1QflVV9MjP8ArxamWyT91nfHGJ7nM24ORWnB2q8dMUdFp62JXtWccHUi9hyrxZXHSo5elaAtDimvaEjpW0qE7bGaqRuYMoOaoXSZBro3sST0ph0wv1WuJ4So3sdKrxSOFuYmL8A1PYWEruvymuzj0VN2So/KtK106OPHyiuull8pfEZTxaWxW8M2htllLfxAf1rcpkaBBgU+vaoUlRpqCPOqT55czCiiitiAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAwPSjFFFABRRRQAUUUUAFFFFACbRRtFLRSsAm0UmwU6iiyC43YKNgp1FHKh3EAA7UtFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing shows the inner parts of the knee as seen from the front. A small bone (called the patella or the \"knee cap\") that sits in front of the knee has been removed so that you can see what is under that bone. The anterior cruciate ligament (ACL) is in the middle in white. It connects the thigh bone (called the \"femur\") to the shin bone (called the \"tibia\"). The meniscus is a cushion of rubbery material (cartilage) between the thigh bone and the shin bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10578=[""].join("\n");
var outline_f10_21_10578=null;
var title_f10_21_10579="Ostio-meatal complex";
var content_f10_21_10579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F50120&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F50120&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Paranasal sinuses - anatomy of the ostio-meatal complex",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The diagram on the left shows a coronal view of the ostio-meatal complex (OMC). Gray arrows indicate the direction of mucociliary flow and blue circles mark areas that can become obstructed. The figure on the right, in which the middle turbinate has been removed, shows the remaining structures that comprise the OMC: the uncinate process, hiatus semilunaris, ethmoid bulla, and ostium of the maxillary sinus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10579=[""].join("\n");
var outline_f10_21_10579=null;
var title_f10_21_10580="TRAM breast reconstruction";
var content_f10_21_10580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F71810&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F71810&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Transverse rectus abdominis muscle (TRAM) reconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Right single pedicle TRAM flap reconstruction following mastectomy for breast cancer. Left panel, preoperative appearance; right panel, postoperative appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jorge de la Pedraja, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10580=[""].join("\n");
var outline_f10_21_10580=null;
var title_f10_21_10581="Nitrofurantoin: Pediatric drug information";
var content_f10_21_10581=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nitrofurantoin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"    see \"Nitrofurantoin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?14/5/14421?source=see_link\">",
"    see \"Nitrofurantoin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F202007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Furadantin&reg;;",
"     </li>",
"     <li>",
"      Macrobid&reg;;",
"     </li>",
"     <li>",
"      Macrodantin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F202008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Nitrofurantoin&reg;;",
"     </li>",
"     <li>",
"      Macrobid&reg;;",
"     </li>",
"     <li>",
"      Macrodantin&reg;;",
"     </li>",
"     <li>",
"      Novo-Furantoin;",
"     </li>",
"     <li>",
"      Teva-Nitrofurantoin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1048970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Miscellaneous",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1048962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"      see \"Nitrofurantoin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants &gt;1 month and Children: 5-7 mg/kg/day divided every 6 hours; maximum dose: 400 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Macrocrystal/monohydrate: Children &gt;12 years: 100 mg every 12 hours for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prophylaxis of UTI: 1-2 mg/kg/day as a single daily dose; maximum dose: 100 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: 50-100 mg/dose every 6 hours; macrocrystal/monohydrate: 100 mg twice daily for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prophylaxis of UTI: 50-100 mg/dose at bedtime",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;60 mL/minute: Avoid use",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F201981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral [macrocrystal]: 50 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Macrodantin&reg;: 25 mg, 50 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral [macrocrystal/monohydrate]: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Macrobid&reg;: 100 mg [nitrofurantoin macrocrystal 25% and nitrofurantoin monohydrate 75%]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral: 25 mg/5 mL (230 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Furadantin&reg;: 25 mg/5 mL (230 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F201965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1048974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with food or milk; do not administer with antacid preparations containing magnesium trisilicate; suspension may be mixed with water, milk, fruit juice, or infant formula. Shake suspension well before use.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1048966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Protect oral suspension from light; store capsules and suspension at room temperature (59&deg;F to 86&deg;F or 15&deg;C to 30&deg;C)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1048973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and treatment of urinary tract infections caused by susceptible gram-negative and some gram-positive organisms including",
"     <i>",
"      E. coli",
"     </i>",
"     ,",
"     <i>",
"      Klebsiella",
"     </i>",
"     ,",
"     <i>",
"      Enterobacter",
"     </i>",
"     , enterococci,",
"     <i>",
"      S. saprophyticus",
"     </i>",
"     , and",
"     <i>",
"      S. aureus",
"     </i>",
"     ;",
"     <i>",
"      Pseudomonas",
"     </i>",
"     ,",
"     <i>",
"      Serratia",
"     </i>",
"     , and most species of",
"     <i>",
"      Proteus",
"     </i>",
"     are generally resistant to nitrofurantoin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrodantin&reg; and Furadantin&reg; (FDA approved in ages &ge;1 month)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrobid&reg; (FDA approved in ages &ge;12 years)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3245417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound alike/look alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Macrobid&reg; may be confused with microK&reg;, Nitro-Bid&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Nitrofurantoin may be confused with Neurontin&reg;, nitroglycerin",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F202055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cyanosis, ECG changes (nonspecific ST/T wave changes, bundle branch block)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Bulging fontanels (infants), chills, confusion, depression, dizziness, drowsiness, fever, headache, malaise, pseudotumor cerebri, psychotic reaction, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, angioedema, erythema multiforme, exfoliative dermatitis, pruritus, rash (eczematous, erythematous, maculopapular), Stevens-Johnson syndrome, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperphosphatemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia,",
"     <i>",
"      C. difficile",
"     </i>",
"     colitis, constipation, diarrhea, dyspepsia, flatulence, nausea, pancreatitis, pseudomembranous colitis, sialadenitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urine discoloration (brown)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, aplastic anemia, eosinophilia, glucose-6-phosphate dehydrogenase deficiency anemia, granulocytopenia, hemoglobin decreased, hemolytic anemia, leukopenia, megaloblastic anemia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatitis, hepatic necrosis, transaminases increased, jaundice (cholestatic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, myalgia, numbness, paresthesia, peripheral neuropathy, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Amblyopia, nystagmus, optic neuritis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, dyspnea, pneumonitis, pulmonary fibrosis (with long-term use), pulmonary infiltration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Acute pulmonary reaction (symptoms include chills, chest pain, cough, dyspnea, fever, and eosinophilia), anaphylaxis, hypersensitivity (including acute pulmonary hypersensitivity), lupus-like syndrome, superinfections (eg,",
"     <i>",
"      Pseudomonas",
"     </i>",
"     or",
"     <i>",
"      Candida",
"     </i>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1048977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to nitrofurantoin or any component; anuria, oliguria, or significant renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;60 mL/minute or significant serum creatinine elevation); infants &lt;1 month of age, pregnant patients at term (38-42 weeks gestation), during labor and delivery (due to the possibility of hemolytic anemia); in patients with a history of cholestatic jaundice or hepatic impairment with previous nitrofurantoin therapy",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1048961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with G-6-PD deficiency (hemolytic anemia-induced by nitrofurantoin appears to be linked to G-6-PD deficiency in the red blood cells of affected patients), patients with anemia, vitamin B deficiency, diabetes mellitus, or electrolyte abnormalities",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1048960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nitrofurantoin should not be used to treat UTIs in febrile infants and young children in whom renal involvement is likely; not indicated for the treatment of pyelonephritis or perinephric abscesses; therapeutic concentrations of nitrofurantoin are not attained in the urine of patients with renal insufficiency (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;60 mL/minute, anuria, or oliguria). Acute, subacute, or chronic (usually after 6 months of therapy) pulmonary reactions, including fatalities have been reported; monitor for dyspnea, cough, fever, malaise, radiologic evidence of diffuse interstitial pneumonitis or fibrosis; if these reactions occur, discontinue nitrofurantoin immediately. Hepatitis, cholestatic jaundice, chronic active hepatitis (onset may be insidious) and hepatic necrosis resulting in death may occur; monitor patients for changes in liver function; if hepatitis occurs, discontinue nitrofurantoin immediately. Peripheral neuropathy may occur; risk is increased by renal impairment, anemia, diabetes mellitus, electrolyte imbalance, vitamin B deficiency, and debilitating disease. Optic neuritis has been reported. Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F201974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Nitrofurantoin may enhance the hyperkalemic effect of Eplerenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Trisilicate: May decrease the serum concentration of Nitrofurantoin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Norfloxacin: Nitrofurantoin may diminish the therapeutic effect of Norfloxacin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Nitrofurantoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Spironolactone: Nitrofurantoin may enhance the hyperkalemic effect of Spironolactone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1048979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food increases the total amount absorbed; cranberry juice and other urinary acidifiers may enhance the action of nitrofurantoin; ensure diet is adequate in protein and vitamin B complex",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F201977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (contraindicated at term) (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F201991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Because adverse effects have not been observed in animals, nitrofurantoin is classified pregnancy category B. Nitrofurantoin crosses the placenta, but very little reaches the amniotic fluid. Most published experiences with nitrofurantoin use during pregnancy have failed to identify any increased obstetric or teratogenic risks. Isolated reports of a potential increased risk for cardiovascular defects and a case report of upper limb paralysis have not been replicated in other studies. Use of nitrofurantoin during pregnancy has been generally well tolerated with rare reports of maternal toxicity including severe pulmonary reactions or hematologic adverse effects. Nitrofurantoin is contraindicated in pregnant patients at term (38-42 weeks gestation), during labor and delivery, or when the onset of labor is imminent due to the possibility of hemolytic anemia in the neonate.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1048969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Signs of pulmonary reaction; signs of numbness or tingling of the extremities; periodic liver and renal function tests; CBC; urine culture and",
"     <i>",
"      in vitro",
"     </i>",
"     susceptibility tests. Observe for change in bowel frequency.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1048959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits several bacterial enzyme systems including acetyl coenzyme A; reduced by bacterial enzymes to active intermediates that may alter ribosomal proteins resulting in inhibition of protein, DNA, RNA, and cell wall synthesis",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1048976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed from the GI tract; macrocrystalline form is absorbed more slowly due to slower dissolution, but causes less GI distress than formulations containing microcrystals of the drug",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.8 L/kg; crosses the placenta; appears in breast milk and bile",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &sim;40% to 60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Partially in the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Presence of food increases bioavailability",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 20-60 minutes and is prolonged with renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: As metabolites and unchanged drug (40%) in the urine and small amounts in the bile; renal excretion is via glomerular filtration and tubular secretion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Dialyzable",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1048968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?14/5/14421?source=see_link\">",
"      see \"Nitrofurantoin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May discolor urine to a dark yellow or brown color; avoid alcohol. Inform physician if diarrhea, chest pain, dyspnea, or cough occur.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Brendstrup L, Hjelt K, Petersen KE, et al, &ldquo;Nitrofurantoin Versus Trimethoprim Prophylaxis in Recurrent Urinary Tract Infections in Children,&rdquo;",
"      <i>",
"       Acta Paediatr Scand",
"      </i>",
"      , 1990. 79(12):1225-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/21/10581/abstract-text/2085111/pubmed\" id=\"2085111\" target=\"_blank\">",
"        2085111",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Coraggio MJ, Gross TP, and Roscelli JD, &ldquo;Nitrofurantoin Toxicity in Children,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1989, 8(3):163-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/21/10581/abstract-text/2652087/pubmed\" id=\"2652087\" target=\"_blank\">",
"        2652087",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Practice Parameter: The Diagnosis, Treatment, and Evaluation of the Initial Urinary Tract Infection in Febrile Infants and Young Children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1999, 103(4 Pt 1):843-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/21/10581/abstract-text/10103321 /pubmed\" id=\"10103321 \" target=\"_blank\">",
"        10103321",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12645 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-906C751B57-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10581=[""].join("\n");
var outline_f10_21_10581=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202007\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202008\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048970\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048962\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201981\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201965\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048974\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048966\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048973\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3245417\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202055\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048977\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048961\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048960\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299767\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201974\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048979\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201977\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201991\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048969\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048959\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048976\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048968\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12645\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12645|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=related_link\">",
"      Nitrofurantoin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?14/5/14421?source=related_link\">",
"      Nitrofurantoin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_21_10582="Intraoperative and postoperative blood salvage";
var content_f10_21_10582=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intraoperative and postoperative blood salvage",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10582/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10582/contributors\">",
"     Arthur J Silvergleid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10582/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10582/contributors\">",
"     Steven Kleinman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10582/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10582/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/21/10582/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;After preoperative autologous donation and intraoperative hemodilution, intraoperative and postoperative blood salvage are the third and fourth components of a complete blood conservation program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=see_link\">",
"     \"Preoperative autologous blood donation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37684?source=see_link\">",
"     \"Acute normovolemic intraoperative hemodilution\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In salvage techniques, blood that is shed during or after surgery (or trauma) is retrieved, processed in some fashion, and returned to the patient. Processing can be as simple as filtration or, most commonly, involves centrifugation and washing prior to re-transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INTRAOPERATIVE BLOOD SALVAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative blood salvage (IBS) is also known as intraoperative autologous transfusion, intraoperative salvage, or intraoperative autotransfusion. IBS is unique among autologous transfusion methods because of its capacity to provide immense quantities of autologous blood very rapidly. In comparison, preoperative collection is limited by time constraints and patient tolerance, hemodilution by blood volume and hemodynamic considerations, and postoperative salvage by mechanical problems and concern about microbial contamination. IBS can be utilized throughout a surgical procedure and can replace blood in proportion to the volume lost. In certain situations, most notably liver transplantation, the rate and volume of replacement may be extraordinary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Technology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The modern era of IBS technology began in the mid-1970s when the two currently available salvage systems &mdash; a centrifuge-based cell salvage instrument and a passive canister collection system (used with or without supplementary washing) &mdash; were introduced. The first commercially available instrument that could concentrate and wash salvaged red cells was the Cell Saver (Haemonetics, Braintree, MA), introduced in 1974. Cell Saver technology has become so widely accepted (through five generations of Cell Savers) that virtually all similar IBS instruments are referred to as \"cell savers\".",
"   </p>",
"   <p>",
"    The procedure starts with the surgeon aspirating blood from the surgical field through a suction wand attached to dual-channel tubing; this allows anticoagulant and blood to be mixed as the blood is aspirated. The aspirated blood is collected in a reservoir (usually a cardiotomy reservoir), until there is sufficient blood for processing. At this point, the salvaged blood is pumped into the centrifuge bowl, where it is concentrated and then washed with an isotonic electrolyte solution, most often saline. The processed red cell suspension is then pumped from the centrifuge bowl into an infusion bag. Modern cell salvage instruments can process a full reservoir of blood, and provide 225 mL of washed, saline-suspended red cells with a hematocrit of 50 percent or more in approximately three minutes. Thus, a massively bleeding patient can be provided with the equivalent of 12 units of banked blood per hour.",
"   </p>",
"   <p>",
"    Canister collection systems began with one marketed by the Sorenson Research Corporation (Salt Lake City, UT), now marketed as Receptal (Abbott Laboratories, Abbott Park, IL). These systems share with the centrifuge systems the dual-channel suction tubing with which shed blood is aspirated and anticoagulated. Salvaged blood is collected by vacuum into a disposable liner bag contained in a reusable, rigid plastic canister. Blood that is collected in the liner bag can be concentrated and washed with standard blood bank washing instruments or it can be transfused directly (through a filter). Canister-based systems are much less expensive to purchase and to operate, as cell saver-type instruments retail for over $30,000 and require trained personnel to operate them. They are, however, unable to provide processed (ie, washed) blood for reinfusion fast enough to be effective in massively bleeding patients, and there remains substantial question about the quality and possibly the safety of unprocessed blood harvested from certain surgical procedures (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;IBS is widely applied in a variety of high blood use surgical procedures, including cardiac [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], vascular [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/5\">",
"     5",
"    </a>",
"    ], orthopedic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/6\">",
"     6",
"    </a>",
"    ], urologic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], gynecologic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/11\">",
"     11",
"    </a>",
"    ] and transplantation surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/1\">",
"     1",
"    </a>",
"    ]. It has also been effective in neurosurgery and plastic surgery, when blood use was anticipated to be high. It has three other advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IBS, when used as the principal form of blood replacement, avoids the substantial (up to 50 percent) wastage of blood collected and not transfused via preoperative autologous donation.",
"     </li>",
"     <li>",
"      IBS, in contradistinction to preoperative autologous donation, is considered acceptable by some Jehovah's witnesses, provided the blood does not leave the operating room for processing [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10986?source=see_link\">",
"       \"The approach to the patient who refuses blood transfusion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IBS may be valuable for the patient with serologic problems for whom crossmatch-compatible blood is unobtainable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several contraindications to the use of IBS. Some are absolute, such as settings in which there is a potential for the simultaneous collection during salvage of microfibrillar collagen hemostats used to promote local hemostasis (eg, Avitene, Alcon Inc, Humacao, Puerto Rico),",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    , or betadine. Other contraindications are relative, as with a patient with a known blood-borne infectious disease, which could endanger health care workers should the IBS apparatus malfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some previously absolute contraindications are undergoing continuous reevaluation, such as patients with malignancies",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bacterial contamination of operative sites. Malignant cells have been seen in shed blood collected intraoperatively, and extensive cell washing does not render contaminated blood sterile. As a result, both of these settings have long been considered absolute contraindications to IBS. However, the pioneering use of IBS in cancer surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/7,14,15\">",
"     7,14,15",
"    </a>",
"    ] and evidence that the benefit of IBS in hemorrhaging trauma patients with enterically contaminated wounds outweighed the potential spread of the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/16\">",
"     16",
"    </a>",
"    ] lend support to those who feel that additional studies might lead to more liberal use of IBS in these conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Product quality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Salvaged, washed red cells differ little from traditional washed red cells. The quality of the red cells, as measured by posttransfusion survival, is excellent. The transfusate is devoid of functional platelets and white cells, and is markedly reduced in coagulation factors and other serum proteins.",
"   </p>",
"   <p>",
"    Unprocessed (unwashed) salvaged blood differs substantially from the washed product: hemoglobin levels are lower (range: 7.0 to 9.0",
"    <span class=\"nowrap\">",
"     g/dL);",
"    </span>",
"    plasma hemoglobin levels are often strikingly high; platelets are present, although their function may be impaired; anticoagulant is present in measurable amounts; and, most important, thromboplastic substances and other coagulation system components that might lead to coagulation abnormalities are present [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/2\">",
"     2",
"    </a>",
"    ]. The latter characteristic has led to an unwavering belief, not entirely substantiated by clinical data, that unprocessed salvaged blood is inherently inferior to (or potentially more dangerous than) processed blood.",
"   </p>",
"   <p>",
"    The author's own view, after reviewing the literature, is that unprocessed blood taken from a systemically anticoagulated patient does not carry a substantially increased risk of inducing a coagulopathy. However, unprocessed blood taken from the surgical abdomen of a nonanticoagulated patient appears to increase the potential for inducing a coagulopathy when infused, and its use should be avoided, when possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of potential and generally avoidable complications of IBS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Air embolism, which can be prevented by draining the reinfusion bag into a separate transfer pack prior to transfusion or, with newer instruments, by in-line air detectors.",
"     </li>",
"     <li>",
"      A coagulopathy, which can be avoided by washing the salvaged blood.",
"     </li>",
"     <li>",
"      The \"salvaged blood syndrome\" refers to the development of disseminated intravascular coagulation (DIC)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      increased capillary permeability in the lungs (acute respiratory distress syndrome) or periphery (anasarca) after the administration of washed autologous red cells [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/17\">",
"       17",
"      </a>",
"      ]. This syndrome appears to be mediated by activation of platelets and white cells during salvage. Platelet debris may be responsible for DIC whereas activated white cells may increase vascular permeability. This rare syndrome can be prevented by avoiding the aspiration of very dilute blood and by using citrate, rather than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , as the anticoagulant.",
"     </li>",
"     <li>",
"      Infection, which can be avoided by using prophylactic antibiotics and by not aspirating from obviously infected sites.",
"     </li>",
"     <li>",
"      Fat embolism, which is preventable by extra washing and by using a microaggregate filter for reinfusion.",
"     </li>",
"     <li>",
"      Microaggregates, consisting of white cell and platelet debris, can develop in salvaged blood. Microembolization can be prevented by using a microaggregate filter for reinfusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Standards",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hospitals with IBS programs or blood center providers of the service, should establish written policies and procedures that are regularly reviewed by a physician with responsibility for the program [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/18\">",
"     18",
"    </a>",
"    ]. There must be written policy for the proper collection, labeling and storage of blood collected by IBS. Collection equipment and technique must ensure that the blood is aseptic. Periodic quality control testing of recovered blood is recommended.",
"   </p>",
"   <p>",
"    If collected under aseptic conditions with a device that washes with normal saline and if properly labeled, blood collected by IBS may be stored either at room temperature for up to six hours, or at 1 to 6&ordm; C for up to 24 hours, provided that cold storage is begun within six hours of initiating the collection. Proper labeling should include at a minimum the name and identifying number of the patient, the component name, the statement \"For Autologous Use Only\", and the expiration date and time. Blood collected by IBS should",
"    <strong>",
"     never be transfused",
"    </strong>",
"    to any patient other than the one from whom it was collected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;IBS is an important method of blood conservation that complements other methods. It assumes increasing importance in the patient who is unable to donate autologous blood prior to surgery but who is anticipated to bleed substantially intraoperatively. Given the high cost of current technology, it becomes cost effective (when compared with the cost of providing allogeneic blood) when at least two or more units of blood can be salvaged and reinfused. It is likely that the future will bring enhancements to the current technology, resulting in even greater cost effectiveness, thereby enhancing interest in IBS for a wider variety of surgical procedures. Additional studies in oncologic surgery, in particular, might pave the way for this technique to become a standard of practice in this vast group of patients who are not currently offered this autologous option.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE BLOOD SALVAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative blood salvage (PBS), or postoperative blood collection, refers to the collection of blood from surgical drains and reinfusion with or, much more commonly, without processing. PBS is an accepted practice in cardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/19\">",
"     19",
"    </a>",
"    ], in which its safety and efficacy have been confirmed in most but not all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. It has also become increasing popular in orthopedic procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/22\">",
"     22",
"    </a>",
"    ]. The contribution of PBS to overall blood conservation is generally less than that of preoperative blood donation or IBS. Furthermore, some have questioned the ability of PBS to reduce allogeneic transfusion, particularly in orthopedic surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cardiac surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood that drains from the chest or mediastinum following cardiac surgery has been in contact with the pericardium and, via an uncertain mechanism, is defibrinogenated and does not clot. It can therefore be collected in a filtered system and returned to the patient without further processing. The dilute, partially hemolyzed blood, contains elevated levels of fibrin degradation products, which can induce a transient coagulopathy and increase bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/24\">",
"     24",
"    </a>",
"    ]. Interpretation of some laboratory studies (creatine kinase, coagulation studies) may also be difficult when shed blood has been given. Nevertheless, PBS can have a measurable impact on allogeneic blood requirements when there is a high rate of mediastinal blood loss.",
"   </p>",
"   <p>",
"    There are several technical points to consider:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      250 mL of blood loss in four hours is an efficient re-transfusion trigger.",
"     </li>",
"     <li>",
"      The collection reservoir should be anticoagulated if blood loss exceeds 400",
"      <span class=\"nowrap\">",
"       mL/h.",
"      </span>",
"      In this setting, not all of the shed blood will come in contact with the pericardium and be defibrinogenated.",
"     </li>",
"     <li>",
"      Re-transfusion should be performed within six hours after the start of collection of each individual autotransfusion unit. The program should be discontinued after 16 hours to minimize the risk of infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Orthopedic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;PBS in orthopedic surgery is less established than in cardiac surgery and is somewhat controversial. The impetus for the increased interest in collecting blood after joint surgery was the development of efficient systems for collecting, anticoagulating, and filtering blood for re-transfusion. One such system, the Solcotrans apparatus (Solco Basle, Inc, Hingham, MA) has proven very popular because of its simplicity and efficiency. However, the Solcotrans has not been the subject of sufficient well-controlled, peer-reviewed studies to justify its wide use. Major concerns persist, as described above, about the safety of unwashed salvaged blood, concerns that will undoubtedly persist until controlled, prospective clinical trials document the safety and efficacy of this form of PBS in orthopedic (and other) surgery.",
"   </p>",
"   <p>",
"    A newer blood salvage device, the OrthoPAT Orthopedic Perioperative Autotransfusion System (Transfusion Technologies Corp, Natick, MA) has been introduced specifically for use in orthopedic surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10582/abstract/25\">",
"     25",
"    </a>",
"    ]. This system is portable, computer-controlled, does not require a designated operator, and uses a dynamic disk separation chamber to wash small volumes of wound drainage blood. Among its proposed benefits are the fact that the same system can be used to collect blood throughout the intraoperative and postoperative periods as well as its ability to collect and wash small, as well as variable, volumes of shed blood in one single-patient use set. Clinical data are scarce but suggest that there may be an emerging role for such devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4033979\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In blood salvage techniques, blood that is shed during or after surgery (or trauma) is retrieved, processed, and returned to the patient. Processing can be as simple as filtration or, most commonly, involves centrifugation and washing prior to re-transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4033987\">",
"    <span class=\"h2\">",
"     Intraoperative salvage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative blood salvage (IBS) is unique among autologous transfusion methods because of its capacity to rapidly provide immense quantities of autologous blood. IBS can be utilized throughout a surgical procedure and can replace blood in proportion to the volume lost. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Technology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IBS is widely applied in high blood use surgical procedures. When used as the principal form of blood replacement, it avoids the substantial (up to 50 percent) wastage of blood collected and not transfused via preoperative autologous donation.",
"     </li>",
"     <li>",
"      IBS is considered acceptable by some Jehovah's witnesses, provided the blood does not leave the operating room for processing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10986?source=see_link\">",
"       \"The approach to the patient who refuses blood transfusion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IBS may be valuable for the patient with serologic problems for whom crossmatch-compatible blood is unobtainable.",
"     </li>",
"     <li>",
"      Some contraindications to the use of IBS are absolute, such as the potential for the simultaneous collection during salvage of microfibrillar collagen hemostats used to promote local hemostasis. Other contraindications are relative, as with a patient with a known blood-borne infectious disease, which could endanger health care workers should the IBS apparatus malfunction. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unprocessed blood taken from a systemically anticoagulated patient does not carry a substantially increased risk of inducing a coagulopathy. However, unprocessed blood taken from the surgical abdomen of a nonanticoagulated patient appears to increase the potential for inducing a coagulopathy when infused, and its use should be avoided, when possible. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Product quality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of IBS include air embolism, coagulopathy, disseminated intravascular coagulation, infection, fat embolism, and microembolization from contaminating microaggregates. Many of these complications can be avoided. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4034366\">",
"    <span class=\"h2\">",
"     Postoperative salvage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative blood salvage (PBS) refers to the collection of blood from surgical drains and reinfusion with or without processing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood drained from the chest or mediastinum following cardiac surgery does not clot. It can therefore be collected in a filtered system and returned to the patient without further processing. The dilute, partially hemolyzed blood, contains elevated levels of fibrin degradation products, which can induce a transient coagulopathy and increase bleeding. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cardiac surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PBS in orthopedic surgery is less established than in cardiac surgery and is somewhat controversial. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Orthopedic surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/1\">",
"      Williamson KR, Taswell HF, Rettke SR, Krom RA. Intraoperative autologous transfusion: its role in orthotopic liver transplantation. Mayo Clin Proc 1989; 64:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/2\">",
"      Griffith LD, Billman GF, Daily PO, Lane TA. Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. Ann Thorac Surg 1989; 47:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/3\">",
"      Breyer RH, Engelman RM, Rousou JA, Lemeshow S. Blood conservation for myocardial revascularization. Is it cost effective? J Thorac Cardiovasc Surg 1987; 93:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/4\">",
"      Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/5\">",
"      Hallett JW Jr, Popovsky M, Ilstrup D. Minimizing blood transfusions during abdominal aortic surgery: recent advances in rapid autotransfusion. J Vasc Surg 1987; 5:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/6\">",
"      Goulet JA, Bray TJ, Timmerman LA, et al. Intraoperative autologous transfusion in orthopaedic patients. J Bone Joint Surg Am 1989; 71:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/7\">",
"      Hart OJ 3rd, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet 1989; 168:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/8\">",
"      MacIvor D, Nelson J, Triulzi D. Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion 2009; 49:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/9\">",
"      Jurkovich GJ, Moore EE, Medina G. Autotransfusion in trauma. A pragmatic analysis. Am J Surg 1984; 148:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/10\">",
"      Brown CV, Foulkrod KH, Sadler HT, et al. Autologous blood transfusion during emergency trauma operations. Arch Surg 2010; 145:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/11\">",
"      Silva PD, Beguin EA Jr. Intraoperative rapid autologous blood transfusion. Am J Obstet Gynecol 1989; 160:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/12\">",
"      The Watchtower Bible and Tract Society. Questions from readers. The Watchtower 1989; 110:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/13\">",
"      Cimochowski GE, Gray DW, Fardin R. Implosion/explosion of a Bentley cardiotomy reservoir during autotransfusion with a cell saver. J Extra-corporeal Technol 1985; 17:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/14\">",
"      Nagarsheth NP, Sharma T, Shander A, Awan A. Blood salvage use in gynecologic oncology. Transfusion 2009; 49:2048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/15\">",
"      Raval JS, Nelson JB, Woldemichael E, Triulzi DJ. Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 2012; 52:2590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/16\">",
"      Timberlake GA, McSwain NE Jr. Autotransfusion of blood contaminated by enteric contents: a potentially life-saving measure in the massively hemorrhaging trauma patient? J Trauma 1988; 28:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/17\">",
"      Bull BS, Bull MH. The salvaged blood syndrome: a sequel to mechanochemical activation of platelets and leukocytes? Blood Cells 1990; 16:5.",
"     </a>",
"    </li>",
"    <li>",
"     Standards for blood banks and transfusion services, 16th ed, Klein HG (Ed), American Association of Blood Banks, Bethesda, MD 1994.",
"    </li>",
"    <li>",
"     Lane TA. Blood salvage in cardiovascular surgery. In: Perioperative Autologous Transfusion, Stehling L (Ed), American Association of Blood Banks, Arlington, VA 1991. p.67.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/20\">",
"      Andrews NJ, Bloor K. Autologous blood collection in abdominal vascular surgery. Assessment of a low pressure blood salvage system with particular reference to the preservation of cellular elements, triglyceride, complement and bacterial content in the collected blood. Clin Lab Haematol 1983; 5:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/21\">",
"      Adan A, Brutel de la Rivi&egrave;re A, Haas F, et al. Autotransfusion of drained mediastinal blood after cardiac surgery: a reappraisal. Thorac Cardiovasc Surg 1988; 36:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/22\">",
"      Semkiw LB, Schurman DJ, Goodman SB, Woolson ST. Postoperative blood salvage using the Cell Saver after total joint arthroplasty. J Bone Joint Surg Am 1989; 71:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/23\">",
"      Umlas J, Foster RR, Dalal SA, et al. Red cell loss following orthopedic surgery: the case against postoperative blood salvage. Transfusion 1994; 34:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/24\">",
"      de Haan J, Sch&ouml;nberger J, Haan J, et al. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10582/abstract/25\">",
"      Warner C. The use of the orthopaedic perioperative autotransfusion (OrthoPAT) system in total joint replacement surgery. Orthop Nurs 2001; 20:29.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7937 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-125.69.132.100-32DA4B247A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10582=[""].join("\n");
var outline_f10_21_10582=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4033979\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INTRAOPERATIVE BLOOD SALVAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Technology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Product quality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Standards",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      POSTOPERATIVE BLOOD SALVAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Orthopedic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4033979\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4033987\">",
"      Intraoperative salvage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4034366\">",
"      Postoperative salvage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37684?source=related_link\">",
"      Acute normovolemic intraoperative hemodilution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=related_link\">",
"      Preoperative autologous blood donation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10986?source=related_link\">",
"      The approach to the patient who refuses blood transfusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_21_10583="Ultrasound image of embryo in gestational sac";
var content_f10_21_10583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F76430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F76430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Measurement of embryo in gestational sac",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 515px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Image of an early gestational sac demonstrating the early embryo. Calipers are placed at both ends of the embryo measuring the longest length from the \"crown to the rump,\" giving the crownrump length. This measurement is used for dating the pregnancy. Surrounding the embryo is the developing amnion as shown by the hyperechoic circular line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10583=[""].join("\n");
var outline_f10_21_10583=null;
var title_f10_21_10584="Warthins tumor Light";
var content_f10_21_10584=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F61792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F61792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 574px\">",
"   <div class=\"ttl\">",
"    Warthin's tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 554px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power (left panel) and high power (right panel) of a Warthin's tumor, a characteristically cystic lesion with well-formed papillae and a prominent lymphocytic stroma. Note the bilayered epithelium consisting of eosinophilic columnar cells (black arrow). A mucous cell is seen at the lower right (red arrow). Squamous or mucinous metaplasia may be confused with a mucoepidermoid carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of G Kenneth Haines, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10584=[""].join("\n");
var outline_f10_21_10584=null;
var title_f10_21_10585="Future diagnostic tools for food allergy";
var content_f10_21_10585=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Future diagnostic tools for food allergy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Doerthe A Andreae, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Wayne G Shreffler, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10585/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/21/10585/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The current tools available for diagnosing food allergy include the clinical history, physical examination, trial elimination diets, diet diaries, prick skin testing (PST), and allergen-specific serum IgE testing. Clinician-supervised oral food challenges remain the gold standard and are often required to confirm or rule out the diagnosis, because of the limitations in the diagnostic accuracy of the other methods available.",
"   </p>",
"   <p>",
"    Improved or new testing methodologies are needed for determining the presence and severity of a food allergy, and the likelihood of resolution of an allergy. This topic reviews improvements in available diagnostic tools and new testing methods that are in development. Current diagnostic tools are discussed separately, as is the initial evaluation of a patient with suspected food allergy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=see_link\">",
"     \"History and physical examination in the patient with possible food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of medical testing for food allergy must be thought of in the context of the suspected mechanism of pathogenesis (ie, IgE- or non-IgE mediated) and the limitations of available testing. IgE-mediated food allergy is more common, better understood, and more actively researched. There is also active research on testing for non-IgE mediated and 'IgE-associated' diseases that are believed to be driven, wholly or partly, by dietary proteins (eg, eosinophilic esophagitis, atopic dermatitis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=see_link\">",
"     \"History and physical examination in the patient with possible food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a persistent and wide gap between the number of individuals who believe they have food allergies and the true prevalence (approximately 30 and 5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/1\">",
"     1",
"    </a>",
"    ]. Part of this discrepancy stems from confusion regarding allergic (ie, immune mediated) reactions versus other adverse reactions to foods. Diagnostic test limitations, including the low specificity of specific IgE for true allergy (particularly when used qualitatively), also contribute to over diagnosis.",
"   </p>",
"   <p>",
"    Research efforts are focused on improving diagnostic tests and on developing tests that have better prognostic performance. To address current limitations, investigators are attempting to characterize the patient immune response in ever greater detail to find phenotypes that more closely correlate with the clinical disease aspect of interest.",
"   </p>",
"   <p>",
"    Instead of measuring the IgE response to complex allergen extracts, investigators are evaluating the specificity of that response on the level of individual allergens ('component resolved diagnosis'), or the epitopes of those allergens ('epitope mapping' or 'profiling'). They are measuring the fraction of total IgE that is allergen-specific, the affinity of the allergen-specific IgE, and the presence and specificity of other, potentially inhibitory, antibodies (eg, IgG4). Methods of assessing the patient's effector cell response to allergen (eg, 'basophil activation testing') are also under investigation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TECHNOLOGICAL ADVANCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several technical developments have gone hand-in-hand with the search for better diagnostic tools for food allergy. Current diagnostic techniques based upon crude allergen extracts suffer from several factors affecting specificity, including potential cross-contamination with other allergens [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/2\">",
"     2",
"    </a>",
"    ] and the presence of highly cross-reactive carbohydrate epitopes [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/3\">",
"     3",
"    </a>",
"    ]. There has been a massive effort to identify, clone, and express major allergens from hundreds of sources. Assays are also being developed in tandem with the molecular characterization of allergens. As an example, microarray-based assays allow numerous proteins to be probed simultaneously, thus requiring minute amounts of patient serum. In addition, recombinant allergens can be used for traditional skin prick testing or other functional tests, such as basophil activation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Allergen microarrays",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of microarrays for food allergy diagnosis has two direct applications: evaluation of sensitization to multiple allergens using protein arrays, and evaluation of allergen epitope recognition patterns using peptide arrays [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Protein allergen microarrays have been developed with up to 5000 allergens on a single assay [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/5-13\">",
"     5-13",
"    </a>",
"    ]. Overall, microarray assays correlate well with serum IgE measurements, although they tend to be somewhat less sensitive. There are a few protein microarray panels that focus on food allergy specifically, although none have US Food and Drug Administration approval yet. This approach is promising, but more prospective studies showing clinical application need to be performed.",
"   </p>",
"   <p>",
"    Epitope pattern analysis by microarray has been applied to food allergy. However, existing literature on the correlation between epitope recognition and clinical reactivity or prognosis is scant. Several studies linking epitope recognition patterns and clinical allergy using methods other than peptide and protein microarray have been performed previously [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Microarray is a versatile tool to define and identify binding patterns and informative epitopes [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An advantage of the microarray approach is that it allows for practical, whole sequence epitope analysis, using individual patient serum [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. As an example, in the case of peanut allergy, there is a high degree of heterogeneity in epitope recognition that is not practical to measure with older methods [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional innovations include multiple antibody isotype detection using different fluorochrome channels, and more sophisticated statistical analyses that can detect multiple epitopes recognized by a population of patients even when the epitopes share overlapping sequences [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Microarray technology allows for evaluation of a patient's B-cell repertoire to a given set of allergens. Peptide and protein microarrays may be particularly useful in better understanding associated antibody repertoire changes in both natural and immunotherapy-induced tolerance.",
"   </p>",
"   <p>",
"    One major disadvantage of the existing technology is its limitation to linear, sequential epitopes. Additional recombinant-based approaches have begun to address this problem [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Basophil activation testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basophils are specifically sensitized effector cells that are readily accessible from the peripheral blood. Basophil responsiveness may have higher specificity than specific IgE testing when judging clinical reactivity, because activation of these cells is a biologic response [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common form of the basophil activation test (BAT) involves direct activation with antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/23\">",
"     23",
"    </a>",
"    ]. Flow cytometry is used to identify the population of basophils and measure their activation based upon upregulation of cell-surface proteins (eg, CD63 and CD203c) that are associated with release of mediators [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     IgE-MEDIATED FOOD ALLERGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A key concept regarding IgE-mediated food allergy is the distinction between sensitization and allergy. Sensitization refers to the presence of IgE capable of binding to a particular antigen, as evidenced by detection in serum by an allergen binding assay or indirectly by mast cell degranulation induced by prick skin testing (PST). Mast cell activation by non-IgE mediated mechanisms is theoretically possible with PST, but this is not regarded as a common problem, unlike with drug allergy. Nonspecific IgE-binding and technical restrictions are potential limitations of serum binding assays.",
"   </p>",
"   <p>",
"    More fundamentally, however, production of specific IgE is necessary for immediate hypersensitivity, but is not sufficient for clinical allergy. Individuals may have positive testing (PST or in vitro) and yet fully tolerate the antigen in the diet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9178323\">",
"    <span class=\"h3\">",
"     Component-resolved diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several plant foods contain proteins that are homologous to plant aeroallergens. This cross-reactivity can lead to overdiagnosis of food allergies. The component-resolved diagnostic approach can improve specificity and improve understanding of cross-reactivity and cosensitization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=see_link\">",
"     \"Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following studies are illustrative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2010 study examining peanut allergy versus sensitization revealed that IgE binding to Ara h 2 was the most predictive of allergy versus tolerance in sensitized individuals, compared with IgE binding to other peanut allergens [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/25\">",
"       25",
"      </a>",
"      ]. Eleven percent",
"      <span class=\"nowrap\">",
"       (110/933)",
"      </span>",
"      of children from a population birth cohort in the United Kingdom were sensitized to peanut at eight years of age. Approximately two-thirds of them (66 of 91 fully assessed) passed oral food challenges, about one-fifth were allergic (12 by convincing history without challenge, seven by challenge), and the remainder (n = 6) were deemed inconclusive. Peanut-specific IgE levels were significantly higher in the allergic group (supplemented by an additional 12 known peanut allergic children), while the tolerant group had more allergic rhinitis, fewer known food allergies, and higher grass-specific IgE.",
"      <br/>",
"      <br/>",
"      The misclassification rate using a peanut-specific IgE level of &ge;15",
"      <span class=\"nowrap\">",
"       kU/L",
"      </span>",
"      or a PST wheal size of &ge;8 mm (results often cited to indicate &gt;95 percent positive predictive value) was about 15 percent in this study [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/25\">",
"       25",
"      </a>",
"      ]. The overall misclassification rate was reduced to about 7 percent using results from a microarray that included multiple recombinant allergens from peanut, tree pollens, grass pollens, and the major glycan structures that make up the 'cross-reactive carbohydrate determinants'.",
"     </li>",
"     <li>",
"      Another study using a microarray with recombinant wheat seed and grass allergens was able to discriminate baker's asthma, food allergy to wheat, and grass pollen allergy more clearly than was possible using crude extracts of wheat or grass allergen extracts [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/26\">",
"       26",
"      </a>",
"      ]. Patients did not overlap clinically and were from geographically distinct areas (Spain and",
"      <span class=\"nowrap\">",
"       Germany/Austria),",
"      </span>",
"      which may undermine this study's applicability to other populations with differing patterns of dominant aeroallergens.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982316\">",
"    <span class=\"h3\">",
"     Allergen epitope profiling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food allergens must at least partially survive digestion and absorption from the gastrointestinal tract to be immunogenic. This fact has lead to the hypothesis that individuals who have IgE antibodies recognizing a greater number or a specific pattern of sequential epitopes (eg, those not easily destroyed by denaturation and partial digestion) are more likely to have clinical allergy rather than asymptomatic IgE sensitization [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple studies have found correlations between epitope patterns, defined using peptides, and clinical disease. Examples of investigations supporting the concept that IgE epitope-recognition patterns can predict clinical outcomes are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Researchers analyzed IgE binding of eight sequential epitopes of the major peanut allergens, Ara h 1, 2, and 3. Ninety-three percent (n = 14) of patients with clinical reactivity to peanut recognized at least one of the immunodominant epitopes of Ara h 1 or 2 in contrast to 12 percent (n = 2) of peanut tolerant subjects with IgE sensitization [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/28\">",
"       28",
"      </a>",
"      ]. Furthermore, reactive patients recognized a greater number of epitopes than tolerant patients. Testing for IgE-binding epitopes may decrease the need for oral challenges to determine if sensitized patients are clinically reactive or tolerant.",
"     </li>",
"     <li>",
"      Another group identified specific epitopes of major wheat allergens, omega-5 gliadin and a high molecular weight glutenin subunit, that were recognized by 97 percent (n = 29) of patients with wheat-dependent exercise-induced anaphylaxis, but were not recognized by wheat-sensitized patients with atopic dermatitis [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26777?source=see_link\">",
"       \"Exercise-induced anaphylaxis: Clinical manifestations, epidemiology, pathogenesis, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, one study has provided evidence that short sequential epitopes contribute little to IgE binding to two major food allergens, Ara h 2 and Pen a 1, from peanut and shrimp, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982323\">",
"    <span class=\"h3\">",
"     Cellular/functional assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of the basophil activation test (BAT) in food allergy diagnosis is increasingly under investigation. One study examined its performance for predicting challenge outcomes in a group of 71 children with egg or milk allergy previously diagnosed by challenge or convincing history [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/32\">",
"     32",
"    </a>",
"    ]. Performance characteristics using optimal cutoff points were comparable to earlier studies following the same design for skin or IgE testing.",
"   </p>",
"   <p>",
"    Other studies suggest that BAT is also comparable to skin or in vitro (CAP-FEIA) specific IgE testing in its ability to distinguish clinical allergy from sensitization alone in patients with food-pollen allergy syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. One study examined the use of BAT with recombinant allergens for the diagnosis of food allergy in three groups of 20 birch-allergic patients with clinical allergy to apple, carrot, or celery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/35\">",
"     35",
"    </a>",
"    ]. Using the recombinant profilin allergens (Mal d 1, Dau c 1, and Api g 1), they achieved sensitivities and specificities of 75 and 68 percent, 75 and 77 percent, and 65 and 100 percent for apple, carrot, and celery, respectively. These results were comparable to CAP-FEIA, but less sensitive than prick-prick skin testing using fresh fruit or vegetable.",
"   </p>",
"   <p>",
"    BAT may also help differentiate between sensitization and clinical allergy in patients with a history of clinical reactivity to one food allergen, and a positive test to another cross-reactive allergen. Ses i 6 is a seed storage protein that has partial immunologic cross-reactivity with a walnut protein, Jug r 4. Basophils passively sensitized with sera from sesame-allergic, walnut-sensitized patients are activated by Ses i 6, but not Jug r 4 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    T cell responses to food allergens may also eventually prove useful in determining if a patient is sensitized or clinically allergic. As an example, T cell proliferation to crude peanut extract and major peanut allergens was studied in children with peanut allergy (n = 18) or peanut sensitization (n = 7) and nonallergic adults (n = 11) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/38\">",
"     38",
"    </a>",
"    ]. The T cell response to crude peanut extract was stronger in children with peanut allergy than those with peanut sensitization or adults without peanut allergy. Only the children with peanut allergy had detectable IL-13 production in response to major peanut allergens (Ara h 1, Ara h 3, and Ara h 6).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982330\">",
"    <span class=\"h3\">",
"     Other diagnostic assessments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various eosinophil mediators, including eosinophil cationic protein (ECP) in serum or stool, and eosinophil-derived neurotoxin (EDN) or eosinophil protein X (EPX) in urine, have been proposed for the diagnosis of food allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. The utility of these tests remains to be seen. They may prove more useful in diagnosing non-IgE mediated eosinophilic inflammatory disorders, such as eosinophilic esophagitis (EoE). (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Non-IgE mediated or mixed food allergy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Non-encoding microRNAs (miRNAs) are other potential EoE biomarkers. Some of these miRNAs are differentially expressed in EoE, either constitutively or specifically with inflammation, compared with normal healthy controls and those with reflux esophagitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/41\">",
"     41",
"    </a>",
"    ]. Several of these miRNAs are detectable in peripheral blood, making them promising noninvasive alternatives to endoscopic biopsy for diagnosing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    monitoring disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beyond accurate diagnosis of food allergy, there are some closely related prognostic questions confronting food allergic patients, their families, and health care providers. Two of the most common questions are: \"Who is at risk for anaphylaxis?\" and for children, \"Will the allergy be outgrown?\".",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Clinical severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reaction severity cannot be reliably predicted from food-specific serum IgE concentrations. The ability to identify those at higher risk for severe reactions would potentially allow for more efficient targeting of resources to those individuals. As in the case of accurate diagnosis, cross-reactivity between inhalant and food proteins has a large impact on the poor association between measured specific IgE to whole allergen source extracts and the clinical phenotype. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982337\">",
"    <span class=\"h4\">",
"     Component-resolved diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study of patients with peanut allergy suggests that differential binding to the three major recombinant peanut allergens may predict allergy severity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/42\">",
"     42",
"    </a>",
"    ]. Sensitization to food lipid transfer proteins, as opposed to the Bet v 1 homologous family or to profilins, is associated with systemic rather than oropharyngeal reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982344\">",
"    <span class=\"h4\">",
"     Allergen epitope profiling",
"    </span>",
"    &nbsp;&mdash;&nbsp;A positive relationship between the diversity of the IgE response to both peanut and milk proteins and reaction severity has been demonstrated. The total number of peanut or milk proteins (epitopes) recognized by patient IgE directly correlates with severity of clinical symptoms during the respective food challenge [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/44-46\">",
"     44-46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, in a retrospective study, IgE from patients with more severe reactions recognized a greater number of peanut allergen epitopes compared with those who had milder reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/18\">",
"     18",
"    </a>",
"    ]. In these same subjects, commercially available tests for peanut-specific IgE levels did not distinguish between the two groups. Further support for the hypothesis that IgE diversity was functionally distinct came from the finding that basophils sensitized in vitro, using sera from patients with greater IgE epitope diversity, degranulated more strongly in response to peanut antigen, but not to anti-IgE control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982351\">",
"    <span class=\"h4\">",
"     Cellular/functional assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;BAT may be useful for distinguishing patients with a more severe phenotype of food allergy. As an example, basophils of patients with more persistent and severe milk allergy had basophils that were more reactive to milk in vivo, whereas natural resolution of the allergy was associated with basophil suppression [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/47\">",
"     47",
"    </a>",
"    ]. Prospective studies are needed to validate this observation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Disease persistence",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important question for patients and clinicians managing the allergic patient is whether or not the allergy is likely to persist. Differences in patient IgE responses may be helpful in making this determination. This will be increasingly important as new therapies become available that focus on patients not likely to outgrow their allergy spontaneously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"     \"The natural history of childhood food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982358\">",
"    <span class=\"h4\">",
"     Allergen epitope profiling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Differences in epitope-specific IgE are seen between patients with persistent versus transient food allergy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two studies of cow's milk allergy, one focusing on epitopes of whey proteins [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/48\">",
"       48",
"      </a>",
"      ] and one on alpha s1-casein [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/14\">",
"       14",
"      </a>",
"      ], showed that patients with transient milk allergy recognized fewer sequential epitopes than those with persistent allergy.",
"     </li>",
"     <li>",
"      A study defining IgE and IgG4 binding milk allergen epitopes using peptide microarray described 10 epitopes that appear to distinguish between tolerant and reactive patient groups [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/49\">",
"       49",
"      </a>",
"      ]. In another study, persistent milk allergy was associated with stable IgE epitope recognition, in contrast to transient allergy, which was associated with falling IgE, but increasing IgG4 epitope recognition [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study of cow's milk allergy found that patients who were still allergic had both high- and low-affinity IgE binding, whereas those who tolerated extensively heated milk (eg, in baked goods) or who had outgrown their milk allergy had mainly low-affinity IgE binding [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One small study of hen's egg allergy demonstrated that all patients (n = 7) with persistent allergy recognized four major IgE-binding epitopes in ovomucoid, while none of the children who outgrew their egg allergy (n = 11) did so [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study evaluated five IgE-binding casein peptides associated with persistent cow's milk allergy that were coupled to a commercial matrix (ImmunoCAP) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/51\">",
"       51",
"      </a>",
"      ]. Milk peptide-specific IgE was significantly higher in children who did not outgrow their cow's milk allergy by a median age of eight years compared with children's whose allergy resolved by a median of three or eight years of age (early or late resolution).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19982365\">",
"    <span class=\"h4\">",
"     Cellular/functional assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combined expression of the T regulatory and Th2 cell markers FoxP3, IL-16, Nfat-C2, and GATA-3 is predictive of persistent cow&rsquo;s milk allergy compared with patients who had early resolution of the allergy or who were nonatopic according to neural network analysis, which mimics biologic neural networks [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An elevated basophil activation test (BAT) was predictive of persisting milk allergy and correlated with the eliciting dose of cow&rsquo;s milk in a series of children who underwent oral challenges to reassess their allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5301673\">",
"    <span class=\"h3\">",
"     Other assessments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelet-activating factor (PAF) and the enzyme that degrades it, PAF acetylhydrolase, are potential markers of anaphylaxis severity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/54\">",
"     54",
"    </a>",
"    ]. In a case-control study, there was a direct correlation between serum PAF levels, and an inverse correlation between serum PAF acetylhydrolase activity, and severity of anaphylaxis. Biomarkers that may be useful in disease monitoring for eosinophilic esophagitis are discussed above. (See",
"    <a class=\"local\" href=\"#H19982330\">",
"     'Other diagnostic assessments'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     NON-IgE MEDIATED OR MIXED FOOD ALLERGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic testing for food allergy not thought to be directly caused by IgE is much more problematic.",
"   </p>",
"   <p>",
"    Traditional IgE testing may be helpful for allergic diseases that are associated with IgE in many patients (eg, atopic dermatitis, allergic eosinophilic gastrointestinal disorders). However, neither the sensitivity nor the specificity of the IgE testing is certain. In addition, the causative role of food antigens in these conditions is not universally accepted, although at least for eosinophilic esophagitis (EoE), the evidence is strong. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Furthermore, some forms of food allergy (eg, food protein-induced enterocolitis syndrome) are unequivocally provoked by food specific immunity, but are generally not associated with IgE [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This section will briefly discuss ongoing development of potential diagnostic tools for these conditions. Potential biomarkers for diagnosing and monitoring EoE are discussed above. (See",
"    <a class=\"local\" href=\"#H19982330\">",
"     'Other diagnostic assessments'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Atopy patch testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patch testing is a method for eliciting delayed-type hypersensitivity reactions in sensitized subjects. Patient skin is exposed to allergen for prolonged periods (usually 48 hours) and reactions are generally interpreted at 72 hours. Patch testing is the gold standard for the assessment of contact allergen sensitization, but is only recently being evaluated for food allergies. The atopy patch test (APT) has been applied to both IgE associated (eg, atopic dermatitis and allergic eosinophilic gastrointestinal disorders) and non-IgE associated conditions (eg, food protein-induced enterocolitis syndrome).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Atopic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have examined the use of the atopy patch test (APT) in children with atopic dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/56-64\">",
"     56-64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the early studies examining the utility of patch testing in children with atopic dermatitis compared traditional skin testing, serum IgE testing, and patch testing to the results of 133 double blind placebo controlled food challenges, 77 of which were positive [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/56\">",
"     56",
"    </a>",
"    ]. The APT was positive in 55 percent of patients with positive food challenges",
"    <span class=\"nowrap\">",
"     (42/77),",
"    </span>",
"    whereas IgE testing was positive in approximately 85 percent. However, in the 21 patients who experienced only late onset symptoms (eg, worsening eczema greater than two hours following challenge), patch testing was superior to either serum IgE measurement or skin prick testing (SPT). The positive predictive value and negative predictive value for patch testing for these delayed reactions was 81 percent and 93 percent, respectively, compared with approximately 40 percent and 75 percent for IgE-based testing.",
"   </p>",
"   <p>",
"    Similarly, other studies have concluded that patch testing is more sensitive for the diagnosis of food-associated atopic dermatitis, particularly in younger children [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. However, one smaller study failed to show that the APT improved the diagnostic accuracy of detecting egg-associated eczema over SPT [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/59\">",
"     59",
"    </a>",
"    ]. Another study found increased sensitivity, but at the cost of lower specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/60\">",
"     60",
"    </a>",
"    ]. The authors concluded that combined testing was most beneficial.",
"   </p>",
"   <p>",
"    The addition of the APT is unlikely to significantly reduce the need for oral food challenges, even though combined testing (APT plus SPT or specific IgE measurement) has improved sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Gastrointestinal food allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of patch testing has also been investigated in children with gastrointestinal symptoms, including those with a diagnosis of allergic eosinophilic esophagitis (AEE, EE, or EoE) or gastroenteritis (AEG or EG) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/63-71\">",
"     63-71",
"    </a>",
"    ]. The use of atopy patch testing in the diagnosis and management of EoE is discussed in detail separately. Its utility in other gastrointestinal disorders is discussed below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30534?source=see_link\">",
"     \"Allergy testing in eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The sensitivity of APT for diagnosing food allergy-related gastrointestinal symptoms increased significantly in one study when fresh foods were used for testing, rather than commercial food extracts [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/65\">",
"     65",
"    </a>",
"    ]. Sensitivity for fresh food versus commercial extract, respectively, was 64 percent versus 6 percent for cow's milk and 84 percent versus 5 percent for hen's egg. In this study, the specificity of APT was high regardless of the preparation used for testing (95 percent for cow's milk and 100 percent for hen's egg). Results from another study suggest that a ready-to-use APT for cow&rsquo;s milk may have better sensitivity and test accuracy than an APT prepared in clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/64\">",
"     64",
"    </a>",
"    ]. Overall, further study is needed to confirm the utility of patch testing in the diagnosis of specific food allergies in eosinophilic gastrointestinal disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43703?source=see_link\">",
"     \"Eosinophilic gastroenteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A retrospective study evaluated patients with gastrointestinal milk allergy diagnosed by elimination followed by oral challenge [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/66\">",
"     66",
"    </a>",
"    ]. These patients' symptoms were largely consistent with EoE or AEG, although they did not have biopsy confirmed diagnoses. Of the 35 patients, 24 were found to be milk allergic by challenge. Only three of these patients had milk-specific IgE, but",
"    <span class=\"nowrap\">",
"     19/24",
"    </span>",
"    were patch test positive. Among the non-cow's milk allergic group (n = 11), none were IgE positive and one was patch test positive, resulting in sensitivity and specificity of 79 percent and 91 percent, respectively for the APT.",
"   </p>",
"   <p>",
"    A study of 19 patients suspected of food protein-induced enterocolitis syndrome (FPIES) compared results of patch testing with open challenge results [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/71\">",
"     71",
"    </a>",
"    ]. Twelve of these patients had positive reactions to a total of 16 foods. In all, 33 challenges were compared with patch test results. The patch test had a sensitivity and specificity of 100 percent and 71 percent, respectively. APT will be a significant tool for the safe introduction of foods in children diagnosed with FPIES if this high degree of sensitivity holds true in larger studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     T cell stimulation tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;One approach for the development of diagnostic tests in the case of non-IgE associated food allergies thought to be exclusively mediated by cellular immunity (eg, FPIES) involves measuring T cell responses to food allergens. Patients with late onset milk reactions and negative specific IgE testing produce higher levels of IFN-gamma than either tolerant controls or IgE-mediated reactors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/72\">",
"     72",
"    </a>",
"    ]. Peripheral blood mononuclear cells (PBMCs) from infants with delayed gastrointestinal symptoms due to milk, secrete large amounts of TNF-alpha, peaking at days one and five after stimulation with cow's milk proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/73\">",
"     73",
"    </a>",
"    ]. Infants with immediate hypersensitivity symptoms have peak TNF-alpha secretion at 24 hours, but low levels by day five. Changes in PBMC responses in patients who have outgrown their gastrointestinal allergy to milk may be related to the induction of tolerance-inducing regulatory T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10585/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between the gastrointestinal allergic symptoms of patients in these studies and the well-defined clinical syndrome FPIES is not entirely clear, and this work has not been widely replicated. In addition, T cell-based tests are relatively laborious and require skilled technicians. However, an in vitro test would be useful for selected cases of FPIES that are suspected to be provoked by multiple food antigens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral food challenges are often required to confirm or rule out presence or resolution of a food allergy because of the limitations in the diagnostic accuracy of prick skin testing (PST) and serum tests. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Improved or additional testing methods are needed for determining the severity of a food allergy, sensitization versus clinical allergy, and likelihood of resolution of an allergy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'IgE-Mediated Food Allergy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Research is promising for improved diagnostics for IgE-mediated allergy, using recombinant allergens, IgE-binding epitopes, and microarrays. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'IgE-Mediated Food Allergy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic tests for non-IgE mediated food allergy remain to be refined and validated, before they will be available in the clinic. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Non-IgE mediated or mixed food allergy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/1\">",
"      Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA 2010; 303:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/2\">",
"      van der Veen MJ, Mulder M, Witteman AM, et al. False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol 1996; 98:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/3\">",
"      van der Veen MJ, van Ree R, Aalberse RC, et al. Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins. J Allergy Clin Immunol 1997; 100:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/4\">",
"      Shreffler WG. Microarrayed recombinant allergens for diagnostic testing. J Allergy Clin Immunol 2011; 127:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/5\">",
"      Bacarese-Hamilton T, Gray J, Ardizzoni A, Crisanti A. Allergen microarrays. Methods Mol Med 2005; 114:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/6\">",
"      Deinhofer K, Sevcik H, Balic N, et al. Microarrayed allergens for IgE profiling. Methods 2004; 32:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/7\">",
"      Harwanegg C, Hiller R. Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development. Clin Chem Lab Med 2005; 43:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/8\">",
"      Hiller R, Laffer S, Harwanegg C, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/9\">",
"      Jahn-Schmid B, Harwanegg C, Hiller R, et al. Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin Exp Allergy 2003; 33:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/10\">",
"      Kim TE, Park SW, Cho NY, et al. Quantitative measurement of serum allergen-specific IgE on protein chip. Exp Mol Med 2002; 34:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/11\">",
"      Lebrun SJ, Petchpud WN, Hui A, McLaughlin CS. Development of a sensitive, colorometric microarray assay for allergen-responsive human IgE. J Immunol Methods 2005; 300:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/12\">",
"      Wiltshire S, O'Malley S, Lambert J, et al. Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clin Chem 2000; 46:1990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/13\">",
"      W&ouml;hrl S, Vigl K, Zehetmayer S, et al. The performance of a component-based allergen-microarray in clinical practice. Allergy 2006; 61:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/14\">",
"      Chatchatee P, J&auml;rvinen KM, Bardina L, et al. Identification of IgE- and IgG-binding epitopes on alpha(s1)-casein: differences in patients with persistent and transient cow's milk allergy. J Allergy Clin Immunol 2001; 107:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/15\">",
"      J&auml;rvinen KM, Beyer K, Vila L, et al. Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy. Allergy 2007; 62:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/16\">",
"      Lin J, Sampson HA. The role of immunoglobulin E-binding epitopes in the characterization of food allergy. Curr Opin Allergy Clin Immunol 2009; 9:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/17\">",
"      Lin J, Bardina L, Shreffler WG, et al. Development of a novel peptide microarray for large-scale epitope mapping of food allergens. J Allergy Clin Immunol 2009; 124:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/18\">",
"      Shreffler WG, Beyer K, Chu TH, et al. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 2004; 113:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/19\">",
"      Shreffler WG, Lencer DA, Bardina L, Sampson HA. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol 2005; 116:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/20\">",
"      Alcocer MJ, Murtagh GJ, Wilson PB, et al. The major human structural IgE epitope of the Brazil nut allergen Ber e 1: a chimaeric and protein microarray approach. J Mol Biol 2004; 343:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/21\">",
"      Ocmant A, Mulier S, Hanssens L, et al. Basophil activation tests for the diagnosis of food allergy in children. Clin Exp Allergy 2009; 39:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/22\">",
"      Shreffler WG. Evaluation of basophil activation in food allergy: present and future applications. Curr Opin Allergy Clin Immunol 2006; 6:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/23\">",
"      Sturm GJ, Kranzelbinder B, Sturm EM, et al. The basophil activation test in the diagnosis of allergy: technical issues and critical factors. Allergy 2009; 64:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/24\">",
"      de Weck AL, Sanz ML, Gamboa PM, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008; 146:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/25\">",
"      Nicolaou N, Poorafshar M, Murray C, et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010; 125:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/26\">",
"      Constantin C, Quirce S, Poorafshar M, et al. Micro-arrayed wheat seed and grass pollen allergens for component-resolved diagnosis. Allergy 2009; 64:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/27\">",
"      Sampson HA. Improving in-vitro tests for the diagnosis of food hypersensitivity. Curr Opin Allergy Clin Immunol 2002; 2:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/28\">",
"      Beyer K, Ellman-Grunther L, J&auml;rvinen KM, et al. Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J Allergy Clin Immunol 2003; 112:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/29\">",
"      Matsuo H, Kohno K, Niihara H, Morita E. Specific IgE determination to epitope peptides of omega-5 gliadin and high molecular weight glutenin subunit is a useful tool for diagnosis of wheat-dependent exercise-induced anaphylaxis. J Immunol 2005; 175:8116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/30\">",
"      Matsuo H, Morita E, Tatham AS, et al. Identification of the IgE-binding epitope in omega-5 gliadin, a major allergen in wheat-dependent exercise-induced anaphylaxis. J Biol Chem 2004; 279:12135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/31\">",
"      Albrecht M, K&uuml;hne Y, Ballmer-Weber BK, et al. Relevance of IgE binding to short peptides for the allergenic activity of food allergens. J Allergy Clin Immunol 2009; 124:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/32\">",
"      Sato S, Tachimoto H, Shukuya A, et al. Basophil activation marker CD203c is useful in the diagnosis of hen's egg and cow's milk allergies in children. Int Arch Allergy Immunol 2010; 152 Suppl 1:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/33\">",
"      Ebo DG, Hagendorens MM, Bridts CH, et al. Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy. Cytometry B Clin Cytom 2005; 64:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/34\">",
"      Erdmann SM, Heussen N, Moll-Slodowy S, et al. CD63 expression on basophils as a tool for the diagnosis of pollen-associated food allergy: sensitivity and specificity. Clin Exp Allergy 2003; 33:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/35\">",
"      Erdmann SM, Sachs B, Schmidt A, et al. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test. Int Arch Allergy Immunol 2005; 136:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/36\">",
"      Moneret-Vautrin DA, Sainte-Laudy J, Kanny G, Fr&eacute;mont S. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 1999; 82:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/37\">",
"      Wallowitz ML, Chen RJ, Tzen JT, Teuber SS. Ses i 6, the sesame 11S globulin, can activate basophils and shows cross-reactivity with walnut in vitro. Clin Exp Allergy 2007; 37:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/38\">",
"      Flinterman AE, Pasmans SG, den Hartog Jager CF, et al. T cell responses to major peanut allergens in children with and without peanut allergy. Clin Exp Allergy 2010; 40:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/39\">",
"      Saarinen KM, Suomalainen H, Savilahti E. Diagnostic value of skin-prick and patch tests and serum eosinophil cationic protein and cow's milk-specific IgE in infants with cow's milk allergy. Clin Exp Allergy 2001; 31:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/40\">",
"      Schwab D, Raithel M, Klein P, et al. Immunoglobulin E and eosinophilic cationic protein in segmental lavage fluid of the small and large bowel identify patients with food allergy. Am J Gastroenterol 2001; 96:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/41\">",
"      Lu TX, Sherrill JD, Wen T, et al. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol 2012; 129:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/42\">",
"      Astier C, Morisset M, Roitel O, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol 2006; 118:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/43\">",
"      Asero R, Mistrello G, Roncarolo D, et al. Lipid transfer protein: a pan-allergen in plant-derived foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol 2001; 124:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/44\">",
"      Flinterman AE, Knol EF, Lencer DA, et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol 2008; 121:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/45\">",
"      Lewis SA, Grimshaw KE, Warner JO, Hourihane JO. The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms. Clin Exp Allergy 2005; 35:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/46\">",
"      Wang J, Lin J, Bardina L, et al. Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy. J Allergy Clin Immunol 2010; 125:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/47\">",
"      Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009; 123:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/48\">",
"      J&auml;rvinen KM, Chatchatee P, Bardina L, et al. IgE and IgG binding epitopes on alpha-lactalbumin and beta-lactoglobulin in cow's milk allergy. Int Arch Allergy Immunol 2001; 126:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/49\">",
"      Cerecedo I, Zamora J, Shreffler WG, et al. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol 2008; 122:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/50\">",
"      Savilahti EM, Rantanen V, Lin JS, et al. Early recovery from cow's milk allergy is associated with decreasing IgE and increasing IgG4 binding to cow's milk epitopes. J Allergy Clin Immunol 2010; 125:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/51\">",
"      Beyer K, Jarvinen KM, Bardina L, et al. IgE-binding peptides coupled to a commercial matrix as a diagnostic instrument for persistent cow's milk allergy. J Allergy Clin Immunol 2005; 116:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/52\">",
"      Savilahti EM, Karinen S, Salo HM, et al. Combined T regulatory cell and Th2 expression profile identifies children with cow's milk allergy. Clin Immunol 2010; 136:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/53\">",
"      Rubio A, Vivinus-N&eacute;bot M, Bourrier T, et al. Benefit of the basophil activation test in deciding when to reintroduce cow's milk in allergic children. Allergy 2011; 66:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/54\">",
"      Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 358:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/55\">",
"      Nowak-Wegrzyn A, Sampson HA, Wood RA, Sicherer SH. Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics 2003; 111:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/56\">",
"      Niggemann B, Reibel S, Wahn U. The atopy patch test (APT)-- a useful tool for the diagnosis of food allergy in children with atopic dermatitis. Allergy 2000; 55:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/57\">",
"      Majamaa H, Moisio P, Holm K, et al. Cow's milk allergy: diagnostic accuracy of skin prick and patch tests and specific IgE. Allergy 1999; 54:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/58\">",
"      Str&ouml;mberg L. Diagnostic accuracy of the atopy patch test and the skin-prick test for the diagnosis of food allergy in young children with atopic eczema/dermatitis syndrome. Acta Paediatr 2002; 91:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/59\">",
"      Hansen TK, H&oslash;st A, Bindslev-Jensen C. An evaluation of the diagnostic value of different skin tests with egg in clinically egg-allergic children having atopic dermatitis. Pediatr Allergy Immunol 2004; 15:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/60\">",
"      Giusti F, Seidenari S. Patch testing with egg represents a useful integration to diagnosis of egg allergy in children with atopic dermatitis. Pediatr Dermatol 2005; 22:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/61\">",
"      Devillers AC, de Waard-van der Spek FB, Mulder PG, Oranje AP. Delayed- and immediate-type reactions in the atopy patch test with food allergens in young children with atopic dermatitis. Pediatr Allergy Immunol 2009; 20:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/62\">",
"      Mehl A, Rolinck-Werninghaus C, Staden U, et al. The atopy patch test in the diagnostic workup of suspected food-related symptoms in children. J Allergy Clin Immunol 2006; 118:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/63\">",
"      Pustisek N, Jaklin-Kekez A, Frkanec R, et al. Our experiences with the use of atopy patch test in the diagnosis of cow's milk hypersensitivity. Acta Dermatovenerol Croat 2010; 18:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/64\">",
"      Kalach N, Soulaines P, de Boissieu D, Dupont C. A pilot study of the usefulness and safety of a ready-to-use atopy patch test (Diallertest) versus a comparator (Finn Chamber) during cow's milk allergy in children. J Allergy Clin Immunol 2005; 116:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/65\">",
"      Canani RB, Ruotolo S, Auricchio L, et al. Diagnostic accuracy of the atopy patch test in children with food allergy-related gastrointestinal symptoms. Allergy 2007; 62:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/66\">",
"      De Boissieu D, Waguet JC, Dupont C. The atopy patch tests for detection of cow's milk allergy with digestive symptoms. J Pediatr 2003; 142:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/67\">",
"      Assa'ad A. Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol 2005; 95:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/68\">",
"      Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005; 95:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/69\">",
"      Spergel JM, Beausoleil J, Brown-Whitehorn T, Liacouras CA. Authors' response to detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol 2006; 96:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/70\">",
"      Spergel JM, Brown-Whitehorn T, Beausoleil JL, et al. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol 2007; 119:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/71\">",
"      Fogg MI, Brown-Whitehorn TA, Pawlowski NA, Spergel JM. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol 2006; 17:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/72\">",
"      Hill DJ, Ball G, Hosking CS, Wood PR. Gamma-interferon production in cow milk allergy. Allergy 1993; 48:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/73\">",
"      Benlounes N, Candalh C, Matarazzo P, et al. The time-course of milk antigen-induced TNF-alpha secretion differs according to the clinical symptoms in children with cow's milk allergy. J Allergy Clin Immunol 1999; 104:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10585/abstract/74\">",
"      Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199:1679.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2414 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-EC2EE36D8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10585=[""].join("\n");
var outline_f10_21_10585=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TECHNOLOGICAL ADVANCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Allergen microarrays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Basophil activation testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      IgE-MEDIATED FOOD ALLERGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9178323\">",
"      - Component-resolved diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19982316\">",
"      - Allergen epitope profiling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19982323\">",
"      - Cellular/functional assays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19982330\">",
"      - Other diagnostic assessments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Clinical severity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19982337\">",
"      Component-resolved diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19982344\">",
"      Allergen epitope profiling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19982351\">",
"      Cellular/functional assays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Disease persistence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19982358\">",
"      Allergen epitope profiling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19982365\">",
"      Cellular/functional assays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5301673\">",
"      - Other assessments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      NON-IgE MEDIATED OR MIXED FOOD ALLERGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Atopy patch testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Gastrointestinal food allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      T cell stimulation tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30534?source=related_link\">",
"      Allergy testing in eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=related_link\">",
"      Diagnostic evaluation of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43703?source=related_link\">",
"      Eosinophilic gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26777?source=related_link\">",
"      Exercise-induced anaphylaxis: Clinical manifestations, epidemiology, pathogenesis, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=related_link\">",
"      History and physical examination in the patient with possible food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=related_link\">",
"      Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=related_link\">",
"      The natural history of childhood food allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_21_10586="Viral meningitis: Clinical features and diagnosis in children";
var content_f10_21_10586=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"19\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Viral meningitis: Clinical features and diagnosis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Cecilia Di Pentima, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/21/10586/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/21/10586/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology, clinical manifestations, diagnosis, and differential diagnosis of viral meningitis in children will be reviewed here. The epidemiology, pathogenesis, management, prognosis, and prevention are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22809?source=see_link\">",
"     \"Viral meningitis: Epidemiology, pathogenesis, and etiology in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link\">",
"     \"Viral meningitis: Management, prognosis, and prevention in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meningitis &ndash; Meningitis is inflammation of the meninges, manifest by cerebrospinal fluid (CSF) pleocytosis (ie, an increased number of white blood cells [WBC]) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1\">",
"       1",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Aseptic meningitis is the clinical syndrome of meningeal inflammation with negative cultures for routine bacterial pathogens in a patient who did not receive antibiotics before lumbar puncture [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1-4\">",
"       1-4",
"      </a>",
"      ]. Aseptic meningitis has a number of infectious and noninfectious causes (",
"      <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"       table 1",
"      </a>",
"      ). Viruses (usually enteroviruses) are the most common cause (",
"      <a class=\"graphic graphic_table graphicRef56505 \" href=\"UTD.htm?30/3/30781\">",
"       table 2",
"      </a>",
"      ). Because viruses are the most common cause of aseptic meningitis, the terms aseptic meningitis and viral meningitis are sometimes used synonymously.",
"     </li>",
"     <li>",
"      Encephalitis &ndash; Encephalitis is inflammation of the brain parenchyma that produces neurologic dysfunction (eg, altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; hemiparesis; and paresthesias) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/5\">",
"       5",
"      </a>",
"      ]. Encephalitis may occur during or after a viral infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=see_link&amp;anchor=H7#H7\">",
"       \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Viral etiologies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myelitis &ndash; Myelitis is inflammation of the spinal cord, manifest by flaccid paralysis and reduced or absent reflexes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link&amp;anchor=H8#H8\">",
"       \"Disorders affecting the spinal cord\", section on 'Acute viral myelitis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence or absence of normal brain function distinguishes meningitis from encephalitis. Certain viruses usually cause isolated meningitis or isolated encephalitis. Others cause less discrete manifestations of central nervous system (CNS) infection, described as meningoencephalitis or encephalomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1\">",
"     1",
"    </a>",
"    ]. Although the distinction between meningitis and encephalitis is sometimes blurred, it is important to try to distinguish between them because the likely causes differ (",
"    <a class=\"graphic graphic_table graphicRef56505 \" href=\"UTD.htm?30/3/30781\">",
"     table 2",
"    </a>",
"    ). The discussion that follows will focus on viruses that most often cause meningitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=see_link&amp;anchor=H7#H7\">",
"     \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Viral etiologies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical features of viral meningitis in children vary with age, immune status, and etiologic agent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1,6\">",
"     1,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Common features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The manifestations of viral meningitis are generally similar to those of bacterial meningitis, but often are less severe [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features and diagnosis of bacterial meningitis in the neonate\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neonates may have an abrupt onset of fever accompanied by nonspecific symptoms (eg, poor feeding, vomiting, diarrhea, rash, respiratory symptoms). Neurologic manifestations may be minimal, ranging from no symptoms, to irritability and lethargy, to frank nuchal rigidity or bulging fontanelle [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1,6,8\">",
"     1,6,8",
"    </a>",
"    ]. Central nervous system (CNS) disease may progress to encephalitis with seizures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    focal neurologic findings [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/9\">",
"     9",
"    </a>",
"    ]. Neonates are at increased risk for severe systemic disease, particularly with herpes simplex virus (HSV). Systemic manifestations may include pneumonia, hepatitis with necrosis, myocarditis, and necrotizing enterocolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/9\">",
"     9",
"    </a>",
"    ]. Disseminated intravascular coagulation and other findings of sepsis can mimic overwhelming bacterial infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H9#H9\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Disseminated disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Older children may present with acute onset of fever, headache, nausea, vomiting, stiff neck, and photophobia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical findings in neonates and older children are variable. Nuchal rigidity, bulging fontanelle, and manifestations of particular viruses (eg, rash, conjunctivitis, pharyngitis, diarrhea) tend to be the most prevalent findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Features associated with specific viruses",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Enteroviruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteroviruses (EV) include poliovirus, coxsackievirus, echovirus, and the numbered enteroviruses. Meningitis due to enteroviruses is associated with the acute onset of fever that ranges from 38 to 40&ordm;C in more than 50 percent of cases and is sometimes biphasic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1,8,10-12\">",
"     1,8,10-12",
"    </a>",
"    ]. Fever is generally accompanied by nonspecific constitutional symptoms, such as anorexia, nausea, vomiting, exanthem, myalgias, and upper and lower respiratory symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Older children typically complain of fever, headaches (usually retroorbital or frontal), and photophobia. More than one-half of adults and children older than one to two years present with nuchal rigidity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1,11,12,14\">",
"     1,11,12,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical features suggestive of EV include conjunctivitis, pharyngitis, rash, herpangina, and hand-foot-mouth disease (",
"    <a class=\"graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef53423 \" href=\"UTD.htm?19/31/19960\">",
"     picture 1A-C",
"    </a>",
"    ). EV71, which usually causes hand-foot-mouth disease, also may cause more severe illness including cranial nerve palsies, flaccid paralysis, and pulmonary edema [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Herpesviruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSV infections of the CNS in neonates manifest primarily as encephalitis with or without multiorgan involvement; however, meningitis in this age group also can present with fever as the only manifestation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/19\">",
"     19",
"    </a>",
"    ]. The long-term prognosis for infants with disseminated HSV",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    HSV encephalitis is poor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H4#H4\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/48/40713?source=see_link&amp;anchor=H13#H13\">",
"     \"Neonatal herpes simplex virus infection: Management and prevention\", section on 'Outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Older children, teenagers, and adults with primary HSV infection who develop encephalitis generally present with fever, altered mental status, focal neurologic deficits, and seizures. Those with meningitis generally present with fever and classic symptoms of meningitis (eg, fever, stiff neck, headache, photophobia). HSV and other herpesvirus meningitis may be complicated by sacral radiculopathy (manifest by urinary retention, constipation, paresthesia, and motor weakness) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=see_link\">",
"     \"Herpes simplex virus type 1 encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Arboviruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arboviruses are spread by arthropod or insect vectors (eg, mosquitoes, ticks, sand flies) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/13\">",
"     13",
"    </a>",
"    ]. The clinical manifestations of meningitis caused by arboviruses are similar to those of other viral pathogens. Most cases are characterized by the acute onset of fever, chills, headaches, nausea, vomiting, and nuchal rigidity in the absence of focal neurologic findings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The manifestations of St. Louis encephalitis (SLE) virus range from a mild \"flu-like\" illness to fatal encephalitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38023?source=see_link\">",
"       \"St. Louis encephalitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The manifestations of La Crosse (California) encephalitis, which primarily occurs in children, include fever, focal neurologic signs, and focal seizures that mimic HSV encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=see_link&amp;anchor=H13#H13\">",
"       \"Arthropod-borne encephalitides\", section on 'La Crosse encephalitis virus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      West Nile virus (WNV) is characterized by fever, headache, malaise, back pain, myalgias, and anorexia. A maculopapular rash appears in approximately one-half of patients (",
"      <a class=\"graphic graphic_picture graphicRef54623 \" href=\"UTD.htm?6/38/6756\">",
"       picture 2",
"      </a>",
"      ). Some manifestations seen in adults (eg, weakness, peripheral neuropathy, diffuse paralysis) are rare in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22264?source=see_link\">",
"       \"Clinical manifestations and diagnosis of West Nile virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Western equine encephalitis (WEE) virus infection is characterized by headache, vomiting, stiff neck, and backache; restlessness, irritability, and seizures are common in children. Neurologic sequelae are relatively common in infants. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=see_link&amp;anchor=H11#H11\">",
"       \"Arthropod-borne encephalitides\", section on 'Western equine encephalitis virus'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link&amp;anchor=H16#H16\">",
"       \"Viral meningitis: Management, prognosis, and prevention in children\", section on 'Prognosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Powassan virus infection is characterized by a short prodrome of fever, malaise, headache, sore throat, and progressive neurologic deterioration [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/22\">",
"       22",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=see_link&amp;anchor=H23#H23\">",
"       \"Arthropod-borne encephalitides\", section on 'Powassan virus'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other viruses",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Human parechovirus &ndash; Most human parechovirus (HPeV) infections occur in infants. The spectrum of clinical manifestations includes neonatal sepsis, meningitis, encephalitis, and paralysis [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/23-31\">",
"       23-31",
"      </a>",
"      ]. In a retrospective review of 58 cases in which HPeV was isolated from the cerebrospinal fluid, the mean age was 6.6 weeks; the most common symptoms were irritability, fever, and nonspecific rash [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/30,32\">",
"       30,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lymphocytic choriomeningitis virus &ndash; Most lymphocytic choriomeningitis virus (LCMV) infections are asymptomatic or associated with mild constitutional symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1,33\">",
"       1,33",
"      </a>",
"      ]. Symptomatic infection manifests as a biphasic illness with an initial phase characterized by fever, malaise, photophobia, headache, nausea, vomiting, sore throat, and adenopathy. Signs and symptoms of CNS disease develop in the second phase, which follows resolution of fever.",
"      <br/>",
"      <br/>",
"      Congenital infection is characterized by chorioretinitis (affecting more than 90 percent of infants in reported cases), micro- or macrocephaly, and neurologic sequelae including seizures, intellectual disability (mental retardation), and cerebral palsy [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/34\">",
"       34",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Meningitis develops in approximately 15 percent of confirmed cases of LCMV [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1\">",
"       1",
"      </a>",
"      ]. Encephalitis and meningoencephalitis are rare complications of LCMV [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1\">",
"       1",
"      </a>",
"      ]. Other complications include transverse myelitis, Guillain-Barr&eacute; syndrome, myocarditis, pneumonitis, and parotitis.",
"     </li>",
"     <li>",
"      Rabies &ndash; Rabies infection, which is more commonly associated with encephalomyelitis, is heralded by a prodrome of 2 to 10 days of nonspecific symptoms such as fever, headache, malaise, myalgias, cough, sore throat, nausea, and vomiting [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/8\">",
"       8",
"      </a>",
"      ]. Anxiety, hallucinations, nightmares, and insomnia may occur during this early stage [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/35\">",
"       35",
"      </a>",
"      ]. Rapid and progressive neurologic deterioration occurs in one to two weeks, leading to coma and death, usually by the third week of illness [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29624?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rabies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Influenza &ndash; Influenza A and B infections of the CNS are preceded by the classic symptoms of typical influenza infection: fever, coryza, cough, vomiting, headaches, and diarrhea. Neurologic manifestations develop within one to four days after the onset of symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Neurologic'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mumps &ndash; Mumps infection is frequently accompanied by a nonspecific prodrome consisting of low-grade fever, malaise, headache, myalgias, and anorexia. These symptoms are generally followed within 48 hours by the development of painful parotitis, the hallmark of mumps infection.",
"      <br/>",
"      <br/>",
"      Meningitis occurs in approximately 1 to 10 percent of mumps infections [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/36\">",
"       36",
"      </a>",
"      ]. CNS infection usually manifests about five days after parotitis, but it may occur as much as two weeks later or one week earlier [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. Mumps meningitis generally has a benign course with full neurologic recovery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/61/8154?source=see_link\">",
"       \"Epidemiology, clinical manifestations, diagnosis and management of mumps\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic approach to suspected aseptic meningitis focuses on identification of conditions and pathogens that require specific therapy (",
"    <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Children who are suspected of having meningitis should be treated as if they have bacterial meningitis until bacterial meningitis has been excluded or a specific viral diagnosis has been made. This includes rapid evaluation and stabilization of cardiorespiratory and hemodynamic status and obtaining initial laboratory studies as soon as is possible (",
"    <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Viral meningitis may be suspected on the basis of epidemiologic data, clinical features, and initial cerebrospinal fluid (CSF) studies, but clinical features cannot reliably differentiate viral from bacterial meningitis; the CSF profiles of bacterial and viral meningitis overlap, particularly during the earliest stages of bacterial meningitis (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/13,39\">",
"     13,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of viral meningitis requires positive identification of a viral pathogen from CSF or other patient samples (eg, blood, urine, throat swab, stool or rectal swab). The identification of a specific viral pathogen may affect treatment and prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link&amp;anchor=H14#H14\">",
"     \"Viral meningitis: Management, prognosis, and prevention in children\", section on 'Specific therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonviral etiologies of meningoencephalitis that require specific therapy should be considered in children with negative CSF cultures for routine bacterial pathogens, particularly when the presentation has atypical features (eg, immunocompromised host, history of exposure to ticks or animals, contacts with tuberculosis, etc) (",
"    <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information from the history helps prioritize among the possible causes of meningitis and aseptic meningitis (",
"    <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"     table 1",
"    </a>",
"    ). Important aspects of the history in a child with suspected viral meningitis include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/3,13,40\">",
"     3,13,40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of classic symptoms (fever, stiff neck, headache, photophobia) but without the presence of severe systemic disease (except for the neonate)",
"     </li>",
"     <li>",
"      Symptoms of encephalitis (eg, altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; hemiparesis; and paresthesias)",
"     </li>",
"     <li>",
"      Symptoms associated with specific viruses (eg, rash, sore throat, vomiting, diarrhea, genitourinary symptoms) (",
"      <a class=\"graphic graphic_table graphicRef56505 \" href=\"UTD.htm?30/3/30781\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Preceding illness (pneumonia or respiratory illness may indicate",
"      <em>",
"       Mycoplasma pneumoniae",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Exposure in preceding two to three weeks to: ill contacts; ticks, mosquitoes, or other animals, including pet rodents; water potentially contaminated with rodent droppings or urine; uncooked meat; swimming in hot springs (associated with primary amebic meningoencephalitis)",
"     </li>",
"     <li>",
"      Prenatal and perinatal history in the neonate and young infant (&lt;3 months), particularly related to congenital infection (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=see_link&amp;anchor=H650131395#H650131395\">",
"       \"Overview of TORCH infections\", section on 'Clinical features of TORCH infections'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Previous episodes (consider herpes simplex virus type 2 [HSV-2], epidermoid cyst)",
"     </li>",
"     <li>",
"      Sexual history and risk factors for human immunodeficiency virus (HIV) infection",
"     </li>",
"     <li>",
"      Immunization history",
"     </li>",
"     <li>",
"      Recent injections",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      medications, including antibiotics, nonsteroidal antiinflammatory drugs (NSAIDs), immunoglobulin",
"     </li>",
"     <li>",
"      Outbreaks of human or animal disease in the community, particularly by season (eg, enteroviruses [EV], influenza, West Nile virus [WNV], measles, rabies, Western equine encephalitis [WEE], etc)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The examination of the patient with suspected aseptic meningitis centers on assessment of meningeal inflammation, brain function (to exclude encephalitis), and clues to specific viral etiologies. Important aspects of the examination include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/3,13\">",
"     3,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Signs of meningeal inflammation (nuchal rigidity, Kernig and Brudzinski signs)",
"     </li>",
"     <li>",
"      Assessment of mental status (Glasgow coma scale) and presence of focal neurologic signs (suggestive of encephalitis or EV71)",
"     </li>",
"     <li>",
"      Findings associated with EV infection (eg, conjunctivitis, pharyngitis, rash, herpangina, hand-foot-mouth disease (",
"      <a class=\"graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef53423 \" href=\"UTD.htm?19/31/19960\">",
"       picture 1A-C",
"      </a>",
"      )) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Findings associated with other potential causes of viral meningitis (eg, generalized lymphadenopathy, suggestive of Epstein-Barr or HIV infection; oral or genital ulcers, suggestive of HSV infection; rash suggestive of chicken pox (",
"      <a class=\"graphic graphic_picture graphicRef55533 \" href=\"UTD.htm?36/3/36927\">",
"       picture 3",
"      </a>",
"      ); parotid swelling, suggestive of mumps (",
"      <a class=\"graphic graphic_picture graphicRef53503 \" href=\"UTD.htm?33/38/34415\">",
"       picture 4",
"      </a>",
"      ) or lymphocytic choriomeningitis virus [LCMV], palmar-plantar erythema suggestive of human parechovirus type 3 infection [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/32\">",
"       32",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Weakness or paralysis, which may occur with poliovirus or EV71",
"     </li>",
"     <li>",
"      Dermal sinus track in midline from coccyx to nose (associated with epidermoid cysts and direct connection with the central nervous system [CNS])",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) of the head is necessary before lumbar puncture in patients with signs or symptoms of increased intracranial pressure. Indications for head CT may include (",
"    <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/7,13,41\">",
"     7,13,41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Altered mental status (Glasgow coma scale [GCS] &lt;12 or drop in GCS of &ge;2)",
"     </li>",
"     <li>",
"      Immune deficiency",
"     </li>",
"     <li>",
"      Papilledema",
"     </li>",
"     <li>",
"      Focal neurologic deficit (excluding palsy of cranial nerves VI [abducens] or VII [facial])",
"     </li>",
"     <li>",
"      CSF shunt",
"     </li>",
"     <li>",
"      Hydrocephalus",
"     </li>",
"     <li>",
"      CNS trauma",
"     </li>",
"     <li>",
"      History of neurosurgery or a space-occupying lesions",
"     </li>",
"     <li>",
"      Signs or symptoms of parameningeal infection or tumor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neuroimaging with nuclear magnetic resonance (MRI)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    electroencephalography may be helpful in assessing brain inflammation and making the distinction between meningitis and encephalitis.",
"   </p>",
"   <p>",
"    Additional imaging studies may be necessary in select patients (eg, chest radiograph in children with a history of exposure to",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral meningitis may be suspected on the clinical and epidemiologic features, but the diagnosis requires a positive identification of a viral pathogen, most often in the context of a negative CSF culture for routine bacterial pathogens.",
"   </p>",
"   <p>",
"    The initial laboratory evaluation of a child with suspected meningitis includes blood tests and lumbar puncture. For children in whom viral meningitis is suspected, CSF studies, discussed below, are essential. Stool and throat swabs may be sent for viral culture [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/3\">",
"     3",
"    </a>",
"    ]. Further testing may be necessary to exclude nonviral causes of aseptic meningitis that require specific therapy, particularly in patients with an atypical presentation (eg, immunodeficiency, structural heart disease or hardware) or specific exposures (eg, tuberculosis, ticks, rodents). (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Virology'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Additional evaluation (including urinalysis, urine culture,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chest radiograph) is necessary for febrile infants younger than three months. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial blood tests for a child with suspected meningitis should include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/7,13\">",
"     7,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Blood cultures",
"     </li>",
"     <li>",
"      Complete blood count (CBC) with differential and platelet count",
"     </li>",
"     <li>",
"      Prothrombin time (PT), partial thromboplastin time (PTT) (particularly in patients with petechiae or purpura)",
"     </li>",
"     <li>",
"      Serum electrolytes, blood urea nitrogen (BUN), creatinine, and glucose",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional studies may be indicated if there are clinical clues suggestive of particular infections. These may include HSV whole blood PCR and serum alanine aminotransferase (ALT) for infants &lt;6 weeks of age with suspected disseminated HSV infection and serologic testing for measles, mumps, arboviruses, varicella, Epstein-Barr virus (EBV), LCMV, HIV, syphilis, and Lyme disease (",
"    <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/42\">",
"     42",
"    </a>",
"    ] .",
"   </p>",
"   <p>",
"    Although preliminary evidence suggests that measurement of inflammatory mediators (eg, C-reactive protein, procalcitonin, tumor necrosis factor) may be helpful in distinguishing viral from bacterial meningitis, these studies have limited availability",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    undetermined utility for early diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H27#H27\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Other tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     CSF studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the CSF is necessary to establish a diagnosis of meningitis and to make a provisional diagnosis of bacterial, viral, or unclear etiology. Lumbar puncture also may provide symptom relief in patients with viral meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CSF should be sent for Gram stain and bacterial culture, cell count, glucose, and protein. Viral studies (viral culture, polymerase chain reaction [PCR]) should be sent if the clinical picture suggests viral meningitis (",
"    <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Virology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Additional antigen detection tests (enzyme immunoassay, fluorescent antibody), pathogen-specific antibody tests,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cultures for bacteria, mycobacteria, fungi, and parasites may be necessary in special circumstances (eg, in immunocompromised hosts) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/3\">",
"     3",
"    </a>",
"    ]. It is helpful to reserve a tube of CSF for further testing, which may be necessary if the patient fails to improve as expected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link&amp;anchor=H15#H15\">",
"     \"Viral meningitis: Management, prognosis, and prevention in children\", section on 'Persistent symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H162433686\">",
"    <span class=\"h4\">",
"     Interpretation of CSF",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory features and diagnosis of bacterial meningitis are discussed in detail separately. The CSF findings in bacterial meningitis typically include: white blood cell (WBC) count of &gt;1000",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    with a predominance of neutrophils (polymorphonuclear leukocytes [PMN]); glucose &lt;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    and protein between 100 and 500",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Interpretation of CSF'",
"    </a>",
"    .) The characteristic findings of viral meningitis are summarized below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cell count and differential &ndash; WBC ranges from 10 to 500",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      (higher values can be seen with some viruses) (",
"      <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"       table 4",
"      </a>",
"      ). Normal CSF WBC counts can be seen in EV meningitis (particularly in young infants) and, more rarely, with HSV meningoencephalitis early in the course of infection [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/1,44-47\">",
"       1,44-47",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      There is a predominance of mononuclear cells in most cases of viral meningitis, although a PMN predominance has been described early (the first 24 to 48 hours) in the course of EV meningitis caused by the most common serotypes [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/39,48-50\">",
"       39,48-50",
"      </a>",
"      ]. Neither the presence nor quantity of bands (immature neutrophils) in the CSF helps to distinguish viral from bacterial meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Glucose &ndash; Normal or slightly reduced, but usually &ge;40 percent of the serum value (",
"      <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Protein &ndash; Normal to slightly elevated, but usually less than 150",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (may be as high as 900",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      in WNV) (",
"      <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Analysis of the CSF is not always predictive of viral or bacterial infection, since there is considerable overlap in the respective CSF findings (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/13,39,52,53\">",
"     13,39,52,53",
"    </a>",
"    ]. In addition, wide variations in CSF findings can occur during an outbreak of a single EV serotype [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/11,12,54,55\">",
"     11,12,54,55",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Virology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Samples of CSF should be sent for PCR analysis for EV and, in the appropriate patients, HSV and WNV. Blood HSV PCR is recommended for infants &lt;6 weeks of age if disseminated HSV is a consideration [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/42\">",
"     42",
"    </a>",
"    ]. Stool (or rectal swab) and throat swabs may be sent for viral culture to confirm PCR results for EV [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/3\">",
"     3",
"    </a>",
"    ]. Serologies may be obtained for the less common etiologies of viral meningitis; for some pathogens (eg, WNV), specific antibody determinations for IgG and IgM also may be performed on CSF. In addition, samples of blood and urine should be sent for viral studies when viral meningitis is suspected in immunocompromised children.",
"   </p>",
"   <p>",
"    PCR has largely replaced viral culture and serologic diagnosis of viral meningitis, improving diagnostic accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/56-60\">",
"     56-60",
"    </a>",
"    ]. PCR results are available sooner than viral culture results (5 to 24 hours compared with 4 to 8 days) and are available from several reference laboratories. Earlier identification of EV or human parechovirus may reduce unnecessary days of hospitalization, intravenous antibiotic therapy, and additional diagnostic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/13,14,60-62\">",
"     13,14,60-62",
"    </a>",
"    ]. It also may help inform prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Which virologic studies should be obtained depends upon the clinical scenario and suspected viral pathogens. Diagnostic testing for the most common causes of viral meningitis in children is discussed in detail separately, and summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enteroviruses. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Laboratory diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      HSV infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H11#H11\">",
"       \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Evaluation and diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arboviruses. Arboviruses are usually diagnosed serologically. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=see_link\">",
"       \"Arthropod-borne encephalitides\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38023?source=see_link&amp;anchor=H18#H18\">",
"       \"St. Louis encephalitis\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22264?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations and diagnosis of West Nile virus infection\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      LCMV infection. Diagnosis of LCMV infection can be achieved by isolation of the virus, serology testing, and RNA detection by PCR. Only serologic testing is widely available. The immunofluorescent antibody test for IgG and IgM has a better sensitivity than complement fixation or neutralizing antibody tests [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. An enzyme-linked immunosorbent assay (ELISA) test for both IgG and IgM is available only at the Centers for Disease Control and Prevention (CDC). PCR testing is not commercially available.",
"     </li>",
"     <li>",
"      Rabies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29624?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rabies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Influenza. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Laboratory diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pending CSF culture results, clinical features and initial CSF results can be used to make a provisional diagnosis of suspected viral meningitis. The diagnosis of viral meningitis is confirmed by negative bacterial cultures and identification of a virus through PCR, culture, antigen detection, or serology.",
"   </p>",
"   <p>",
"    Features supportive of a provisional diagnosis of viral meningitis include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/43,63\">",
"     43,63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      CSF WBC of &lt;500",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      with a mononuclear predominance",
"     </li>",
"     <li>",
"      Normal CSF glucose",
"     </li>",
"     <li>",
"      CSF protein &lt;100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Negative CSF Gram stain",
"     </li>",
"     <li>",
"      Enterovirus disease in the community or close contact with an individual with an enterovirus-compatible disease process",
"     </li>",
"     <li>",
"      Improvement in symptoms following lumbar puncture",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of children with suspected viral meningitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=see_link&amp;anchor=H2#H2\">",
"     \"Viral meningitis: Management, prognosis, and prevention in children\", section on 'Overview of approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is particularly important to consider causes of aseptic meningitis that require specific therapy and affect prognosis (",
"    <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Among nonviral conditions that may cause cerebrospinal fluid (CSF) pleocytosis with a predominance of mononuclear cells, the CSF glucose concentration helps narrow the differential diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/64\">",
"     64",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal CSF glucose concentration &ndash; Syphilis, Lyme disease, leptospirosis, Rocky Mountain spotted fever, ehrlichiosis, Kawasaki disease, postinfectious encephalomyelitis, and drugs (nonsteroidal antiinflammatory drugs [NSAIDs],",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/65\">",
"       65",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Decreased CSF glucose concentration &ndash; Partially treated bacterial meningitis,",
"      <em>",
"       Listeria monocytogenes",
"      </em>",
"      ,",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      , fungal infections, primary amebic meningoencephalitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Bacterial infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial infections can cause a clinical picture that overlaps with that of viral meningitis for a variety of reasons, including [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early in the disease process, bacteria do not always elicit a marked polymorphonuclear response",
"     </li>",
"     <li>",
"      Pathogens with unusual growth requirements may not grow in routine bacterial cultures (eg, Mycobacteria, spirochetes,",
"      <em>",
"       rickettsii",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Subtherapeutic concentrations of antibiotics administered for other reasons (eg, to treat otitis media) may inhibit bacterial growth",
"     </li>",
"     <li>",
"      Bacteria may be sequestered in pockets adjacent to, but not directly communicating with, the CSF (eg, sinuses, epidural abscess, subdural abscess)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bacterial meningitis is an important consideration in the differential diagnosis of viral meningitis. However, the clinical and laboratory presentations often overlap and it can be difficult to exclude bacterial meningitis with certainty. The Bacterial Meningitis Score (BMS) is a clinical prediction rule for children with CSF pleocytosis (CSF white blood cells [WBC] &ge;10",
"    <span class=\"nowrap\">",
"     cells/microL)",
"    </span>",
"    that classifies children who have not been pretreated with antibiotics at &ldquo;very low risk of bacterial meningitis&rdquo; if they",
"    <strong>",
"     lack",
"    </strong>",
"    all of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/69\">",
"     69",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Positive CSF Gram stain",
"     </li>",
"     <li>",
"      CSF absolute neutrophil count &ge;1000",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"     </li>",
"     <li>",
"      CSF protein &ge;80",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Peripheral blood ANC &ge;10,000",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"     </li>",
"     <li>",
"      History of seizure before or at the time of presentation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a meta-analysis of data from eight validation studies (one of which was prospective) including 5312 patients, the sensitivity and specificity of the BMS for bacterial meningitis were 99.3 percent (95% CI 98.7-99.7 percent) and 62.1 percent (60.5 to 63.7 percent), respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings suggest that the BMS may be used in conjunction with clinical judgment to identify children with CSF pleocytosis who are at very low risk of bacterial meningitis. To avoid misclassification, the BMS should not be used in children who are younger than two months, immunocompromised, ill-appearing, have been pretreated with antibiotics, have petechiae or purpura on examination, have a ventriculoperitoneal shunt, or have recently had neurosurgery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/21/10586/abstract/69,70\">",
"     69,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The interpretation of CSF in children who received antibiotics before lumbar puncture is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Interpretation of CSF'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Partially treated bacterial meningitis",
"      </strong>",
"      &ndash; The interpretation of CSF in children who received antibiotics before lumbar puncture is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Interpretation of CSF'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Parameningeal infection",
"      </strong>",
"      &ndash; Parameningeal infections include brain abscess, epidural or subdural abscess, and infections of the sinuses or ear that can occasionally extend to involve the CNS. Parameningeal infections can be diagnosed through neuroimaging. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17033?source=see_link\">",
"       \"Epidural abscess\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Lyme meningitis",
"      </strong>",
"      &ndash; Lyme disease, which may cause meningitis, occurs during the same season as enterovirus (EV) infection, the most common cause of culture-negative aseptic meningitis. Lyme disease usually occurs in older children and has a longer duration of symptoms than EV infection. Additional features suggestive of Lyme meningitis include erythema migrans (",
"      <a class=\"graphic graphic_picture graphicRef81270 graphicRef62480 graphicRef67424 \" href=\"UTD.htm?21/59/22457\">",
"       picture 5A-C",
"      </a>",
"      ) , cranial neuropathy, papilledema, and CSF neutrophil count &lt;10 percent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link&amp;anchor=H13#H13\">",
"       \"Lyme disease: Clinical manifestations in children\", section on 'Meningitis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Viral encephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral encephalitis is a febrile illness in which signs and symptoms of neurologic dysfunction indicate parenchymal brain involvement. Manifestations of encephalitis include: altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; hemiparesis; and paresthesias. The prognosis for viral encephalitis is usually worse than that for viral meningitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Immunocompromised host",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathogens that must be considered in immunocompromised hosts include unusual bacteria (",
"    <em>",
"     M. tuberculosis",
"    </em>",
"    and nontuberculous mycobacteria), fungi (eg,",
"    <em>",
"     cryptococcus",
"    </em>",
"    ), and parasites (",
"    <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/34/28194?source=see_link\">",
"       \"Patient information: Viral meningitis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/35/16946?source=see_link\">",
"       \"Patient information: Aseptic meningitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/48/1796?source=see_link\">",
"       \"Patient information: Meningitis in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aseptic meningitis is an acute illness with signs and symptoms of meningeal irritation, cerebrospinal fluid (CSF) pleocytosis, and negative routine bacterial cultures in a patient who did not receive antibiotics before lumbar puncture and has no associated neurologic dysfunction. Aseptic meningitis has a number of infectious and noninfectious causes, among which viruses are the most common (",
"      <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The manifestations of viral meningitis are generally similar to those of bacterial meningitis but are usually less severe. Neonates may present with abrupt onset of fever, nonspecific symptoms, and minimal neurologic manifestations. Older children may present with acute onset of fever, headache, nausea, vomiting, stiff neck, and photophobia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical features and diagnosis of bacterial meningitis in the neonate\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Enterovirus (EV) infection is the most common cause of viral meningitis. Clinical features suggestive of EV infections include conjunctivitis, pharyngitis, rash, herpangina, hand-foot-mouth disease (",
"      <a class=\"graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef53423 \" href=\"UTD.htm?19/31/19960\">",
"       picture 1A-C",
"      </a>",
"      ), and",
"      <span class=\"nowrap\">",
"       late-summer/early-fall",
"      </span>",
"      outbreaks of enteroviral disease in the community. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Enteroviruses'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children who are suspected of having meningitis should be treated as if they have bacterial meningitis until bacterial meningitis has been excluded (",
"      <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Empiric therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Viral meningitis may be suspected on the basis of epidemiologic data, clinical features, and initial CSF studies (",
"      <a class=\"graphic graphic_table graphicRef66525 \" href=\"UTD.htm?18/25/18845\">",
"       table 4",
"      </a>",
"      ), but clinical features cannot reliably differentiate viral from bacterial meningitis. The diagnosis of viral meningitis in a normal host requires negative CSF culture for routine bacteria and positive identification of a viral pathogen in the CSF or other patient samples. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonviral etiologies that require specific therapy also must be considered, particularly in severely ill patients and when the presentation has selected features, such as receipt of antibiotics before lumbar puncture, immunocompromised host, or history of various exposures (eg, ticks, tuberculosis) (",
"      <a class=\"graphic graphic_table graphicRef80651 \" href=\"UTD.htm?35/24/36237\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/1\">",
"      Rotbart HA. Viral meningitis. Semin Neurol 2000; 20:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/2\">",
"      Tapiainen T, Prevots R, Izurieta HS, et al. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 2007; 25:5793.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Bronstein DE. Aseptic meningitis and viral meningitis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.494.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/4\">",
"      Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Shields WD, Bronstein DE. Encephalitis and meningoencephalitis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.504.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/6\">",
"      Dagan R, Jenista JA, Menegus MA. Association of clinical presentation, laboratory findings, and virus serotypes with the presence of meningitis in hospitalized infants with enterovirus infection. J Pediatr 1988; 113:975.",
"     </a>",
"    </li>",
"    <li>",
"     Fleisher GR. Infectious disease emergencies. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, 2006. p.783.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/8\">",
"      Romero JR, Newland JG. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 2003; 14:72.",
"     </a>",
"    </li>",
"    <li>",
"     Romero JR. Aseptic and viral meningitis. In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG.  (Eds), Elsevier Saunders, Edinburgh 2012. p.292.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/10\">",
"      P&eacute;rez M&eacute;ndez C, O&ntilde;a Navarro M, Ballesteros Garc&iacute;a S, et al. [Enteroviral meningitis. Clinical and laboratory findings in a series of 60 children]. An Esp Pediatr 2001; 55:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/11\">",
"      Singer JI, Maur PR, Riley JP, Smith PB. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 1980; 96:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/12\">",
"      Wilfert CM, Lehrman SN, Katz SL. Enteroviruses and meningitis. Pediatr Infect Dis 1983; 2:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/13\">",
"      Logan SA, MacMahon E. Viral meningitis. BMJ 2008; 336:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/14\">",
"      Sawyer MH. Enterovirus infections: diagnosis and treatment. Semin Pediatr Infect Dis 2002; 13:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/15\">",
"      Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child 1980; 55:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/16\">",
"      Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007; 356:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/17\">",
"      Wu JM, Wang JN, Tsai YC, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 2002; 109:E26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/18\">",
"      Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999; 341:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/19\">",
"      Filippine MM, Katz BZ. Neonatal herpes simplex virus infection presenting with fever alone. J Hum Virol 2001; 4:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/20\">",
"      Kawamura M, Kaku H, Takayama N, et al. [Acute urinary retention secondary to aseptic meningoencephalitis in an infant--case report]. Brain Nerve 2007; 59:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/21\">",
"      McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001; 344:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/22\">",
"      Hicar MD, Edwards K, Bloch K. Powassan virus infection presenting as acute disseminated encephalomyelitis in Tennessee. Pediatr Infect Dis J 2011; 30:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/23\">",
"      Levorson RE, Jantausch BA. Human parechoviruses. Pediatr Infect Dis J 2009; 28:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/24\">",
"      Boivin G, Abed Y, Boucher FD. Human parechovirus 3 and neonatal infections. Emerg Infect Dis 2005; 11:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/25\">",
"      Benschop KS, Schinkel J, Minnaar RP, et al. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis 2006; 42:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/26\">",
"      Figueroa JP, Ashley D, King D, Hull B. An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J Med Virol 1989; 29:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/27\">",
"      Gubler DJ. The global resurgence of arboviral diseases. Trans R Soc Trop Med Hyg 1996; 90:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/28\">",
"      Verboon-Maciolek MA, Groenendaal F, Hahn CD, et al. Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 2008; 64:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/29\">",
"      Levorson RE, Jantausch BA, Wiedermann BL, et al. Human parechovirus-3 infection: emerging pathogen in neonatal sepsis. Pediatr Infect Dis J 2009; 28:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/30\">",
"      Selvarangan R, Nzabi M, Selvaraju SB, et al. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J 2011; 30:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/31\">",
"      Sharp J, Harrison CJ, Puckett K, et al. Characteristics of Young Infants in Whom Human Parechovirus, Enterovirus or Neither Were Detected in Cerebrospinal Fluid during Sepsis Evaluations. Pediatr Infect Dis J 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/32\">",
"      Shoji K, Komuro H, Miyata I, et al. Dermatologic Manifestations of Human Parechovirus Type 3 Infection in Neonates and Infants. Pediatr Infect Dis J 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/33\">",
"      Barton LL, Hyndman NJ. Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. Pediatrics 2000; 105:E35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/34\">",
"      Barton LL, Mets MB. Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis 2001; 33:370.",
"     </a>",
"    </li>",
"    <li>",
"     Whitley RJ. Rabies. In: Infections of the Central Nervous System, 2nd ed, Scheld MW, Durack WR (Eds), Lippincott Raven, Philadelphia 1997. p.181.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/36\">",
"      Hviid A, Rubin S, M&uuml;hlemann K. Mumps. Lancet 2008; 371:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/37\">",
"      Johnstone JA, Ross CA, Dunn M. Meningitis and encephalitis associated with mumps infection. A 10-year survey. Arch Dis Child 1972; 47:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/38\">",
"      RITTER BS. Mumps meningoencephalitis in children. J Pediatr 1958; 52:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/39\">",
"      Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000; 105:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/40\">",
"      Norris CM, Danis PG, Gardner TD. Aseptic meningitis in the newborn and young infant. Am Fam Physician 1999; 59:2761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/41\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/42\">",
"      Cantey JB, Mej&iacute;as A, Wallihan R, et al. Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. J Pediatr 2012; 161:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/43\">",
"      Jaffe M, Srugo I, Tirosh E, et al. The ameliorating effect of lumbar puncture in viral meningitis. Am J Dis Child 1989; 143:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/44\">",
"      Seiden JA, Zorc JJ, Hodinka RL, Shah SS. Lack of cerebrospinal fluid pleocytosis in young infants with enterovirus infections of the central nervous system. Pediatr Emerg Care 2010; 26:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/45\">",
"      Simko JP, Caliendo AM, Hogle K, Versalovic J. Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. Clin Infect Dis 2002; 35:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/46\">",
"      de Crom SC, van Furth MA, Peeters MF, et al. Characteristics of pediatric patients with enterovirus meningitis and no cerebral fluid pleocytosis. Eur J Pediatr 2012; 171:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/47\">",
"      Yun KW, Choi EH, Cheon DS, et al. Enteroviral meningitis without pleocytosis in children. Arch Dis Child 2012; 97:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/48\">",
"      Feigin RD, Shackelford PG. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med 1973; 289:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/49\">",
"      Amir J, Harel L, Frydman M, et al. Shift of cerebrospinal polymorphonuclear cell percentage in the early stage of aseptic meningitis. J Pediatr 1991; 119:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/50\">",
"      Rice SK, Heinl RE, Thornton LL, Opal SM. Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin Infect Dis 1995; 20:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/51\">",
"      Kanegaye JT, Nigrovic LE, Malley R, et al. Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis. Pediatrics 2009; 123:e967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/52\">",
"      Malcom BS, Eiden JJ, Hendley JO. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics 1980; 65:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/53\">",
"      Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/54\">",
"      Jarvis WR, Tucker G. Echovirus type 7 meningitis in young children. Am J Dis Child 1981; 135:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/55\">",
"      Howden CW, Lang WR, Laws J. An epidemic of Echo 9 virus meningitis in Auckland. N Z Med J 1966; 65:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/56\">",
"      Verboon-Maciolek MA, Nijhuis M, van Loon AM, et al. Diagnosis of enterovirus infection in the first 2 months of life by real-time polymerase chain reaction. Clin Infect Dis 2003; 37:1.",
"     </a>",
"    </li>",
"    <li>",
"     Aseptic and viral meningitis. In: Principles and Practice of Pediatric Infectious Diseases, 2nd ed, Churchill Livingstone, New York 2008. p.305.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/58\">",
"      Noordhoek GT, Weel JF, Poelstra E, et al. Clinical validation of a new real-time PCR assay for detection of enteroviruses and parechoviruses, and implications for diagnostic procedures. J Clin Virol 2008; 41:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/59\">",
"      Kupila L, Vuorinen T, Vainionp&auml; R, et al. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis 2005; 40:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/60\">",
"      Wolthers KC, Benschop KS, Schinkel J, et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin Infect Dis 2008; 47:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/61\">",
"      King RL, Lorch SA, Cohen DM, et al. Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger. Pediatrics 2007; 120:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/62\">",
"      Ramers C, Billman G, Hartin M, et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000; 283:2680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/63\">",
"      Overall JC Jr. Is it bacterial or viral? Laboratory differentiation. Pediatr Rev 1993; 14:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/64\">",
"      Roos KL. Pearls and pitfalls in the diagnosis and management of central nervous system infectious diseases. Semin Neurol 1998; 18:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/65\">",
"      Dengler LD, Capparelli EV, Bastian JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 1998; 17:478.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Bronstein DE. Aseptic meningitis and viral meningitis. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.494.",
"    </li>",
"    <li>",
"     Fleisher GR. Infectious disease emergencies. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.783.",
"    </li>",
"    <li>",
"     Sawyer MH, Rotbart HA. Aseptic and viral meningitis. In: Principles and Practice of Pediatric Infectious Diseases, 2nd ed, Long SS, Pickering LK, Prober CG (Eds), Churchill Livingstone, New York 2008. p.305.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/69\">",
"      Nigrovic LE, Kuppermann N, Macias CG, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA 2007; 297:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/21/10586/abstract/70\">",
"      Nigrovic LE, Malley R, Kuppermann N. Meta-analysis of bacterial meningitis score validation studies. Arch Dis Child 2012; 97:799.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5983 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-0AA24E0359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10586=[""].join("\n");
var outline_f10_21_10586=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Common features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Features associated with specific viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Enteroviruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Herpesviruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Arboviruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Blood tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - CSF studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H162433686\">",
"      Interpretation of CSF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Virology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Bacterial infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Viral encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Immunocompromised host",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5983\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5983|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?34/44/35521\" title=\"algorithm 1\">",
"      Management of suspected meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5983|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/2/13344\" title=\"picture 1A\">",
"      Hand-foot-and-mouth disease - buccal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/27/20912\" title=\"picture 1B\">",
"      Hand-foot-and-mouth disease - tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/22/14689\" title=\"picture 1C\">",
"      Hand-foot-and-mouth disease - foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/38/6756\" title=\"picture 2\">",
"      WNV fever and rash",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/3/36927\" title=\"picture 3\">",
"      Rash of primary varicella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/38/34415\" title=\"picture 4\">",
"      Parotid gland swelling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/10/10400\" title=\"picture 5A\">",
"      Erythema migrans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/16/19712\" title=\"picture 5B\">",
"      Erythema migrans bulls eye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/20/35140\" title=\"picture 5C\">",
"      EM vesicular",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5983|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/24/36237\" title=\"table 1\">",
"      Etiology aseptic meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/3/30781\" title=\"table 2\">",
"      Clues viral CNS infections children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/55/14204\" title=\"table 3\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/25/18845\" title=\"table 4\">",
"      CSF patterns viral meningitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=related_link\">",
"      Arthropod-borne encephalitides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=related_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22264?source=related_link\">",
"      Clinical manifestations and diagnosis of West Nile virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29624?source=related_link\">",
"      Clinical manifestations and diagnosis of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/61/8154?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis and management of mumps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17033?source=related_link\">",
"      Epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/62/1001?source=related_link\">",
"      Herpes simplex virus type 1 encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=related_link\">",
"      Lyme disease: Clinical manifestations in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/48/40713?source=related_link\">",
"      Neonatal herpes simplex virus infection: Management and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=related_link\">",
"      Overview of TORCH infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/35/16946?source=related_link\">",
"      Patient information: Aseptic meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/48/1796?source=related_link\">",
"      Patient information: Meningitis in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/34/28194?source=related_link\">",
"      Patient information: Viral meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38023?source=related_link\">",
"      St. Louis encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22809?source=related_link\">",
"      Viral meningitis: Epidemiology, pathogenesis, and etiology in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35640?source=related_link\">",
"      Viral meningitis: Management, prognosis, and prevention in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_21_10587="Comparison of advantages of the exercise ECG versus imaging";
var content_f10_21_10587=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F87059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F87059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of advantages of the exercise ECG versus imaging",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Exercise treadmill testing (ETT)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Imaging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lower cost",
"       </td>",
"       <td>",
"        Exercise or pharmacologic stress",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        More widely available",
"       </td>",
"       <td>",
"        Higher sensitivity than ETT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less influenced by technical processing",
"       </td>",
"       <td>",
"        Incremental prognostic value over ETT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less technically demanding",
"       </td>",
"       <td>",
"        Localize ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No radiation",
"       </td>",
"       <td>",
"        Additional information",
"        <br/>",
"        (cardiac structure and function)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10587=[""].join("\n");
var outline_f10_21_10587=null;
var title_f10_21_10588="Heat index and wet bulb globe temperature risk";
var content_f10_21_10588=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Heat illness risk based on heat index or wet bulb globe temperature",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Category",
"       </td>",
"       <td class=\"subtitle1\">",
"        Heat index &deg;C (&deg;F)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Wet bulb globe temperature &deg;C (&deg;F)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Suggested action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extreme danger",
"       </td>",
"       <td>",
"        &ge;52 (&ge;126)",
"       </td>",
"       <td>",
"        &gt;29 (&gt;85)",
"       </td>",
"       <td>",
"        Cancel organized athletic activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Danger",
"       </td>",
"       <td rowspan=\"3\">",
"        40-52 (104-125)",
"       </td>",
"       <td rowspan=\"3\">",
"        26-29 (79-84)",
"       </td>",
"       <td>",
"        Restrict activities for unacclimatized children and those at high risk for heat illness&bull;.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reschedule activities to a cooler time of day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase number of rest periods, hydration breaks, and frequency of substitution during practice and competition.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Extreme caution",
"       </td>",
"       <td rowspan=\"2\">",
"        33-40 (91-104)",
"       </td>",
"       <td rowspan=\"2\">",
"        24-25.9 (75-78.6)",
"       </td>",
"       <td>",
"        Reschedule activities to a cooler time of day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase number of rest periods, hydration breaks, and frequency of substitution during practice and competition.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Caution",
"       </td>",
"       <td>",
"        27-32 (80-90)",
"       </td>",
"       <td>",
"        &lt;24 (&lt;75)",
"       </td>",
"       <td>",
"        Unrestricted activity but monitor participants for signs of heat illness.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Full sun exposure may increase the heat index value by as much as 8&deg;C (15&deg;F).",
"     <br>",
"      &bull;&nbsp;Refer to&nbsp;table, \"Medical risk factors for heat illness in children\".",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Bytomski, JR, Squire, DL. Heat illness in children. Curr Sports Med Rep 2003; 2:320. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins and NOAA's national weather service heat index. National Oceanic and Atmospheric Administration. file://www.nws.noaa.gov/om/heat/index.shtml (Accessed on September 2, 2009).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10588=[""].join("\n");
var outline_f10_21_10588=null;
var title_f10_21_10589="QTd and inducible VT post MI";
var content_f10_21_10589=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54411&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54411&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    QT dispersion and inducibility of ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 373px; background-image: url(data:image/gif;base64,R0lGODlhdAF1AcQAAP///4CAgAAAAMDAwEBAQP8zAP9AEDAwMHBwcNDQ0BAQECAgIKCgoFBQUODg4LCwsPDw8JCQkP+zoGBgYH8ZAIA/ML9zYL8mAL+AcAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAB0AXUBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en4IOEQERECIQDAEMpiIPpA6gsYAEArUHIgcCtLcACAIHCgqwssR6DxAQCwIDDwINAA0CxwIKABECCMXaesoOAQIBAN8BA7oA5QTnAevsA9vvbNfZ4+Lg6OfmA+zrBOHw/2Z8TRAhr5eACAl+AWj2zMQ6gBDFRFuwboADAQsGdAOg7EE0BiceRhzZpZbJcAyU/y0ACSBBLgXZQvojSXOOyJo439zMyVPNzp5Ay/wMShTM0KJItxxVMaCpuxWoVLEiISrAgxFVr5IYkCBp0qUpTFLrWgLC01y7SjgIlivbWgVtRST4ls5rUbAoallzRhWBgnQMoUkj4SsCAAUCIBQ+nBgALXN2ieI9offeQloEWNKjN4KWO8+eHS8TYTky0MkmagXIBTIaAbIiNoMjERr06ND46pruibpELQKZW+Vq8HRvtsUjol3NlUA5AOakIe/m2ZuEXhMDJmAEeTHjRnMMnDVbACB8g/Fyrx0YMHU6zeojrp+AEGBgeZUsIfv9RXb/AbKP1VKceyTBR+CBPhiI4P+COSjI4IM0OAjhhC9ISOGFKliI4YYlaMjhhx5+uGGIIl5IYokTnojigyquuGCLmUhgQAEGSOBiETBiMmMBNN5IRI6X8Cikj0MAacmOPRKJAlenONWUKQk42d4IRlYiI402KlnCXJCVI9ZnX8qkpWmP1WXWAOEJAAstETwp5piRlSaCdvbtEpw6+/QDZ5zSAXCRmiIgEMB+V+mT50x7IiUnnQ7N5hCiiQaVgHrs4QOoCAsgsN+AVEIaaU8B3oYNCdFsh0KVn1LnaaoYospqTa6+WuCqskIYa60Q3YrrP7ru+k6vvmoDbLDEDEtsLMYe+0myynbCbLObPAttJtJOe0n/tdZWgm22k2zLbSTefvtIuOI2Qm65i5yLbiLqrntIu+4WAm+8g8xLbyD23vtHvvr2wW+/e/wLMBhMkubkCK5EMMyjA2fCpW5iCRDoL8EsTILADW9RZnzLNAUABNQY92bGlpT2G3G5pWwoO3qSXLJ0DdRHjQP31LxPAC27TImcIniW0C2BMczTlTVGOukv7A1wgMwKmNLRRyPjhKQBkYZqUS78yfVSTELnJCSP9GJsx9Rh0xoR0Vm6K7bOcKzNthtuv81G3HL7ZHbdstCN9xl67y3U3X570nfgYgxOuFGAH66J4Yp3wXjjSiUOuSWPT45F5ZZbgXnmVGzOuRSefw5F/+iiO0F66UycTgbaZfdEdryqj/F1Aa3z9Lrakr/DOuy5oz5HwX6OUopcUkbtOxoN3LJW4g93ZhIvVht/vBmD9aJbChu3gowyYLZZadfTn1E9AtenwDNHgNrJ0sr89B6+Fg3AhNwKPBfUy6CIFXpzzu+XkYAyv5jSkvokkEatKnY8AV5VhteKV8QBeCs42npMMZGKcERTiOFUbNwnrub17HkTA4Yw3OCSZSzAMCuIXsTCUaqVnIqDx4oSOWjzG4Rtbxkgq4b9ROCNB0zgNQ8gQEwS8MMGgIQ+BDgPD8mnRCaIcADkO8JO2HezGeKpiha8IhafQsWbcRGL7SANGLPYxf99fHGMZwRjGrcoRjS2UY1vZKMWq7hGOpKGfCoRIqfO142a9clLtFDAApTBgIssbQLPAMZqBJAACASjPuVDgjQIoI9IBmGKY7RiGcM4Ry+KAAMUCGUF7NhJM8aRlJskYybr6MlScjKVmlzlKVsJS1aaUh0QxE6fRObH65UjHLTARwASkqlSJKQf2iGFAFhisSQoIAIEeMAC7IMjGPLgdhySUwFbopCgRQeYEvvlZRCzHl204xsaVMI3TJJOIFRrdiKSYKUqOMOnLXMrswnmL7PzgAEE4zAKYMAAIsCAn6GpIUyAZhONUC1sYkiFYglHCWFSAnHqExwOwNp/WtLCqzz/AGvW1EECukJQJFRrd/2TwQEEVQutVDOl1BsAAQ7QAIT+KKQwjYI0sIEzKeI0p08oFQNq6lOgjsEBDUAABKJZVKM6AoGWiwBiasjQnzp1CdQAjhCbelUvUGQJUAUDSiekEXaw5KW2ExLVLoQ1qqLVa1/DkDOcApubuk6tGEIANU1q1U6MFUKhsqQ7+9rVI5BPq1yzaxP+WtgpNBSvjdUcYWsAz8hW4bE8WqtlHTtZGjB2s6brLGiDkJ12/iCsmUuILup6SdGOlrSqYAHworIKhDlQeq99AhbPmgIPPkcXCjGICJu5wdxSIWJuxR5VA6OcHIoMfMZ9QlNO2BT+mQ8y/7IhRz7ysT/XxuCzm61eT2WL3dmMo5dztG4SHDraBSgAfza9bl0KUpifLYQv0E1CZY2bgKkqgLUnkCcEuqMRQNmTt51yAntf67EWRC8lpmrJ1l7oBPA29htNQO3hMJw671rCwu6hi1a3WtW7ZpZC6xSLYE/r4Ursl0UdoytXpQZZW0mswz0B8XT0keEWR3cGSCTA8BjgUiFomHAQaCtGkPjWH5sOG03xBQH+0mQnM4HEE6tekXzcAh3bwctkSiwCDkDcwSq4xn5Y8Bii4lLaChBuUIaio6qs37gC4sVlSPIvRvXbtMxBzyZZwJvN3AQ158HQU5ChaQvSDeZq2U9W+f9hAoI4xCIeEWdNzA4BJgDgJgQ5AIN2Zz/g6EpVunGOFQglBSpgy1fKstSxPHUtZ3nLVFbgAjSywKtnDetWkxGPGNFjCr6RDc9kF5/AFSQhDVmfRL6XOeVYmnoDNmo58vrau862rLVNamxv+9vd5ra1s53LFPxpyss49ggsGk5wEBMBxjRnMqMxjDLr4cgQmQuERTY/YYrG30EkJzraEUxC4BsgAo2GWzBSYIuxW5j89Gc1giFQgl5jAobCF5dZVYuvigDCLsQnOIWZUVt0pTkdv0oAlKGAIvtr41aOXMxfPnM+HLzm4oA5ziW78zzcvOYnnVHReq5YJiCa6Dp4p53/kd7aM5+Y6U1frNDTBvUUnMkppnBSO3+eUy+xEwARo3DVu3CmNMFCQA2m4rTHngVGgV0XKEuvztmegz8NI2baGWF+6X4Ft9MwnUHHEt8HeCmlMe3NmE3S4EtAC66VPGu4PQKeF1+DxGuW8jYI/NAxn/m5c77oSwDz54ft+RMcffQZKr0JJo96F1i+9TPQPNVh73rV034HXI+57G8Pg9fzvvZOYP3vI2+E0w8/5xWe+vFZkHsrN9/Ju19+6p2ueOkTvwjCtz7yC41m7V/M9iQQ/e+f/2PyR9f8xkV/bqPv/Q6BfwTGH77Sh9R+91P/8pjX+ilSUdvrEyH+TBd2fRZc/3sneUvHeWjnDo6mP4dyf6h3Mu5wbGr3fiIgfkiHdzOjbvZXf0bgGfR1EP7HgTdgeHk3YAy3EQVoBBbYc4+3UfcRYSlYBADIe/MHNiJYXNz3dDfoeztIgQCQfdbHgyLIfkPogzcYgkfIV0nIWUsIOkbYhDgIhaGVfIJ3hELIgTVIO1bogzN4e0SIhT64grR3hfWXhUlIhu33hWX4hFCofq/lhqMFh6Alh5tFh5Zlh5+zQKygf0gohS4QILwggDHohzBwDMkwGgl4SmtHiDTwHXBXR4vIiDFgPxiodxsoiTawTX/Xh5iIAvTUFIdEDYjHhrC3Qi3YadvXiTOmiqDHiv9b5oolBoutKIssRoWbV4QOuIXBd4BgmIs9aIuzt4a0+IrDGHXFWIvHiIzJ2AN4eGGkuITNWFjR2FXTeFXV6FTXaFTZCFTbmFPdCFPfmFLhCDluRnrLCANoQYCDeI4IwxfOwYnLqG5qV22ZVI/2eI/4mI/6uI/82I/++I8ASUq/Yl6OAksBeZAImZAKuZAM2ZBZ9A4fiELsWAMEhoITWQMgh2AXuZEc2ZER4SYfwxVaZxFqAJJmESVatzAM8BosgGUrEEUrWVcxCTBQUx4HgVwcJE5VUJPhcQ0rtG4BYG/WsWIlkAr1MCDoBDDhAT1qAooHQZJi5ENM1RI/pFQAoB3/kbgES/lBNKM0T7kw+gALqgBNE8AKOIOV5eEPRlkeDSBEUVEPEVBTXZGUSLRQ6IIYDnARCIUbVJJVtZCXcBEAcPFbC0CUTICXeuk8nJKUtqAMA+ELMWMOBRdM3xAzGUGZ5vRPSalI0LEuvqBMLsWXsTEavjBQg+ELUTJnVPCZ1xCao3ExiJgOIJMOgiQCknljwVSbH7NUEpOUpYlOxyQzz4ggxORemwibEZhuo4FOOlkFxVkNitkhsWmb6QAZt/lBYHc9mJmc+tAx5vSQ6II1iSWaR3mUCUEcxlkOdjkF4nmcfekO1pkOtPAA4ZEO0ZBUiCEYbUIcmBkBD6CZo0Fx/wOlkd9idu45mtz5gi4YSFdgoNGJnNlJnS2hDJgxoc6QCx8zAYixAA6AmRs6l6OBchjhch5ZoiZ6oqiXAHeiAi6pAlGkorwFo5joDaYVH4Y5AkbZnP4miTSalh7RAGRxluChlv6gaZyWo9jwQ4UyG3VJoiLIbguQC+QBmXTxb/8WbTiDM+1GEdA2G5zJSE34cL91GOQRoZMpMfTGQxcVDs2gXcMkb6p5g2IaTPFppcFUcNgpTvtkD99pRUk4pxIzn/UpGPgpMRdnKBeFcV0aDgJaUksIqBZaof9zoTe2ctQQRO2GGAHlbyK6AE6KoqAaqqI6qqRaqqZ6qqiaqqq6qhSs2qqu+qqwGquyOqu0Wqu2+gQhAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Values for QT dispersion (QTd) in patients with and without inducible sustained monomorphic ventricular tachycardia. Inducible VT was present in all three patients with QTd above 120 msec but in none of those below 90 msec.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bogun F, Chan K, Harvey M, et al. Am J Cardiol 1996; 77:256.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10589=[""].join("\n");
var outline_f10_21_10589=null;
var title_f10_21_10590="Nitrate induced vasodilation";
var content_f10_21_10590=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Nitrate-induced vasodilation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 228px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the mechanism by which nitroprusside and nitrates induce vasorelaxation via the formation of nitric oxide and subsequent activation of guanylate cyclase and generation of cyclic guanosine monophosphate (cGMP).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10590=[""].join("\n");
var outline_f10_21_10590=null;
var title_f10_21_10591="Paratracheal lymph node CT";
var content_f10_21_10591=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50988&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50988&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Paratracheal lymph node enlargement in lung cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 260px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEEAYoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAvabPEqTwTQK4lAxKI97xkZ+6CQOcnP4elW9N1O2tHmhlsLeeCSMRb5I8yJhs7wMgbs9j2496doO6G2uLy1u5be7gdcCCRllZCCDtx2zjP1FbVmltqY1O9W4gstThiilU+aUfI++UGcs+Bk456mgDlbueN4oYIY0EcJbEuza8mT/FyfwHaqlbviSazuLfTJoI0S8aE/aiHZmZwxALZP3iME9M1hUAFFFFABRRRQAUVJHEXIJIVP7x6VI7xR8Qjc399qAGpASm9yET1PU0CRUUhEUn+83JqN3ZzlmJPvSKpY4AzQAE5pURnOFGa29E8PXGoygFWVMZJr0PRfCOn2QH2pQ75zyxFAHD6J4SutRCO2UQ4JJXtXoWgeBrW2ZZZgJEA7rjNdLbw20aKIgFgHGB3rpPDGjTa3ceRHEHxyFGQFHqaAMvTbaGPaLW0iEQP92un0fQdQv5wsNo+xuQ2zAH416h4a8G2OmW6G7iSa4z1PRfYDvW7f39vp9uduzcBhUFAHBQ/DRrlAb65RCedqpnH61o23w3tYEAS8PA6+UP8AGtCbVLu4G4O0QHZeM0kepXQGC79epNAEUPw80oyK15JLcgfwn5V/StB/BHh8rhNOhQ4xlRzTP7Sl+XczcdcGi01G7vNR8uNyIQpYnFAHm0vwpvbzxXclJ0ttJjcFJCuXfgZ4z65FeuaZoGmadAsVrZQqFH3igJP41eZ/LjyevvTVlwcE/rQBga/4G0DXFb7ZYRhyNu5BtIrzuX9n/QjdM8d0wQtnaY84Hp1r2YyAcU4MCM9KAPLLf4MaRbygxyLtUcHyv/r1db4X20RVraeMMo6GLH9a9HzVW4klX7gBoA860TwfDLqtza3y7PJ5GF+8PWusk8HaUybRFt960LxdyrcJlJkH5j0q1b3sU0IdWAPoe1AHAa38KdKvmMkSwiXHGY//AK9eU+KPhxqukSzSyactzacndAMkD3FfSkl4sZwRke1MW/gc7XYDP940AfIsfhLSdRRgUMZ9MYIrlNe+HG2ZjYT7lx0K/wD16+1r/wAL6HqEvm3OnwPIf4hlT+hrzvxv8PxabrrR4i1uBloskkH2oA+LtT0e70+Z0njYbSRnHBrO6GvovUtHhuS0FxCjrzweorhPE3gKIoZdM+UjkoT0oA84hvZY4zG22SM/wuMilEUU4ZonCSdfLI4/A0y9tJbOYxTKQwqCgBXRkYq4IYdQabVqGZZXC3ZLKeA5PK1HcwiGTCuroeQw70AQ0UUUAFFFFABRRRQAUUUUASCJiX6AJ94k8Cuz0bwrDdeF7XUm0/Urx55JFLW00aKgXHYgk9a4ouxXaTxnP41YnvZZrK2tX2iK33FMdTuOTmgBt9ClteSxQyiREbAcd6gBIIIJBHcUlFACnk80lFFABRRU8UBZDI52RDqfX6UARIjO21ASanj8mEHzVLy9lH3R9aY02AViGxfXufrUNADndnOWOaERpG2oCT6CtPSdEutRddilYz/ER2rtNM8NW9ku+RgzAdx3oA4+w0C7uOWQqPc122j6JaWcKSz4LjBxirKp+/wcbQOtNuLyFeCwXHAAHWgDcj1COMBAFCqODUU3iGOMhm2BV45rlLi/kkcpCpJ7muo8DfDy58SxTarrV6um6Lbn5pXX72MEgZIoA6zwPZ3fie8iMEW2zVgZpm4CLnn9K9htPG/hLwvImnC4WBFGGkOOT69a+cPF3xaistN/sDwRbpb6dGoQ3LqfMlxjnr3xXkuoapeahOZbuZnc9yaAP0HX4keEXkVE16xYsu4YlFeT6r8aPCkmoozXN2wWTBMcQIxnrya+RxM4/iNN3nNAH6B6N438Oa5pputNvonRVw3mYUr9axdf8c6ZaSLaQTJLNIM/IQRXw9HfXEcZjSZ1Q8lQSAafDqV1DIskc8iuOhDUAffPhDVLS+JW6YJIOgY9a6y0lsEkMcMkYfqRu5r89IfHHiCF1ePU51ZehDUyTxnr0l4bt9UuvtBGN/mHNAH6MyeXIApZcD3pjCCEb5JFUDuzYAr88oPH3iSF9yavd59TKT/WotQ8beIL8AXeq3ci+jSsR/OgD9CJNc0mJgrX9qGPQeYtWob61nXMNxE46/K4Nfm6uuX4fd9ofPruNXoPGeu25/c6lcJ9HIoA/RsFTyCD9KGUN2r4A034ueMtOZTba1OMHOG+Yfka6Jf2h/HaqB9rtCcYybcZoA+25UDRkYGaqPaK+1gQGHXBr4guvjv48uInjOsBFc/wQqCPocVjWPxY8Y2Wopexa1OZV5w53KfqOlAH2/rk0enEec5ORuFcFqfjXTra6MbSsrZwMivnfU/jt4t1KNFvDYuy/wAYhIJ/WuR1fxxq+qXZnuGhDdgqYA/WgD7h8GeMLbVbhbRXyzD5PwFdbdXiwfMyMyjrivgPwr8UNf8ADmow3dobaRoyTtlQkHIx2I9a9j0X9pcXkkcet6RDBnAaSBiR+RP9aAPavEfhKz1yOW808BbpgW2nA3H3ryDXdCurC6kS4ieM9K9g8K+L9D1q0ju9F1K2nEx+aPdhlPoR1pPiVDaXNmqxun2/BZEB5cAcigD5s8Q6Jbaj8l0m1yuFfHavJvEHh270meTdGWgBO1wc8V7PqOqwF3R0dJFONrfwmuZ1C+S4iljmjVkPBBoA8iqSGUxt0BU9Qe9a2u6SLRjNbMXhY9MdKxaALDwiQNJb5KDkg9VqvT43aNtyHBpW2uCyjae6j+lAEdFFFABRRRQAUUUUAFFFFABRRRQAUUVbtgtv++nTdkfIp9fX6UANgjiVTJcHj+FAeW/+tUMkjvgMxwOg7CiWRpXLucsamsbOa+uEht0LsxA4oAgRGdgqAknsK7nwn4Na8QT3ylU6gHNdH4P8Jppyma7VRMfXBxXSSzqk8iK48sDHH0oAxZY4tPgSOBAkajBxWVHdkCSedjtHCKxxmptc1KNiY41JPascade6ioPlkRDqc44oAhvtUlmL+QSM8cHrU1hpbiFJrovlueT2rf0yzsNOjBuHUBRktXF+KvFP9ouY7IOkQ43N1P0oA6VdY0Pw+xnmiW9nxhLdX4B9WI6VyfibxprPiCR1uLuWGy/gs4XKwoPZc4/GubJJOTyaSgAooooAKKKKACiiigBaM0lFAC5pc02lAoAc/AFNzQeaSgBc0ZpKKACiiigAooooAKKKKALFpeXVnKslpcTQSKcho3KkfiK6XQvG+s2utW95fape3Pln70s7OR+ZrkqKAPqObTdO8c+Hxr2iNEdQhUC6hjb7/X5setef3NjC+TEQDna6E5IP0rl/hN4+n8Da55zCSWwmws8S9ceoz9a9F+ImkyhB418OK1xoWoZmcrjMTEnIIz65oA5e40wBDHIoZc4Oa5bxB4XeJDcWSZT+JR2rrLHW7XUIgPnWUcn0Na1rJHtfJOGGVxQB4ewKsQRgjg0AkHI4Neh+KPDJvUlvbBAXALsvTNefSxvE5SRSrDqDQAu3eCyDkD5gP51HT4pGicOhwwqWWIyI08YymfmH900AV6KKKACiiigAooooAKKKlgj3kljhF5JoAdFFiMzPjavQH+I1HLI0rlm6mh3LnnoOAPSkjQu4VRyaAJrO1ku5ljiGSTivXfC/hxNGtFmYhp2Ckkr0qj4D0GG1gSe5T96x3Ant0rrbybzGWOMkgccd6AK1wTIA+7AGfbmqEiYD55B5J/pV9tgK+d8vHIqjNPG1w4iIZRzmgCnY6Qskv2m8f92PmIA/So9b1VLWER25VY/b0qPWdWjt4wrOQgXOe3/66831bUXvZjhmEY6DPWgCzrutS30hjRgIAeMd6xaKKACiiigAooooAKKKKACiiigAooooAWtrS9AvNRR2t0LJGpZiOwFP8M+Hb7WrhUs4GfJxnsK9GPwm8WadZvPBKyK52MkchGR70AeQSoqM655Bxmoq62+8F6xb3DJJZylhyTjNc9qFnJaSFXGPX60AU6KKKACiiigAooooAKKKKACiiigAr1D4XfEuTQdPn8N62i3Hhy9VopAVJeDeCCy89Oc4ry+igD1Lx94Nk8I6uj2VwLizl+aGVRwwrMs9cljO2cA46cVhab4mvfsiadqNzLcWCtlFkct5Rx/DnoPatuGC3vo2aHaVx2PegDp9EvFuotqOAWBAB/lWF4q0BL22a4tl2ToeVA61k20txYXBRWYAHKnNdN/bGxgSRuPJHagDyuRGjco4wwODSxSNGTjkEYIPcV1virTortTfWYAbHzqP51x1AE1xD5RDI26NvutUNSwsCfLkJ8s/ofWmyIUYqfzHegBlFFFABRRRQA5EaRgqDJNSTsABGhyq9T6mnZNupAP7xhhv9kVXoAVQWIA5JruvBuiBHEt4uGdcotcroEIn1a2R/u+YufpmvX7WKATeeFwirhfegCZBKQphBCIcHNPa7jtUdxy+3APaopbwHMSBVA5wPWue1vVIbWBRuDt1IoAtanqQghWZzy2dvPNYUuq7kGzIXq7GsXUL+a+mQYG3sB2rN1K+fa1shGwfePcmgB2t6sdQYKgKxDseprJoooAKKKKACiiigAooooAKKKKACiiigArq/APhwa3qObjK2yDJP9456VzEMZllVFGSxAFeq+CcWc8EDfIoGDn1oA+i/hl4es7WxDxQhUXAA49K7TU4fMUKMfezkVxng/XYINPiijdWyegOa619QtxgySqBmgDLuNGWeRZQnzLwQO9fP3xV8BzTX+p3cEIQksyrkDJr6dtL+0lX91IrfSvLfiRdK7zxb1XJbJoA+Opo3hlaORdrqcEUyuq8caT9kujco25HbB4rlaACiiigAooooAKKKKACiiigAooooAK2PD1+bW48tmwrkYz0BrHpQSCCOooA9TaJL+HpztyMetZl1byR7GKZXOPrUXhy/wDPsoyWxIDgj1rbYmfdFIoBPzDH9KAKMOIYwW5XgEGuU8T6W9vctdRDNvKSwI7V1N1bSCNwG5x+dMgtxe6Y1rNw21gCfXtQB53U0YEi7D98fd/wp9/aSWVw0Mo5Hf1qtQApBBIPBHBpKmI85WYH94Blh6+9Q0AFP4Rf9v8AlTlbyc8fvPftUVACk5OT1o7UlFAHW+CNPD3AuX528rXb6xfRW9qqtKiZ4wDgnFedW2tPp1isVtxMRy3pWXcXl1ey5kkZ27CgDptW8R4LC2c7jxwaxLSK51CcEl3Gckk1u+EvBV/rFxHvhYIx46c17L468LWXgL4TvcTBVvrsJHGON3JBP6ZoA8C1J1s49sR/evxnPKisU89adNI0sjO5yTTKACiiigAooooAKKKKACiiigAooooAKKKKAPof9l74bWPiGSfXtahE1tbOEgiYkAv13HHXFdj8fPBmm+HtMgv9EtTbvLI3mbWJHQep4qX9lPxlpk3hyPw2z+VqEBZwGwBICc8etdh8cr+2bT7az8xGkIk3JnnkACgD5k8O+J7yK5WFLiRXLYG1sV9XaB4fjksEe/Jmkxn5ietfImnaBqlvq8d1HZyPCkm7PtX2d4d1FL3T4XUnJXkHrmgDNv8AQoY4ZPsYMc2CRtJFfM3xA8RXtl4kvbO9diEZlBJr61vLuK3V5JJFVVGTk18s+OfD91428fXKaUokQyEF8gADNAHC3F9BqcLRXLKwboc9OK4/VLFrKYDIaNhlWFe1+Lvg1qXh7Tft9g/2ryhl1yAR715FeyTz7oWQ5zjb6UAYlFWLq0ntSPOjK55Gar0AFFFFABRRRQAUUUUAFFFFABRRRQBqaBdi3vFVydjn16GvQY87S45bbnIrysEggjqK9K0O/UiHJOxhkflQBZhbMiFyWByM1bhgAUnHGCARVOcxhCy5BVt1WrO4MtswThOTzQBz3jKyjltUZBmZT171whBBweDXo988MVzGLp2Cyetcd4nhjh1M+UQVZA386AMkEg5BwaSiigBaSiigAooooAkhjM0gUdScV6h8Lfh9LrV4Z7jKwIuc7c5ORXIeDtKOoarZQqm5pplQD3JAr7i8DeEbfSNJgjWEKxTD0AZXgXwHBaL9od/lRgFG3tXzr+0541bxB4xbR7Vk/s7S/wB0u0/efuT9OlexfGr4vQeDXuND0Vo2vxHglWz5ZI4z7818czSyTyvLM7PI5LMzHJJPcmgCOiiigAooooAKKKKACiiigAooooAKKKUAkEgHA6n0oASiiigDQ0LV7zRNUttQ06UxXNu4kRge4Oa9Z+HOv6h4w8YzXevTGfEZJHbqBxXM6F8F/iFrQRrTwvfRI3O67224x6/vCDXT6N4cvfhj4tXTNdvNPk1Ga33yW1pK0jW+SNokO0AEjkAEnHJxkZAPd9O020DbYUUR4zyKl1SW4sbSSTSgpkjBIQ9DWf4duZF0l7mZgIuSXY8YxWHr/jjR7e1cJqlqHXgBJVz/ADoA8i8Y/FPX7y4ntpBFbgcEIGB/nVj4Q+Nf7I1kS3+1kkPLEnvXCeKYzqGp3N5busqsdx2GsmzJQjBIYHtQB9feL/iRotto0yxTxzyyKQI8+1eZeA/Dmk6yl1dzxhndgQMfd61ynhzwNP4g01rne4YcjJPNdr4btBoYFpBOVkXlwG5oAw/iz4es7ZYViRVLLtJA6ehrxC4iaCZo36qcV7V8Q7r7VHM2/dgHHPSvJtZRTHBMMZPBoAyqKKKACiiigAooooAKKKKACiiigAra0i/eOHaMExHIz6GsWprSTy51Y9OhoA7bS9RW5V0m2hj6VqWKPscK3ykEkCvOWnkt7ksjEYOetdb4f11CoWeQA7cHJoAva7pUl7bRSRudy9q5rXNKmVUuFyyhAG46V6Hb3FuUDiaPbjDcisma6jNybclJIXHY5FAHmVFaGuWn2TUZUUYRiWX6Vn0AFFFLg4zg49aAEp8fJx61LaiErL52chcrj1pbVQXyKAPYf2dNLe+8d6WCAUhcTN+FfTHxo8e23gHwv5zZa8uN0dui45OOp9ua+dv2e9Wg0bX7y9uCoS3tGfJ9hXE/Gb4g3XjvX1kchbO23LCg98ZP6CgDjNd1S51rV7rUL1y9xcPvZjWfRRQAUUUUAFFFFABRRRQAUUUUAFFFFABU8V1PFbzQRyusM2BIgPD4ORn8agooAK67T/B/2Wyi1Lxdef2Lp0ih4oim+8ul/wCmUOQcH++5VfQnpSaZ4j03w9YW76Bpvma6VBl1K/CyCBvSCLlQR/fbc3cBK5q/vbrUbya7v7ma6upm3STTOXdz6ljyTQB9Y2H7SmjWfwvlWztrlfEdmq2VpbXbeaZQFwk7uqqDgDLDA+bgcHNeA+GDf6vreoa7rV2TktcXV3MeWYnP4knoBXFWcRnu4IlGS7qo/E10Pi6+WNYdKtTtht8mXHG9z6/SgDY8Z/EjU9ZBsbK4kg0uNRGkY+UsMc5x681wjSMxySTUdFAGho2pSabfRzoSQp+ZfUV180Nnq+qfa9NiaOGT5tjdj3/WuCFeqfDnTi2lwTsNyuzYH0NAHceA7bWFk8qyB8kj5lzXbReA7qe4lupGxMQO45rpvBWn28FuJIlCsw6Yrso1Urjpjn60AfKnxH8G6zppuZfs7NCcncCDxXj+pK8cSRyKQwOea+8fGVlHdaDeLKFIETHJHtXxL4+aP+1zHEoAX070AcvRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAE23fCzk8qQKiBIOQcGpbYgv5bfdfg1HIuyRl9DigCUXc4QqJX2ntmpLbULi3+5IcHsaqUUAbGoX0eoWSl22zx9j3rHoooAdGu+RV9TivXdK0nSIfDbpPaI0nlhvMJOSfzryEHBzW9J4infTkt8kFV20AZmopHDfSpF/qwelNtTydoxzVYks2TyTVmzB3H1oA1k1SWxsruOCRkaePYSpwcZHFc/VzUD8yL3xmqdABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAXtFkEOpQzkZ8kmT/AL5Gf6VUmkaWV5HJZmJJJOSaaCR0pKAClpKUUAXNLtHvb2KCPlnOK+hPDmmRWuk21pBjbEvOD1JJJrxHw0rQB5yuC5CqxHbvXufwpQ3qnIBUHvQB7D4cVltYwPlOzoa3lLbeetU7GIRFVx2yfatWGP5znkEUAc34mFzcabcRJ/EpHXqMV8VfEC3ktvEl1HKpUq5GK++57VWVgyAqV6ntXyv+0n4dis5rfUoI1UySeW5UYzwTk/lQB4PRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACgkEEdRVq5izCs4z83X61Ur0PwX4OuvEXhu4nggd1j3YbHGRnigDzyrdlbLciQbtrqMj3p+rabcaZdPDdRPGwP8QxVJWKnKnBoACCCQeopKU80lABRRRQA5Rlq07O1kHzkcNS+GtNbVdXt7VesjACvp/wb8HLG6tWivPNG4fK4I+U4+lAHytqYK3O0jG1QKp11PxH0aTQ/FNzZyrsZDgiuWoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA0dF0e81m4aCwRZJQM7M4JHtWnN4P1W0ga4voRb26nBdzWPpWoXGmXsd1ZyGOVDkEV6R4w16LVvhzaPFJ+++2Ksqk8/cY0AcnozSTvJDbruiiXOf61798DrOQ6YZCBtLnBPbmvBfBcwhlus/xKB/OvqP4RWiReHYzH/wAtMk5+poA9Fth+85GR61oRAg579MU2GL+FQARVgIGY89PSgBJi3lN9K8I/aAsReaDKpxmM7wCe+D/jXvTcoy+1eWfF/RxdaKSOCWxn14NAHxQ4KuQe1Nq5qtubW/mibqrEVToAKKKKACiiigAooooAKKKKACiiigAr6x/ZltzcfCvUQMbvtEmD+FfJ1fVH7ImpLLoOq6U+MCTePxGKAON+PXhk2+lpqSKMicIx9QQf8K8Jr7g+MfheO/8ABtzbqDlTvB+ma+J76D7NdyxH+FiKAK9FFFAGnq2kT6bDbyTD5Zl3KazK6nVY7vUrW1Rgf3S7RmqH/CP3Y5KdOtAHT/A6NZPiHpYkAKb+4yK++rS1hhUGJFXjsK+EPhSq6N4z0y6uMFFlAbnGM196WsgkgR15VlBBH0oA+Pv2vNGNn4ytL+OErFdQ8uFwCwODz69K8Ar7Y/ay0FdS+GrakoXzdNmRyT1KswQgfiw/KviigBKKKKACiiigAooooAKKKKACiiigAoop8LKkqM6B1UglT39qAGUV0HizVtL1Z7R9K0gaa0ce2XEu8SN69BiufoAKKKKACiiloABUq5xjnFMAq1ZKDdRBuV3DNAHR+BLSS4vp9qkqseTx+VfVfwkiYeGLdHVlZQx/U14z4etLLS7Y+VHtkuMDJ7/5zX0P4AtPI0C3XPVc/XmgDpbYMp5Tt1qyjkc4psPGQeakdQx4wPxoAjk5OcVx3xBiM+mPvU7Qe30NdjjC+1cb47jll0srGQDvHLHigD4q8dWzWviK5RhjJ3D6Zrnq6z4nAr4suVaQSEAAkVydABRRRQAUUUUAFFFFABRRRQAUUUUAFesfs264dK+IdtAxzHdAx4968nro/h7qZ0jxlpV4M/u5lz+dAH6Ea7ZpfaVPCQPmUjp7V+efjq1+xeKtQt/+ecrL+pr791vW4rLwvd6g2MRxk9e+K+AfGs/2vX7i5PWZi559SaAMGiiigD3ybSoVjy0a+WuDuUdfemraxNHgKp45x61svb7ivlqfJbC4FNvLUiGRowGK8gKOtAHE+JtP/sq4heLIyd+fQ8V9Z/CDXTr/AIHsbl33TIPKkP8AtAD/ABr5d8aqbiCzgj3GTHORyOleg/APxSmh6nLo983l29wQUJ6b+lAHo37Rd1GPhNrsTEZdYxj/ALaKf6V8Gnqa+5vjwIbr4fa7b5zMI1dV9QGByPyr4ZbhjQAlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRSgUAAFOApVWr2madc6hdJb2kDzStwFRSTQBUVa2PC9ml3rlpDM2yNn5b9a9O0j4K6kbZZNS3pMRu8mNCxAx3qy3wsvLFGl+zzKB/E0ZGKAJ9UuYDq9nb2xVliQZx65r6C8ET79HgznG3n2r5bh0ifTNcSOFzKAPmZa+iPh9ehNMggkfEgH3fxoA9IjABBApzng4qvbTeZtPbpVh2HbGPWgBhXrluOtcv4slVrEgkYXLH8jXSuf3ZY9cHgV498b/EaaJ4bnbdiWY+UgB7kGgD5V8Zztc+Jb+Rm3ZlbB9s1h0+Z98jMepOaZQAUUUUAFFFFABRRRQAUUUUAFFFFABU1m5iu4XU4KuCD+NQ1JbrunjGM5YUAfTvj/wAbfavhzFaxTEyzTAEd9oB/+tXzZq0jS3RZ+tdHqF+fLSJmJ2rwB2rm75GebKKTx6UAUqK6XRfDj3SeZMrAYyBjrXP3SeXcyoBgK5XH0NAH0k0l3aXccCIX6Egf3qsNZyAF5GEYY42ng17n4g8J6deI86QeXOF4MYxXm9/YFAXLqxGFG4fzoA4saS0s7SNtm2jCjNcrqUUlnqMrxEq8ZDA+h9q9T8mBQW2tE2OxyK4rxFBF9tkPJDDketAHYal4ltvE3grzJAWuYrYQ3C9ycAZ/PmvlDVLc21/NERwGOPpXp+n6k+j3siBpPLchZEzkEZrlviFYRJdx3tnuME+Sc9jQBx1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFLSgUAGKeq0KKsW8JkcKoJJOABQBZ0fTZ9Sv4bW3XMkrBRntk9TX0z8J/hqbMxvbruuiMy3LD5V5HA9TUfwY+DLNZW+q6009u8qK6opAO0jPccV9HadZQWFpHbWybIoxtAoAZY2EVonyrlyBuc9TViaCKaMxyIrIwwQR1pzNik8xVXJ4HrQB5b4p+GtsL+fU7DaiFctF7+1cHomrLZarKu4giQqq/Svo50WaFlb7rDHFfF3xCluNA8c6pAGkVI7mQpn+6WOP0oA+k9E1lJYky3JHJrf8AtClCRn1zXzL4c8ey27xAyFk9DXo9v8QrUaXJc3l0sYA4XigDvtf1u30vTZri6faiIzHnsOa+Pfi747/4Sq9EFrGUtIXyCWyWPTNL8RviXqniO5uLeKcx6fkqEAHzLnua83Yknk0AIaSiigAooooAKKKKACiiigAooooAKKKKACtDRYTLeK23cqckVn19AfBj4TLrPhqPXNTkkjhmLeWi4+YAkZ6e1AHkzwSea00o4qzY22/52Ax9O9e2/EL4fwaf4fuby3QoqOCB68GvKdHtl58wH2x60AdBpUP+hRyO6p2wT6V5NqIJ1C6ORzK38zXrMEUqxfMAXU5wOcCvKNUJ/tO7wuP3z/8AoRoA/SS3l82IFlI9iK4XxZoEiO88GTAwORjIU13SMNinHYdTTZBFcRPE+1lYYIoA+fbqaexnZZImZNpBA7n1rntRv7SbfHJHtlCdCuP1rtfi1aJol3assUhifOCG7ce1eW3V0vmyyNC3Dd+cigDF1BbeaaPY4ZyRjI/StO40GLULR0iCybEDMgG7Gf5Vj3xh8y3kiGHRwc+vNe4fDfRFvdHOo6fFCJN2ZQ3Jb2zQB8n6/pcul6hLC6MEB+UkY4rMr69+KvwufxRpTano8ca3Kr+8iOckgduK+TNQsprC5eG4Xa6nBoAq0UUUAFFFFABRRRQAUUUUAFFFOoABTgKQU9RQA5Bk17d+zP4Pj1/xS9/e26zWdiNxDpuUv26/nXi0KbmFfYn7MXhXUNE8MvqF4USG/Pmxx/xYwACfyoA9ujRURQoAAGAAMYoY4pwNBUMRkUAHGKZLGJEII4NPxxSigCKFdnyjpXg/7TvhBLnTI9dtLc+ah2Tsi9uxOP5179isXxnpi6x4V1awK7mntpFUf7W04/XFAHwhLpjQCMpcI64ydp5Fcxf3byyMu47QehrqtbtJ9MmuDOhQxsU2n1ripTuYn1oAiY0ynGm0AFFFFABRRRQAUUUUAFFFFABRRRQAUUVe0PS7rWtWtdO0+PzLq5cRxr70Adj8GfA8/jbxbDAYXbTrdlkupAvyqvOAT6nB/WvuKHTYLHTYLGwhSC3iUIkaLhVH0Fcp8GPAEXgLwz9lcpJf3BD3Mq5wWHQD2GTXfTOsUbO5wqgnmgDy347X8Vh4SS2DhZZ5AoXGSRg5r5201EkBXa7PjIyMCun+LnjMeIPGq20WRawExrznd71zsShbhiHCADHPNAG/ZQCJNqeUAy43dea8S1MMupXYJORM4P5mvVV1T7OUihBZzyW7j8K8jvpGa+uCepkYn86APqbU/HPiGeyUW+qEAqOVRB2+lZuj+MddtrhZort3bIJUkHJ9K5aC+VPJaaIbGUZIGcUh+xeX50G5XB6A4zQB7d8Q5bfxP8N4tRO5ZYiGO3qrdCK8DZZQjpFMWxyA3evYfhTd2+pW19o10xa3uoyyLJg/Nx0rzPxf4cn8Pa1c2rSfIjbhnjIPNAHKazbT/ZWMqfdwQSAMV3nwI8XnQtXNvdSt9inG1lJyAcjBrDVGlgHmKZYmAUjAPH0rk7+1bT72XyldV6qSuKAPuy2C7RLbkGGQZwOhrw/4+fCKy1HRbzXdEjlXUIgHaFMbWGRnjGelXvgB8QLe90ldH1W5AvEciHcD8y4HGfrmvbQishRl3IR0PIIoA/MqeF4ZGR1KsDgg1FX1/wDHn4Lx63Guq+ErGKO9QN59vCoXzemCAO/WvlDWdIv9HvpbTUrSe1uYzho5oyjD8DQBn0UUUAFFFFABRRRQAU8CminCgBQKkUU0CrEETOwCgknjAFAGp4Z06TU9as7KAZknlWNR7kgV+iOjWostMtLVVA8mJUAHTgYr5y/Zm+HF5baq/iLXbAxQJEVtUuIyGLkj5wCOwBGfevppcdKAHCgdiKToM9qry31vECZHCj3oAs4payR4h03dg3KjnHINaUU0cqho3VgfQ5oAk45oIHSikBBzQB8zfH/4f2lkb3W5rsw2smSigdZMHAr5emADHFfbf7Uls9x8L2dVLGG8jc4HQYYf1FfEs4wxoArmkpW60lABRRRQAUUUUAFFFFABRRRQAUUUUAFe5fs1aPp9vqcniPUiTNbEx2yZGMlSCSPoa8OUFjgDJr3L4P8Ah7Ubq9tWEDpaKD80gIHQ80AfV2g6k2pRvIEKxg4UnvXCfGXxumjaTc6dZyj7ZNGysRjKgjFZPj74m2PhOzXR9IZZ9QEfzMoO2Pt+deELcSapetPdsZJpnLtkZyScmgDKfSbia6ivHf5i2c+lbK2u1x50zMzfdC1qm3ik/wBceF6elRMIoWR1BPOMCgCz4M8MS6zrkUMIk8vPzOewryHXrAQ65qMSE7EuZFH0DEV9W/BJg+la1dOg3xMdvy9BjPFfL+tNv1m/Yscm4kPT/aNAHp0Ny0ukqJVBJUMAVBxxWekpRNuxWAORjipbG6xbRpLAp/drhl7jFOkbaVKfMoIwM8gUAWNA1oafeJPDujliIPysR3+ley32l2vxO8OfbbfEGpW58ptx4bAB54968RcI5lAjJzyARWt4N8a3nhPWozBIxtJCBNCR1H496AKt/YT6RcGJ42C5wwZcFT61lanI12nlylRIPukjqK+ntV8PaV420eK+spAHmRXVx057GvHfGPwz1awP7uMSpklSvagDxyzv7vRNSSWBvLlifcrKcV9Y/Cn4q2Xii2trK8UW+pBFQ5bIkOMZH19K+ZNc0a5gV1uYpElQ85Fc3YajdaXexXFnO8VxC4dGU8gg5FAH6KA98VxHxF+Heg+OLRo9RgSO9xiO6QYdfT6ivLfhF8bzd3A03xfcYdhiK6KhQTkcHA/WvfE8m9iWeCQOrDIZTwaAPh/4gfBXxT4QtpLyeGG8sE5M9oxYKM45BAIry90KEhhg1+jOpXFzbROJsNERgq6AqRXz38R/AekeIL17iysRZ3ABJa1IVXPupH8sUAfNFFbniDw3e6PdvHLDJsB4JFYhUjqDQAlFLikoAcoqRVJ6V0Xg7wbq3im7jh06H5CwVpXOFXPcmvojwr+zhpUVqs2v6ld3M5GfKtCqL+ZUk/pQB87eFPCmr+J9QSz0azkuZmPO0cL7k9AK+nvhX8BLfQbm31PxPLFd3sTLJHbxEmNGHIySBuIP4V6d4R8O6Z4S0t4NOs49PtFO485dzjqzHqa1JdcskiV3uVjVuVB+8aAL8s6wyxwRpukboo6KB3NSQRMGZ5CC59OgFc5c+ILdSX0+PzpT1PetrRbua7slluE2SE4IoAvy7vKfZ97HH1rwDUvFt9Lq15ZaxmFoZSApyOM19AZ9ua8l+PfhpLnQRrNogS6tCS5Xjepx1+mKAMG11WGQjyZx7grmquo+Op/DUSz2j73DY8tjw2a8ZsNb1B71IIZMMzBetfSvh74VacJLa71lpbqVPnMTEFCcd+KAOm+G/im58V6Q15c2RtcEAckh/pxXXVBbwR20SxW8axxqMKqjAAqXdigDD8eaCPE3hPUdJLKrXEZVGboG7H86/Pzxbod54f1u607UYjHcQMVYH+Y9q+/LHxIZPFFzo91FsbG63kHSQY5H1HNcR8bPhJa+O4m1OykaDW4YfLTp5coBJAbjOeTzQB8Nv1ptaOs6bc6XqNzZ3kTRXFvI0UiMOVYHBFZ1ABRRRQAUUUUAFFFFABRRRQAU5EZ2CqMk1NY2k97cLBbRtJI3QKM16p4G+F2p35M9xbSQQIAzPKMZ+lAHLeHtBWOBbu8KiPvXd3vxPltNPXS/D6CFsbWnOM4x0A7Vh/ECybTJvsUUm2LoAB1FctaWMQVmj8xpe3FAF+2ludR1GT955sh+aSRzXWWQjt1jLP8AOB/D0rmtCs5LV5T5TszYzngV00UR+zYlQJ8pPHagC7aS22XLo0hHOWOBUU19C8ixQ2oLk9m5/Co9PtWud0UbswJ/hHavVfhN8P7cXE2ramjOqkeSrYx3yTx9KANXwnay+H/hvqN1cxiGS5jdo05yOCBmvj+/uC19cMQcmRj+pr6N+L3xAefUpdG05sW0G5DtAwSOK+Y5XLyuxPJYmgD1O0kk+x2rbznYv8qeXb96NxwKKKALcUpaPJC5xjOKzNSB3CQM2760UUAd74C8Qalpc1t9kuWVXI3Keh/Cvo7w3fy6nYh7tY2OOwoooAyfFuhaZdQTGayt2JHJ8sZ/lXyZ470ezsryT7PHt59qKKAOUuLaNIFdcgkZ612Hwr8b674c1JLbTrs/ZpJAWhkG5STx0oooA+0NJnOpaTby3SRs0sYZgBxkioZ9F0/zFP2WIZzkBRRRQBh6r4S0W7lZZ7CFh/uiuH1v4feGo4JCul22Qevlrn+VFFAHmPirwto9rPFFBZQorZzhB/hXK634Z0y2h82KABvwx/KiigDQ+F9tHJrsUZGFVgQBxjmvsDw5CkOmQ7BjK5OaKKAKXjSGOXTwZFDFDkZFeLaXpUN5es00k/DZwHoooA9X8EaDZWkQmRXdyP8AlociuyjVUXCqAPYYoooAk7VDf2sF7ayW13Ek0EilXRxkEUUUAc3beAfC1vCUj0Kw553mFS3/AH1jNdRDEkMSpGMKoAAoooAcepri/Hl1KLZolYqh64OKKKAOZ8IXUj39vG4Vlycbhkjjsa9XhYsgzRRQB5n8a/Anh3WfCOs6ndabAmpW9tLOl1CoSQsqkjcQPmHHevha5QJIQvrRRQBDRRRQAUUUUAFFFFABWjoNnHf6nb28xYRu4U7Tg9aKKAPuLwv8PPDHhbSkn0vSrc3IUHz5lEj5I9TVm4gS7V2mBIVchRwPyoooA+TfF7G68Xao03JW4dV9gCcVe0W1iEcr7ckYxmiigDZtII53VWG0bv4eKp6woW6WJSQp6880UUAeofCjQNPu7qL7REZABkqTweO9egfEO7k03RUtrEJDFJ8pCDGB7UUUAfOviK2his9SkWJTIA/zHr0NeKnqaKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows right high paratracheal lymph node (arrow). This indicates an N2 lesion, provided that the primary cancer is on the ipsilateral side.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_21_10591=[""].join("\n");
var outline_f10_21_10591=null;
